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Chapter 1 Introduction 
1.1 Abstract 
This study characterizes Pur-α structurally and functionally. Pur-α is a highly conserved 
RNA- and DNA-binding protein involved in a multitude of cellular processes such as 
transcription, replication, cell cycle control, and mRNA transport. No homologous 
proteins with known structures are available. 
X-ray crystallography is often hampered by the lack of diffraction-quality protein 
crystals. This study demonstrates how this bottleneck was overcome by the combination 
of iterative use of sensitive bioinformatics tools and structure determination of a bacterial 
homolog. The identification of three repeat regions (PUR repeats) in eukaryotic Pur-α 
enabled the detection of a bacterial homolog, which corresponds to one PUR repeat. The 
crystal structure of Borrelia burgdorferi Pur-α was solved at 1.9 Å and was employed for 
precise domain boundary prediction for the Drosophila melanogaster ortholog. 
Therewith it became possible to obtain diffraction-quality crystals of eukaryotic Pur-α. 
The crystal structure of D. melanogaster Pur-α repeats I-II was solved at 2.1 Å and 
shares a highly conserved fold with B. burgdorferi Pur-α. One PUR repeat has an overall 
ββββα− topology, and two PUR repeats interact with each other to form a globular PUR 
domain.  
Small angle X-ray scattering (SAXS) analysis together with analytical size-exclusion 
chromatography provided evidence that dimerization of full length Pur-α requires PUR 
repeat III. PUR repeat III is proposed to form a PUR domain with a PUR repeat III from 
another Pur-α molecule. Surface envelopes calculated from SAXS data comply with this 
dimerization model.  
DNA- as well as RNA-binding properties of Pur-α were examined by filter binding 
assays and electrophoretic mobility shift assays. Structure-guided mutagenesis identified 
the β-sheets of the PUR domain as the nucleic-acid binding surface.  
To assess the protein-binding properties of D. melanogaster Pur-α, a yeast-two-hybrid 
screen was commissioned and evaluated. It confirmed the self-interaction of Pur-α and 
yielded Arrestin1, LaminC, Eye and Cka as putative previously unknown interaction 
partners. 
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1.2 Scientific background 
1.2.1 Learning and memory 
The biochemical basis for learning and memory is the ability of the nervous system to 
transfer neural activity into persistent changes in synaptic connectivity. Activity-
dependent synaptic plasticity is established by long-term potentiation or long-term 
depression of the synapse (Steward and Schuman, 2003). This requires regional and 
temporal regulation of protein levels, substantially, but not exclusively, attained by 
localized protein synthesis in the dendrite (Schuman et al., 2006). The observation that 
translation does not only take place in the cell soma of a neuron, but also in dendrites, 
was groundbreaking in the early 1980s (Steward and Levy, 1982). The process allows a 
fine-tuned, spatially restricted gene expression in quick response to specific stimuli. 
Local expression of proteins requires the translocation of specific mRNAs from the site 
of transcription in the nucleus to the sites of translation in the distal dendrites. The 
delivery of mRNA is achieved by active transport with molecular motors (Kindler et al., 
2005). 
 
 
1.2.2 Active transport 
In contrast to passive transport (diffusion), active transport requires ATP-consumption 
and is performed by motor proteins that move birectionally through the cytoplasm, 
exploiting the polarity of the cytoskeleton (Mallik and Gross, 2004).  
The cytoskeleton provides mechanical support to the cell and fulfills several functions: it 
spatially organizes the cell contents, connects the cell to the extra-cellular environment, 
segregates the chromosomes during mitosis, and establishes cellular forces and shape 
change. The cytoskeleton is constituted by three classes of highly dynamic polymers, that 
are microtubules, actin, and intermediate filaments (Fletcher and Mullins, 2010). 
Microtubules are longitudinal polymers composed of α- and β- tubulin, having a slow 
growing “minus end” and a fast growing “plus end”. In axons and distal dendrites, 
microtubule orientation is highly polarized with the minus ends directed to the cell body 
and the plus ends pointing away from the soma (Hirokawa and Takemura, 2005).  
There are three classes of molecular motor proteins: myosins, dyneins and kinesins. 
Myosin-mediated cargo transport is performed by the class of non-conventional myosins, 
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that are neither muscle nor filamentous myosins. Most non-conventional myosins 
advance towards the plus end of actin filaments. Cytoplasmic dyneins perform minus-end 
directed movement on microtubules (Mallik and Gross, 2004). The kinesin superfamiliy 
encompasses 45 members in mice and human, based on 14 evolutionary related families 
(Lawrence et al., 2004). All kinesins are highly homologous in their globular motor 
domain, which contains the ATP-binding site and a microtubule-binding site. In contrast, 
the C-terminal cargo-binding domain shows a high degree of diversity, enabling various 
cargoes to travel with the help of kinesins (Hirokawa and Takemura, 2005). Most 
kinesins (KIFs) support anterograte transport by moving along microtubules in plus-end 
direction (Lawrence et al., 2004), as it is required for mRNA transport from the cell soma 
to the distal dendrites.  
Active transport of mRNA is a key mechanism in multiple cellular processes, as 
reviewed by Martin and Ephrussi (Martin and Ephrussi, 2009). For instance, the 
formation of the body axis in the developing Drosophila embryo is established by the 
localization of mRNAs such as bicoid, nanos and oskar to the anterior respective 
posterior pole of the oocyte (Becalska and Gavis, 2009; Johnstone and Lasko, 2001). 
Another well-studied example is the regulation of mating-type switch in budding yeast, 
which requires the localization of ASH1 mRNA to the daughter cell (Muller et al., 2007).  
Active transport does not only apply to mRNA, but to a diversity of cargoes including 
proteins, vesicles, organelles, and cytoskeletal filaments (Vale, 2003). 
 
1.2.3 Dendritic localization of mRNAs 
The mRNAs locally translated in dendrites encode for a multitude of proteins with 
diverse functions such as receptors, protein kinases, cytoskeletal proteins, and scaffolding 
proteins (Table 1-1) (Eberwine et al., 2001; Kosik and Krichevsky, 2002; Steward and 
Schuman, 2003). Recent evidence supports there are hundreds of localized mRNAs as 
opposed to a handful, as previously thought (Eberwine et al., 2001; Martin and Ephrussi, 
2009) (Table 1-1). 
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mRNA  Abbreviation  Classification 
Activity-regulated cytoskeleton-associated protein Arc cytoskeletal protein 
Brain-derived neurotrophic factor BNDF growth factor 
Calcium calmoduline dependent kinase II-α CaMKII-α protein kinase 
Cyclic AMP response elelment binding factor CREB transcription factor 
Glutamate receptor subunit 1 GluR1 receptor 
Glutamate receptor subunit 2 GluR2 receptor 
Microtubule-associated protein 2 MAP2 cytoskeletal protein 
N-methyl-D-aspartate receptor NMDAR1 receptor 
Neurotropic tyrosine kinase receptor type 2 TrkB  receptor  
Shank - scaffolding protein 
vasopression - neuropeptide 
β-Actin - cytoskeletal protein 
Table 1-1. Examples of mRNAs transported in dendrites  
(Kosik and Krichevsky, 2002; Martin and Zukin, 2006). 
 
 
An ordered multistep process is suggested for the transport of dendritic mRNAs 
(Figure 1-1) (Wilhelm and Vale, 1993). The starting step constitutes the assembly of the 
transport granule, a large ribonuleoprotein particle (RNP). It contains the mRNA together 
with a variety of protein factors (Figure 1-1, Step 1) (Kanai et al., 2004). Then the 
transport granule is equipped with a motor protein, which moves along the cytoskeleton 
(Figure 1-1, Step 2). At the site of destination, the transport granule is anchored at the 
local cytoskeleton, presumably to the actin network of distal dendrites (Figure 1-1, 
Step 3). In a regulated process in response to stimulation, the granule is rearranged and 
the translation of the mRNA starts (Figure 1-1, Step 4) (Krichevsky and Kosik, 2001) 
(Wilhelm and Vale, 1993). 
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Composition of the mRNA transport granule 
The mRNA transport granules are highly complex macromolecular structures (Kanai et 
al., 2004) and contain mRNAs together with a multitude of protein factors (Barbarese et 
al., 1995; Kanai et al., 2004; Knowles et al., 1996). One of the factors essential for the 
transport is Pur-α, on which this study focuses. 
Kanai and colleagues purified large RNA-transporting granules from mouse brain lysate 
by exploiting their affinity to the cargo-binding domain of conventional kinesin (KIF5) 
(Kanai et al., 2004). The granules had a size of about 1000 S, contained CamKII-α as 
well as Arc mRNA and were resistant against detergent, but RNAse sensitive. 
Characterization of the protein content of the granule revealed at least 42 different 
factors, including RNA-binding proteins, RNA transport proteins, RNA helicases, 
heterogenous ribonucleoproteins (hnRNPs), and proteins involved in translation (Kanai et 
al., 2004). Following the hypothesis that some factors might constitute a functional core 
complex while additional factors might have regulatory function, Kanai and colleagues 
washed the complex with increasing salt concentrations. They identified four proteins 
that were more strongly bound to KIF5 than the other factors, namely Pur-α, Pur-β, 
hnRNP-U and Staufen. Their importance is underlined by RNAi knock down 
experiments, which revealed that those four (among others) are essential for mRNA 
transport in dendrites (Kanai et al., 2004). However, a potential diversity in granule 
composition could not be resolved by this approach.  
Figure 1-1. Schematic drawing of the 
mRNA transport mechanism in neurons. 
Step 1: mRNA and RNA-binding proteins 
assemble to form the transport granule 
(RNP). Step 2: Motor proteins actively 
transport the granule along the 
cytoskeleton. Step 3: At the site of 
destination, the RNP is anchored to the 
cytoskeleton. Step 4: Rearrangement of 
the granule and initiation of translation. 
Picture taken from (Wilhelm and Vale, 
1993). 
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Barbee and colleagues examined the composition of single granules using GFP-labeled 
Staufen and antibody staining of RNPs in Drosophila neurons (Barbee et al., 2006). They 
assessed the co-localization of known granule components and revealed heterogeneity 
among the RNPs. For example, only 45 % of Staufen-positive granules also contained 
Fmr protein (Barbee et al., 2006). Similarly, only 50 % of β-actin mRNA containing 
granules co-localized with zipcode-binding protein1 (ZBP1) (Tiruchinapalli et al., 2003). 
Barbee and colleagues propose that different classes of mRNAs are repressed by different 
mechanisms. This opens up the possibility to specifically release mRNAs for translation 
(Barbee et al., 2006). 
 
The transport of the mRNAs and the regulation of localized translation are thought to be 
functionally interdependent, and there are various trans-action factors that bind 
localization elements in the mRNA and are responsible for transport as well as for 
translational control (Kindler et al., 2005).  
Besides its crucial role for transport (Kanai et al., 2004), Pur-α seems to be also involved 
in translational regulation. Pur-α is associated with polysomes in mouse brain, together 
with Staufen, Fmr protein, and Myosin Va (Ohashi et al., 2002). Together with additional 
factors, these four proteins form a large RNP, which is RNAse sensitive, indicating that 
RNA is required for complex stablility. Pur-α has also been suggested to play a role in 
the RNA-dependent assembly of the granule, a process not yet understood (Ohashi et al., 
2002).  
Further RNA-binding proteins required for mRNA transport are Staufen, zipcode-binding 
protein1 and 2 (ZBP-1 and ZBP-2), and cytoplasmic polyadenylation element-binding 
protein (CPEB) (Kindler et al., 2005; Martin and Ephrussi, 2009). Staufen is a double-
stranded RNA-binding protein, which associates with microtubules and is crucial for 
somatodendritic localization of mRNAs, possibly by linking the microtubule-associated 
transport machinery to the mRNAs (Martin and Zukin, 2006). Staufen is also a key factor 
of mRNA localization in the Drosophila oocyte and embryo (Kiebler et al., 1999; St 
Johnston, 2005). ZBP1 is a nucleo-cytoplasmic shuttling protein that binds β-actin 
mRNA in the nucleus and promotes its translational silencing as well as its incorporation 
in RNPs. This indicates that mRNA targeting is already initiated in the nucleus 
(Bramham and Wells, 2007; Kindler et al., 2005). The cis-acting recognition element of 
CPEB, cytoplasmic polyadenylation element (CPE) is contained in a subset of dendritic 
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mRNAs. Binding of CPEB mediates both translational control and transport to dendrites 
(Huang et al., 2003). 
 
Localization elements  
It is assumed that many different mRNAs travel in one granule (Gao et al., 2008; Kosik 
and Krichevsky, 2002). The destination of a transcript is encoded by cis-acting elements 
in the mRNA sequence, which are referred to as “zipcodes” (Martin and Ephrussi, 2009; 
Martin and Zukin, 2006; Singer, 1993).  
Some general principles for cis-acting localization elements emerged from the 
investigation of related processes such as transport of bicoid mRNA in Drosophila 
oocytes or ASH1 mRNA localization in budding yeast. Most of the localization elements 
identified so far lie in the 3’-untranslated region (UTR) of the transcript. One mRNA 
often carries several repetitive and redundant localization elements, but there are also 
examples where different cis-acting elements are responsible for distinct steps in 
localization (Martin and Ephrussi, 2009). A common feature is the formation of 
secondary structures that are required for localization, e. g. stem loops (Martin and 
Ephrussi, 2009). However, the search for dendritic targeting elements (DTEs) in mRNA 
is just emerging and reveals great complexity. The so far described DTEs differ vastly in 
length, sequence and number per mRNA (Kindler et al., 2005). The interplay between 
distinct DTEs in one mRNA, e. g. in CaMKII-α  mRNA, is not yet understood and might 
direct the mRNA to different target sites within dendritic branches (Kindler et al., 2005).  
 
Translocation 
The current model of mRNA transport in dendrites proposes kinesin-based translocation 
along microtubules for long distances from the soma to the dendrites (Ohashi et al., 
2002). Myosin-driven motility is proposed for the peripheral regions of the dendrites, 
which are rich in actin fibers (Ohashi et al., 2002). Not all granules translocate at all 
times, some appear docked to microtubules, while others move with a speed of 4-
6 µm/min, consistent with fast transport motors such as kinesins or dyneins (Kosik and 
Krichevsky, 2002). Kanai and colleagues characterized the movement of RNA 
transporting granules in mouse dendrites and found that they move bidirectional, driven 
by a kinesin motor and an opposing motor, presumably dynein (Kanai et al., 2004). 
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1.2.5 Activity-dependent translation 
Krichevsky and Kosik propose a model which links RNA localization to activity-
dependent translation and synaptic plasticity (Figure 1-2) (Krichevsky and Kosik, 2001). 
The research group sedimented RNA fractions from cultured neurons on a sucrose 
gradient and assigned a distinct fraction heavier than polysomes to the transport granules 
(Krichevsky and Kosik, 2001). They suggest that during transport, the mRNAs are 
translationally silent, as shown by the failure of the granule fraction to incorporate 35S-
labelled amino acids. Furthermore, the transport granules lack tRNAs and the rate-
limiting initiation factors eIF4E and 4G. Upon depolarization by incubation with 
potassium chloride, the granules reorganized and specific mRNAs (CaMKII-a, TrkB, 
NMDAR1) were shifted to the polysome fraction (Krichevsky and Kosik, 2001). 
 
Several lines of evidence support the idea that neuronal activity triggers translational 
initiation. Ouyang and colleagues found that induction of long term potentiation in 
hippocampal neurons enhances the expression of CaMKII-α (Ouyang et al., 1999). 
Furthermore, stimulation with a glutamate receptor agonist increased reporter protein 
translation in living dendrites (Job and Eberwine, 2001). Consistently, rapid initiation of 
translation in response to NMDA receptor activation was shown for Arc (Steward et al., 
1998; Steward and Worley, 2001).  
 
Figure 1-2. Shematic drawing of localized 
translation in neurons. An RNA granule 
(GR) containing mRNA, the translation 
machinery and regulatory factors is 
transported along a microtubule (MT). 
During transport, the granule is 
translationally silent. Upon depolarization 
(indicated by an arrow), the granule 
reorganizes, releasing mRNAs, ribosomes 
(R) and polysomes (P). Global protein 
synthesis is reduced, but specific mRNAs 
are shifted to the polysome fraction and 
translated. Figure taken from (Krichevsky 
and Kosik, 2001). 
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Not only translation, but also localization of specific mRNAs is triggered by neuronal 
activity, as demonstrated for Arc, TrkB, β-actin, GluR1, GluR2, and BDNF (Martin and 
Zukin, 2006). This requires a pathway for synapse-to-nucleus signaling, whose 
mechanism is still unclear but seems to involve the active nuclear import pathway 
(Thompson et al., 2004). 
 
 
1.3 Pur-α  
Pur-α and its family members Pur-β and Pur-γ constitute the purine-rich element (PUR) 
binding protein family, which is highly conserved from bacteria to metazoan (White et 
al., 2009). PUR proteins are named after their specific binding to purine-rich nucleic 
acids and show sequence-specific affinity to DNA as well as RNA (Bergemann et al., 
1992; White et al., 2009). They preferably bind repeat regions of their consensus 
sequence (GGN)n, with N unlike guanine. The PUR family members are highly 
homologous to each other, especially in their central nucleic-acid binding region. The 
overall sequence identity of human Pur-α and Pur-β is 61 %, whereas it is 74 % in their 
central region. PUR proteins are also highly conserved between species, as illustrated by 
the fact that human and mouse Pur-α differ only in 2 amino acids (Liu and Johnson, 
2002). 
Pur-α is a ubiquitous protein, which is expressed in nearly every metazoan tissue. To 
perform its various cellular functions, it is present in the cytoplasm as well as in the 
nucleus (White et al., 2009). Pur-α  binds sequence-specifically to dsDNA, ssDNA and 
RNA and is involved in a variety of cellular processes such as transcription, replication, 
cell cycle control, and, as already stated, transport of mRNA in dendrites (Gallia et al., 
2000; White et al., 2009). 
Previous work described the modular structure of human Pur-α (GeneID 5813), which is 
composed of 322 amino acids (34.9 kDa) (Figure 1-3). Pur-α has a glycine-rich N-
terminus, a highly conserved central core region, and a C-terminus bearing a Psycho 
motif as well as a region rich in glutamines and glutamates (Gallia et al., 2000). The 
glycine-rich N-terminus (amino acids 7 to 53) is predicted to be unfolded and contains a 
stretch of 18 glycines interrupted by only one single serine. At the C-terminus, the 
Psycho motif (amino acids 251 to 278) shows limited homology to the large T-antigen of 
several polyomaviruses and is named after its content of proline (P), serine (S), tyrosine 
 10 
(Y), and cysteine (C). In the glutamate/glutamine rich region (amino acids 276 to 321), 
half of the residues are either glutamates or glutamines (Gallia et al., 2000). The core 
region (amino acids 54 to 250) was found to be the RNA- and DNA-binding region as 
well as the interaction domain for many protein partners (White et al., 2009). It was 
previously proposed that the core region contains repetitive sequence elements that can 
be classified into three class I repeats (amino acids 66-88, 148-170, and 224-246) and 
two class II repeats (amino acids 107-131 and 195-220) (Bergemann et al., 1992; Gallia 
et al., 2000; White et al., 2009).  
 
 
 
Figure 1-3. Schematic 
representation of human 
Pur-α . The modular protein 
is composed of a glycine-
rich domain at the N-
terminus, a central core 
region bearing the repetitive 
elements, and a C-terminus 
with a Psycho motif as well 
as a region rich in 
glutamines and glutamates. 
The central core region is 
reported to be the nucleic 
acid binding region. It is 
also the interaction domain 
for various proteins, as 
indicated by the black bars. 
Picture taken from (White 
et al., 2009). 
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1.3.1 Cellular functions of Pur-α  
Transcription 
Appropriate to its role in replication and transcription, Pur-α is reported to have DNA 
double strand destabilizing properties (Darbinian et al., 2001a). Pur‐α  interacts with TATA-less promoters and functions as transcriptional activator as 
well repressor. There are at least 19 target genes known whose transcription is regulated 
by Pur‐α (White et al., 2009). These findings are mainly based on the use of a fusion 
plasmid bearing the promoter of the gene of interest and a reporter gene, monitoring the 
transcriptional activity in dependence of Pur‐α co-expression in cell culture. 
Interestingly, among the gene targets of Pur‐α, several gene products are involved in 
apoptosis or cell proliferation, e.g. Bax (Kim et al., 2008), tumor necrosis factor α 
(Darbinian et al., 2001c), transforming growth factor β (Thatikunta et al., 1997), platelet-
derived growth factor subunit A (Zhang et al., 2005), GATA binding protein2 (Penberthy 
et al., 2004), and somatostatin (Sadakata et al., 2000). This underlines the involvement of Pur‐α in cell cycle regulation and tumor suppression, as described below. 
Furthermore, several target gene products have a specific importance for neuronal cells 
like myelin basic protein (Dobretsova et al., 2008), myelin proteolipid protein1 
(Dobretsova et al., 2008), FE65 (Zambrano et al., 1997), CD11cβ-2 integrin (Shelley et 
al., 2002), and somatostatin (Sadakata et al., 2000). The importance of Pur‐α  for the 
nervous system is described below (section 1.3.2 and section 1.3.3).  
Pur-α often exerts its regulatory function in multimeric complexes in concert with other 
factors. For example, the repression of smooth muscle α-actin gene transcription is 
mediated by both Pur-α and Pur-β via binding to the MCAT enhancer element (Kelm et 
al., 1999a; Knapp et al., 2006). 
Pur-α auto-regulates its own expression by binding to its own promoter and preventing 
its transcription (Muralidharan et al., 2001). E2F-1, which is a crucial transcription factor 
for cell cycle control and an interaction partner for tumor suppressor proteins, acts as an 
antagonist and enhances transcription of the PURA gene (Darbinian et al., 2006).  
 
Pur-α is also hijacked by viral genes, and activates transcription of human 
immunodeficiency virus (HIV-1) and human polyomavirus (JCV). Pur-α activates HIV-1 
transcription by binding to the HIV-1 TAR element and interacting with the HIV-1 Tat 
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protein (Chepenik et al., 1998; Krachmarov et al., 1996). Further, Pur-α interacts with 
HIV-1 Rev protein and the RRE element in HIV-1 genomic RNA and thereby enhances 
the export of unspliced viral RNA from the nucleus (Kaminski et al., 2008a).  
JC virus is a ubiquitous virus, which is latent in approximately 80 % of the population 
and usually subclinical. In severely immunosuppressed individuals, like AIDS patients, it 
causes progressive multifocal leucoencephalopathy (PML) (Cinque et al., 2009). PML 
leads to demyelination in regions of the central nervous system, severe brain lesions and 
death. HIV-1 protein Tat acts synergistically with Pur-α to activate the major late 
promoter of JCV via the Tat-responsive element, upTAR. Pur-α was shown to bind the 
upTAR element, which contains the Pur-α consensus sequence (GGN)n (Krachmarov et 
al., 1996). 
 
Pur-α also controls gene expression at the translational level. It was shown to bind the 
mRNA transcript of the vascular smooth muscle α-actin gene to suppress translation 
(Kelm et al., 1999b).  
 
Replication 
Pur-α associates with zones of initiation of DNA replication. Pur-α was first discovered 
by its specific affinity to the purine-rich element (PUR) near the center of chromosomal 
replication upstream the human c-myc gene (Bergemann and Johnson, 1992; Bergemann 
et al., 1992). In eukaryotes, the PUR element is conserved in origins of replication and in 
gene flanking regions, such as near hamster dhfr and rhodopsin genes, the human β-
globin gene, and the mouse adenosine deaminase gene (Itoh et al., 1998). The function of 
Pur-α is not known for most of these interactions.  
Pur-α is also involved in the replication of several viruses. It associates with the origin of 
DNA replication and the plasmid maintenance region of bovine papilloma virus (BPV) 
(Habiger et al., 1992; Jurk et al., 1996). The replication of the human neurotrophic 
polyomavirus (JCV) is negatively regulated by Pur-α, possibly by interfering with JCV 
T-antigen (Chang et al., 1996).  
There is also recent evidence that Pur-α might be involved in replication-dependent 
repair of DNA lesions, as Pur-α deficient cells show an enhanced sensitivity to the DNA-
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replication inhibitor hydroxyurea and to the DNA-crosslinking anti-tumor drug cis-platin 
(Kaminski et al., 2008b; Wang et al., 2007).  
 
Cell cycle control 
Various protein interaction partners have been identified that suggest a role for Pur-α in 
cell cycle regulation. These are the retinoblastoma tumor suppressor protein (Johnson et 
al., 1995), E2F-1 (Darbinian et al., 1999), Sp1 (Tretiakova et al., 1999), the Y-box 
binding protein1 (Safak et al., 1999), CyclinT1/Cdk9 (Darbinian et al., 2001c), and  
CyclinA /Cdk2 (Liu et al., 2005). The binding of Pur-α to most of these cell cycle 
regulating proteins was demonstrated with purified protein to be direct and specific. 
Although the functional consequence for most of these interactions is not explored, 
binding to this conglomerate of cell cycle regulating proteins suggests a role for Pur-α in 
cell cycle control. This interpretation is supported by the cell-cycle dependent variation 
of Pur-α expression levels. Pur-α levels in monkey CV-1 cells peak during mitosis and 
drop at the onset of S-phase (Itoh et al., 1998). Consistently, cell cycle arrest at G1/S and 
G2/M checkpoints is caused by microinjection of Pur-α in NIH-3T3 cells (Stacey et al., 
1999).   
 
Tumor suppression 
Cell cycle control is highly connected to oncogenic transformation. Pur-α acts as a tumor 
suppressor in human brain tumor (glioblastoma cells) (Darbinian et al., 2001b) and 
prevents growth of Ras-transformed NIH-3T3 cells in soft agar (Barr and Johnson, 2001). 
Furthermore, PURA gene deletions are frequently associated with myelogenous leukemia 
(Lezon-Geyda et al., 2001). For prostate cancer, loss of Pur-α is reported to promote 
cancer progression by triggering androgen repressor over-expression (Inoue et al., 2008; 
Liu et al., 2010). Taken togehter, these results indicate that Pur-α is a tumor suppressor 
protein.  
 
RNA binding  
In mouse brain, Pur-α binds to an abundant non-translated RNA homologous to 7SL 
RNA, named PU-RNA. The 290 nt long PU-RNA contains Alu core sequences with the 
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repeat motif GGAGGC and is predicted to form a stem-loop structure (Tretiakova et al., 
1998). The binding of Pur-α to the MBP promoter sequence is specifically reduced by 
PU-RNA and is restored by the addition of RNAse (Gallia et al., 1999; Tretiakova et al., 
1998). Tretiakova and colleagues propose that PU-RNA is a cofactor that negatively 
regulates the expression of the MPB gene. 
 
Pur-α was also shown to bind to rat BC1 RNA and is proposed to enhance its 
transcription, which relies on RNA polymerase III (Kobayashi et al., 2000). The non-
translated BC1 RNA is preferentially expressed in neurons, and is specifically transported 
to the dendrites in RNPs (Tiedge et al., 1991). BC1 RNA is suggested to control activity-
dependent neuronal plasticity by directing the mRNA transport granule to its destination 
and by regulating translational silencing during transport (Lin et al., 2008; Wang et al., 
2002). Ohashi and colleagues propose that the binding of Pur-α and Pur-β to the two 
dendritic targeting elements in BC1 RNA cross-links the BC1 RNA to microtubules 
(Ohashi et al., 2000). Wang and colleagues showed that BC1 RNA represses translation 
by directly interacting with the translation initiation apparatus (Wang et al., 2005; Wang 
et al., 2002).  
In addition, Pur-α binds the functional homolog of BC1 RNA, human BC200 RNA 
(Johnson et al., 2006) and the HIV-1 TAR element (Chepenik et al., 1998). Further, Pur-α 
is proposed to bind r(CGG)-expansions in the 5'-untranslated region of the Fmr1 mRNA 
in the neurodegenerative disease Fragile X Tremor/Ataxia syndrome (section 1.3.2) (Jin 
et al., 2007).  
 
 
1.3.2 Fragile X Tremor/Ataxia syndrome 
Recent evidence establishes a crucial role for Pur-α in the pathogenesis of the 
neurodegenerative disorder Fragile X Tremor/Ataxia syndrome (FXTAS) (Oostra and 
Willemsen, 2009). The predominantly male FXTAS patients suffer from progressive 
action tremor with ataxia and general brain atrophy leading to cognitive decline and 
dementia (Berry-Kravis et al., 2007; Hagerman et al., 2001). FXTAS is caused by 
(CGG)n-repeats in the 5’-untranslated region of the fragile X mental retardation1 (FMR1) 
gene. Normal alleles contain <55 repeats, while FXTAS is associated with the so-called 
premutation between 55 and 200 repeats. The prevalence of the premutation is estimated 
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to be 1 out of 1000 males with an onset of the disease in the 5th decade (O'Donnell and 
Warren, 2002). The so-called full mutation with >200 repeats induces transcriptional shut 
down of the FMR1 gene, resulting in Fragile X syndrome. This disease is a common form 
of inherited mental retardation with an estimated prevalence of 1 out of 4500 males 
(O'Donnell and Warren, 2002). A pathological hallmark of FXTAS are ubiquitin-positive 
nuclear inclusions in neurons and astrocytes, which contain Fmr1 mRNA and more than 
20 proteins, including Pur-α as well as LaminA/C (Greco et al., 2002; Iwahashi et al., 
2006; Jin et al., 2007). In FXTAS carriers, Fmr1 protein levels are reduced, while Fmr1 
mRNA levels are elevated (Kenneson et al., 2001; Tassone et al., 2000). A recent model 
suggests that the toxic r(CGG)n-repeat RNA is the underlying cause of the 
neurodegenerative disease. Jin and colleagues showed that the expression of r(CGG)90-
repeats is sufficient to cause neurodegeneration in a Drosophila model of FXTAS (Jin et 
al., 2007). They propose a mechanism by which r(CGG)n-binding proteins are 
sequestered from their normal functions by the abundant premutation RNA (Jin et al., 
2003). The group further found that Pur-α binds directly and specifically to r(CGG)n-
repeat RNA. Moreover, over-expression of Pur-α rescues the r(CGG)n-mediated eye 
neurodegeneration phenotype of the FXTAS fly model. Jin and colleagues propose that 
loss of functional Pur-α could impair mRNA transport in neurons, leading to neuronal 
cell death (Jin et al., 2007).  
 
 
1.3.3 Pur-α  knockout mouse  
The crucial role of Pur-α for brain development is highlighted by its genetic inactivation 
in the mouse. Homozygous animals lacking both alleles of the PURA gene (PURA-/-) 
appear normal at birth, but after two weeks, they develop neurological problems. 
Suffering from severe tremor and spontaneous seizures, they die four weeks after birth 
(Khalili et al., 2003). In PURA-/- mice, the number of neuronal cells in hippocampus, 
brain cortex and cerebellum is reduced. Lack of proliferation of precursor cells might 
reflect the role of Pur-α in DNA replication (Khalili et al., 2003). Possibly Pur-α is 
required for developmentally timed DNA replication, leading to cell differentiation. In 
PURA-/- mice, astrocytes, oligodendrocytes and Purkinje cells show a pathological 
development and the number of synapses is significantly decreased in the hippocampus 
(Khalili et al., 2003). Lamination is defective in the hippocampus and cerebellum of 
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PURA-/- mice. This is in accordance to a role of Pur-α in the transcription of myelin basic 
protein (MBP) and myelin proteolipid protein1 (Plp1) gene (Dobretsova et al., 2008; 
Tretiakova et al., 1999). However, Pur-α is not absolutely required for MBP expression, 
as the myelin sheath is present in the spinal cord and optic nerve of the PURA-/- animals 
(Khalili et al., 2003). A crucial role for Pur-α in dendritic mRNA transport is underlined 
by the dramatic mislocalization of Staufen and FMRP, both components of mRNA-
transporting granules (Johnson et al., 2006; Kanai et al., 2004; Ohashi et al., 2002). It is 
speculated that despite the essential role of Pur-α, survival of the PURA-/- animals is 
prolonged by its homolog Pur-β, which might rescue loss of Pur-α (Khalili et al., 2003). 
 
In summary, Pur-α is multifunctional protein with diverse roles in cellular gene 
regulation. By interacting with dsDNA, ssDNA, RNA as well as proteins, Pur-α is 
involved in transcription, replication, cell cycle control, and mRNA transport in neurons. 
Multifunctional proteins such as Pur-α provoke the conventional “one protein – one 
function” paradigm, and transcription factors that interact with both DNA and RNA raise 
the intriguing question how specificity is achieved (Cassiday and Maher, 2002).  
 17 
1.4 Objectives 
In a reductionist approach, this study aims to contribute to the understanding of mRNA 
localization by the structural and functional characterization of one essential factor, Pur-
α. Since PUR proteins show no sequence homology to other protein families with 
previously determined structures, their 3-dimensional fold is unknown. It was aimed at 
obtaining the crystal structure of Pur-α to gain an understanding of its interaction with 
various protein partners as well as with nucleic acids. It would be especially interesting to 
find out whether there are distinct or common binding modes for DNA and RNA targets 
and what determines specificity. 
X-ray crystallography provides structural information at the atomic level and has led to a 
tremendous increase in biological understanding since the 1960s (Kendrew et al., 1958). 
In recent years, the combination of structural methods has proven very successful when a 
classic approach was aggravated by technical limitations (e. g. hampered crystallization) 
or the problem’s complexity (e. g. multi-protein complexes) (Cowieson et al., 2008). 
Small angle X-ray scattering (SAXS) is a technique complimentary to X-ray 
crystallography, as it allows the investigation of macromolecules in solution, providing 
additional information about oligomeric state, shape and structural dynamics (Putnam et 
al., 2007). Moreover, SAXS independently assesses whether fold and oligomeric state of 
the crystallized protein are predicated on the crystal lattice or if they are also found in 
solution and thus have biological relevance. 
Structural information was related with functionality by the identification of the RNA- 
and DNA- binding surface of Pur-α. Therefore, structure-guided mutagenesis was 
performed and nucleic-acid binding properties of wild type and mutant Pur-α were 
assessed.  
Since Pur-α is a multi-functional protein, this study also aimed at identifying new 
protein-binding partners, which might act together with Pur-α to exert its diverse cellular 
functions. Therefore, a yeast-2-hybrid screen was commissioned and evaluated. 
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Chapter 2 Results 
The crystal structures of two orthologs, B. burgdorferi Pur-α and D. melanogaster Pur-α 
repeats I-II, were solved (section 2.1.1.1 and section 2.1.1.2). The solution structure of 
D. melanogaster Pur-α repeats I-II was obtained by SAXS and complemented the 
crystals structure (section 2.1.2.2). SAXS analysis further showed that D. melanogaster 
Pur-α repeats I-III is dimeric and lead to a dimerization model (section 2.1.2.2). Nucleic-
acid binding properties of B. burgdorferi, D. melanogaster, and human Pur-α were 
characterized by electrophoretic mobility shift assays and filter binding assays 
(section 2.2.1). Binding affinities were also determined for truncated and mutated protein 
fragments of B. burgdorferi and D. melanogaster Pur-α. This allowed for the mapping of 
the nucleic-acid binding surface on the respective crystals structure (section 2.2.1).  
 
2.1 Structural studies  
2.1.1 Crystal structure of Pur-α  
2.1.1.1 Human Pur-α  
Human Pur-α is comprised of 322 amino acids with a molecular weight of 34.9 kDa 
(GeneID 5813). In humans, the PUR family is also represented by Pur-β and two 
isoforms of Pur-γ. The latter appears in two isoforms that arise from different 
polyadenylation sites (Liu and Johnson, 2002). 
 
Crystallization trials of human Pur-α  
Initially, crystallization trials of human Pur-α were performed. Because of its functional 
relevance for nucleic-acid binding, crystallization trials focused on protein fragments of 
the previously described core region (Figure 1-3 and section 1.3) (Gallia et al., 2000). 
The glycine-rich stretch at the N-terminus is predicted to be unstructured and thus likely 
preventing crystallization. Accordingly, expression constructs were designed that lacked 
the N-terminal glycine-rich region and also had different parts of the C-terminus deleted 
(Table 2-1).  
The design of expression constructs also relied on previous work by D. Niessing and 
limited proteolysis (section 5.11). This method identifies stable protein fragments via the 
enzymatic digestion of flexible regions with sequence-specific proteases. Protein 
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fragments that yield diffraction quality crystals are typically resistant to proteolytic 
digestion (Gao et al., 2005).  
Fragments of human Pur-α were expressed in different expression systems (E. coli or a 
baculovirus-based insect cell expression system) and purified using different affinity tags 
(Histidin, MBP, or GST) (section 5.7 and section 5.8). They were purified to 
homogeneity using affinity chromatography, anion-exchange chromatography and size-
exclusion chromatography (section 5.8 and section 5.9). Numerous constructs tested were 
unstable, i.e. degraded or precipitated (Table 2-1). 
 
Construct Tag Expression Purification/ 
Stability 
Initial  
Crystals 
Refined  
Crystals 
Comment 
hPurA1-322 GST + +   a) 
hPurA140-268 GST +/-  -    
hPurA191-259 GST +/- -    
hPurA42-186 GST +/- -    
hPurA56-245 MBP + + -  b) 
hPurA56-245 His + + +/- - c) 
hPurA56-245 GST + -    
hPurA56-274  His +/- -    
hPurA56-274 GST + -    
hPurA56-287 C272S MBP + + +/- - d) 
hPurA56-287 C272S GST + + + - e) 
hPurA60-105 GST -     
hPurA60-202 GST +/- -    
hPurA60-245 His + + +/- -  
hPurA96-287 GST +/- -    
Table 2-1. Protein fragments of human Pur-α  for crystallization trials. hPurA refers to human 
Pur-α . The numbers indicate the start and stop site of the amino acid sequence.  
a) Full length protein, b) crystallization trials as MBP-fusion protein, also after reductive 
methylation, c) crystalllization trials with and without RNA or DNA, d) crystallization trials as 
MBP-fusion protein, e) crystalllization trials with and without RNA or DNA. 
 
Fragments of human Pur-α comprised of amino acids 56-245 and 60 to 245, respectively, 
were expressed in E. coli and were purified employing a Histidin-Tag. The fragment Pur-
α 56-287 C272S was expressed in E. coli and purified with a GST-Tag. It had cysteine at 
position 272 replaced by serine because previous work of D. Niessing hinted at improved 
purification properties of this fragment (Table 2-1). 
For these fragments, protein stability was highly depended on the ionic strength of the 
buffer. Initially, buffer containing 200 mM sodium chloride and 50 mM potassium 
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phosphate buffer pH 8.0 was used. The protein fragments could be concentrated only to 
0.5 mg/mL, as precipitation occurred at higher concentrations. Initial crystallization trials 
(section 5.10) yielded crystals in various conditions, but when their diffraction was tested 
at Deutsches Elektronen Synchrotron (DESY, Hamburg, Germany), they were identified 
as salt crystals. Obviously, the phosphate buffer had to be replaced.  
To improve the solubility of the protein fragments, several different buffer compositions 
were screened, including the variation of the buffer and the pH (HEPES, TRIS, pH 6-9), 
the variation of concentration and type of salt (100-500 mM sodium chloride or 
potassium chloride) and the use of solubility-enhancing additives (15 % glycerol or 
50 mM arginine/glutamic acid). It was found that a salt content as high as 500 mM was 
required to prevent degradation and precipitation. Best stability was achieved in buffer 
containing 500 mM potassium chloride and 100 mM TRIS pH 8.4 at 4°C. The fragments 
could be concentrated up to approximately 2 mg/mL in this buffer. Unfortunately, no 
initial crystals were obtained with this buffer, presumably because the high salt content 
averted crystallization. It was then tried to replace a part of the potassium chloride by the 
volatile salt ammonium carbonate, but no crystals were obtained either (Table 2-1). 
The maltose-binding protein (MBP) is used as an affinity-tag for protein purification. It 
was also reported to enhance the solubility of proteins and promote their crystallization 
(Smyth et al., 2003). Therefore, human Pur-α 56-287 C272S and Pur-α 56-245 were 
expressed and purified as MBP fusion proteins. Solubility of the fragments was 
dramatically increased and initial crystal trials were set up with concentrations varying 
from 5 mg/mL to 65 mg/mL. For the Pur-α 56-287 C272S MBP fusion protein, 
crystalline material was obtained in 5 out of 384 conditions of the initial screen. 
Unfortunately, the crystals could not be reproduced in the refinement screen (Table 2-1).  
Chemical modifications of surface residues change the surface properties of the protein 
of interest and can therefore constitute a rescue strategy for proteins that resist 
crystallization. For instance, methylation of lysine residues can reduce solubility and 
promote crystallization (Kobayashi et al., 1999). Reductive methylation of a fusion 
protein of human Pur-α 56-245 and MBP and was carried out as described (Walter et al., 
2006). Unfortunately, the methylated protein yielded no initial crystals, either 
(section 5.12 and Table 2-1). 
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The expression of Pur-α 56-245 and Pur-α 56-287 in a baculovirus-based insect cell 
expression system (section 5.7.2) did not improve the solubility of the fragments and no 
initial crystals were obtained (Table 2-1).  
Since also the crystal structure of Pur-α in complex with nucleic acids was desired, filter 
binding assays were performed (section 2.2.1.1). The oligomers JCVupTar ssDNA, 
TAR14AU ssRNA and TAR14GC ssRNA (Table 5-2) showed good affinity to human 
Pur-α 56-287 C272S (Table 2-12). The addition of the nucleic acid improved the 
solubility of the protein fragments and initial crystallization screens were performed at 
concentrations of 2-5 mg/mL. Pur-α 56-245 mixed with JCVupTar ssDNA (2 mg/mL, 
1:1.25) yielded crystals that turned out to be salt crystals when tested at a synchrotron 
beamline. No initial crystals were obtained for Pur-α 56-287 C272S and TAR14AU 
(5 mg/mL, 1:1.1). Pur-α 56-287 C272S and TAR14GC (2 mg/mL, 1:1.1) yielded initial 
crystals in 7 out of 380 conditions. In the refinement, crystals were reproducible only in 
one condition (Figure 2-1 and Table 2-1). The crystals were very small with the smallest 
dimension below 5 µm. For improvement, the composition of the crystallization solution 
was varied (pH, concentration of salt and concentration of MPD). Furthermore, an 
additive screen with 48 conditions was performed (custom screen by D. Niessing). 
Unfortunately, no crystal improvement was achieved. Due to their small size, the crystals 
were not fished and tested for diffraction. It is thus well possible they were salt crystals.  
 
Figure 2-1. Crystals of human Pur-α . Pur-α  56-287 C272S 
and TAR14GC RNA (1:1.1) were mixed with crystallization 
solution containing 100 mM sodium cacodylate pH 6.5, 
100 mM sodium acetate, and 30 % MPD. 
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Identification of PUR repeats in Pur-α  
Protein expression constructs based on the previously reported boundaries of the class I 
and class II repeats of Pur-α (Figure 1-3) either failed to yield soluble proteins or resulted 
in degradation of the  protein fragments (Table 2-1). This indicated that these repeats 
might not represent folded domains, or at least no independent structural entities. It was 
thus questioned if the class I and class II repeats are accurately defined. To further 
investigate this issue, a cooperation with J. Söding (Gene Center, Munich, Germany) was 
initiated. J. Söding performed a computational search for repetitive elements in Pur-α 
using the HHrepID server (Biegert and Söding, 2008; Söding et al., 2005). HHrepID is 
very sensitive to distant homology, especially for repeat-proteins. It was found that 
human Pur-α contains three independent and consecutive repeat elements in its core 
region (Appendix 7-2). These repeats were termed PUR repeats. They are not identical 
with the previously described class I and class II repeats (Figure 1-3 and Appendix 7-2). 
PUR repeats are conserved throughout species and various metazoan Pur-α orthologs 
have three PUR repeats (Appendix 7-2). The sequence identity of the PUR repeats 
compared to each other is about 30 %  (Table 2-5).  
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2.1.1.2 Borrelia burgdorferi Pur-α  
The newly identified PUR repeats were employed in sequence homology searches to 
identify Pur-α from a prokaryotic species. Interest in a bacterial homolog arouse when 
crystallization trials of metazoan Pur-α constantly failed (section 2.1.1), as the use of an 
ortholog has proven successful in many cases (Kundrot, 2004). Savchenko and 
colleagues performed a high throughput crystallization screen and found that the usage of 
one more ortholog doubles the success rate of structural studies (Savchenko et al., 2003). 
Since the ortholog approach utilizes sequence alteration between species and thus 
constitutes a trial and error game, it is not predictable which organism to favour. 
However, homologs with shorter loop regions show the tendency to crystallize more 
willingly, as do bacterial proteins when compared to their metazoan counterparts.  
J. Söding performed homology database searches with the consensus PUR motif using 
the HHblast server (Söding et al., 2005). Homology database searches with the PUR 
motif resulted in the identification of a bacterial (spirochete) homolog, that is 
B. burgdorferi B31 gene bank entry BB0047 hypothetical protein. Due to its homology to 
the PUR motif, it was named B. burgdorferi Pur-α. The protein is comprised of 122 
amino acids and its core region (amino acid 3-74) corresponds to a single PUR repeat 
(Figure 2-2). The homology region is referred to as B. burgdorferi PUR in the following. 
Its sequence identity is compared to the three PUR repeats of D. melanogaster Pur-α, 
because the latter was investigated later on. The sequence identity (similarity) of 
Figure 2-2. Modular Structure of 
Pur-α . A: Schematic drawing of Pur-
α . D. melanogaster Pur-α  is 
comprised of three PUR repeats, 
B. burgdorferi Pur-α  bears one PUR 
repeat. B: Amino acid sequence 
alignment for the PUR repeats of 
D. melanogaster (dm) and 
B. burgdorferi (bb) Pur-α . Dm PUR-I 
is composed of amino acids 40-92, 
dmPUR-II of amino acids 116-190, 
dmPUR-III of amino acids 193-242, 
and bbPUR of amino acids 3-74.  
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B. burgdorferi PUR is 19 % (47 %), 21 % (38 %) and 13 % (38 %) to PUR repeat I, PUR 
repeat II, respective PUR repeat III, of D. melanogaster Pur-α (Figure 2-2). 
 
In the GeneBank entry, BB0047 is reported to contain 127 amino acids, but a slightly 
different open reading frame was found when the nucleotide sequence was translated 
using the Expasy Translate Tool (Gasteiger et al., 2003). Translation started 15 
nucleotides later, resulting in a 122 amino acid protein (14.1 kDa). To assess if the later 
start of translation is correct, the sequences of homologous proteins from other Borrelia 
species were compared. The protein sequences of B. garnii, B. afzelii, B. valisiana, and 
B. spielmanii gene products were highly homologous (more than 95 % identity) and none 
of them included the first start of translation. Thus, the later start of translation chosen as 
the correct start for B. burgdorferi Pur-α and all numbering refers to this definition.  
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Crystallization of B. burgdorferi Pur-α  
Various truncation mutants of B. burgdorferi Pur-α were designed, expressed in E. coli 
and purified using a GST-tag (section 5.7 and section 5.8). The protein fragments of 
B. burgdorferei Pur-α showed a much better stability and solubility than the fragments of 
human Pur-α (Table 2-2). 
 
Construct Tag Expression Purification/ 
Stability 
Initial  
Crystals 
Refined  
Crystals 
Comment 
bbPurA1-100 GST ++ ++ + +  
bbPurA1-120 GST ++ ++ + +  
bbPurA1-122 GST ++ ++ +/- - a)  
bbPurA3-100 GST ++ ++ + ++ b) 
bbPurA3-100 
L12M,F22M,I59M 
GST + + + ++ c) 
bbPurA3-105 GST + + + +  
bbPurA3-110 GST + + + +  
bbPurA3-120 GST + + + +  
bbPurA3-70 GST + -    
bbPurA3-74 GST + -    
bbPurA3-78 GST + -    
bbPurA3-82 GST + + +  d)  
bbPurA3-90 GST + + + + e) 
bbPurA3-95 GST + + + +  
bbPurA3-95 
L12M,F22M,I59M 
GST + + +/-   
bbPurA5-100 GST + + + +  
bPurA5-95 GST + + + +  
Table 2-2. Protein fragments of B. burgdorferi Pur-α  for crystallization trials. bbPurA  refers to  
B. burgdorferi Pur-α , the numbers indicate the start and stop site of the amino acid sequence. a) 
Full length protein, b) used for structure determination,  also co-crystallization trials with DNA 
and heavy atom soaks,  c) used for structure determination, also co-crystallization trials with 
DNA, d) also co-crystallization trials with DNA, e) also co-crystallization trials with DNA.   
 
 
The crystallization experiments were performed at room temperature, unless stated 
otherwise (section 5.10). 
Full length B. burgdorferi Pur-α 1-122 yielded initial crystals in 78 out of 480 
crystallization conditions tested (Figure 2-3, A). The crystals could be refined to 
(40 x 40 x 20) µm size by varying the concentration of the protein and the crystallization 
solution composition. When the crystals were tested at DESY, no diffraction was 
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observed, possibly due to their small size. Therefore, it was aimed to increase their size. 
This was attempted by variation of the expression construct. B. burgdorferi Pur-α 1-100 
crystallized in 48 out of 384 conditions tested, Pur-α 1-120 crystallized in 2 out of 192  
conditions, and Pur-α 3-120 crystallized in 25 out of 288 conditions. Refined crystals had 
a size of approximately (200 x 80 x 50) µm (Figure 2-3, B). The crystals were tested for 
diffraction at a beamline at the European Synchrotron Radiation Facility (ESRF, 
Grenoble, France) and diffracted up to 3-4 Å. Several cryo-protectants were tested, and 
PEG 400 and ethylene glycol were superior over MPD and glycerol (20 % in each case). 
Final refinement employed Pur-α 3-100, which crystallized in 36 out of 193 conditions. 
Refinement of the crystallization conditions was also performed at 4 °C, which improved 
the diffraction quality of the crystals. Finally, B. burgdorferi Pur-α 3-100 was 
crystallized at a concentration of 2.2 mg/ml at 4 °C. The crystallization solution 
contained 100 mM HEPES pH 7.2, and 20 % PEG 3350. After 2-4 days, cuboid crystals 
of approximately (200 x 100 x 30) µm size appeared, which diffracted up to 2.1 Å 
(section 5.10.1, Figure 2-3, C).  
Selenomethionine-derivatized protein was produced as described (section 5.7.1). The 
fragment B. burgdorferi Pur-α 3-100 does not contain any methionines, so they had to be 
introduced by site-directed mutagenesis. To reduce the probability of folding defects, the 
methionines were introduced in positions that bear methionines in Pur-α orthologs from 
other Borrelia species. Methionines were introduced in position leucine 12, 
phenylalanine 22, and isoleucine 59. Surprisingly, selenomethionine-derivatized 
 
Figure 2-3. Crystal of 
B.burgdorferi Pur-α .  
A: Initial crystals of Pur-
α  1-122 obtained with 
200 mM sodium chloride, 
100 mM HEPES pH 7.5, 
25 % PEG 3350.  
B: Refined crystals of Pur-α  
1-120 obtained with 125 mM 
sodium chloride, 100 mM 
HEPES pH 7.2, 23 % PEG 
3350. C: Refined crystals of 
Pur-α  3-100 obtained with 
100 M HEPES pH 7.2 and 
20 % PEG 3350 at 4 °C.  
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B. burgdorferi Pur-α 3-100 L12M, F22M, I59M did not crystallize in the same 
conditions as the native protein. After refinement of the composition of the crystallization 
solution, only needle shaped crystals of approximately (50 x 5 x 5) µm size were 
obtained (Figure 2-4, A). In initial crystallization screens, the protein crystallized in 9 out 
of 193 conditions tested.  
Because a co-structure with DNA was also desired, screening was also performed with 
the addition of DNA oligonucleotides. In filter binding assays, B. burgdorferi Pur-α 
showed affinity for the hTel12 ssDNA oligonucleotide (Table 5-2 and Table 2-13). Thus, 
initial crystallization trials were performed with Pur-α 3-100 L12M, F22M, I59M and 
hTel12 ssDNA (1:1). Crystals were found in 36 out of 193 conditions (Figure 2-4, B). 
Finally, selenomethionine-derivatized B. burgdorferi Pur-α 3-100 L12M, F22M, I59M 
was mixed with hTel12 DNA (1:1) and crystallized at a concentration of 1.2 mg/mL in 
2.8 M sodium formate at 4 °C. Spindle-shaped and cuboid crystals of (100 x 50 x 50) µm 
appeared after 2-5 days and diffracted up to 1.9 Å (Figure 2-4, C and section 5.10.1). 
 
 
 
 
 
 
 
Figure 2-4. Crystals of selenomethionine-derivatized B. burgdorferi Pur-α .  
A: Refined crystals of Pur-α  3-100 L12M, F22M, I59M obtained with 200 mM 
sodium chloride, 100 mM HEPES pH 7.5, 25 % PEG 3350. B: Initial crystals of 
Pur-α  3-100 L12M, F22M, I59M with hTel12 DNA (1:1) obtained with 3.5 M 
sodium formate pH 7.0. C: Refined crystals of Pur-α  3-100 L12M, F22M, I59M 
with hTel12 DNA (1:1) obtained with 3.8 M sodium formate pH 7.0 at 4 °C. 
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Structure determination and refinement 
Synchrotron radiation diffraction data were collected ESRF and Swiss Light Source 
(SLS, Villingen, Switzerland).  
The crystals of native protein diffracted up to 2.2 Å and belong to spacegroup P212121 
(Table 2-3 and Figure 2-5). Cell constants are a = 47.79 Å, b = 57.75 Å, c = 142.31 Å and 
angles α = β = γ = 90.00°. A native dataset was recorded at beamline ID 23-1 (ESRF) 
with a wavelengh of 0.9724 Å. A Q315r ADSC CCD detector was used to collect 360 
frames with an oscillation angle of 0.5°.  
For phasing, it was initially aimed at obtaining heavy-atom derivatized protein crystals by 
soaking. Different mercury and platinum derivates were added to the crystallization drop 
and incubated (section 5.13). The crystals were tested at the ESRF, and it was found that 
the diffraction quality was decreased. Most crystals showed total loss of diffraction, 
while some produced smeared spots with a diminished resolution (4.5 Å). Therefore, the 
selenomethione-approach was followed.  
Selenomethionine-derivatized B. burgdorferi Pur-α crystallized in spacegroup I212121 
with cell constants a = 48.17 Å, b = 58.33 Å, c = 141.84 Å and angles α = β = γ = 90.00°. 
Crystals diffracted up to 1.9 Å (Table 2-3 and Figure 2-5). 
An anomalous data set at the selenium K-edge was collected at the X06SA/PXI beamline 
(SLS). Using a PILATUS 6M detector, 180 frames with an oscillation angle of 1° per 
image were recorded. Prior to data collection, a fluorescence scan determined the optimal 
wavelengths. The peak wavelength was 0.9792 Å (12.6617 keV, f’ = -7.276, f’’ = 6.838) 
and the inflection point was 0.9797 Å (12.6556 keV, f’ = -10.562, f’’ = 3.406). 
 
 
Figure 2-5. 
Diffraction images 
of B. burgdorferi 
Pur-α .  
A: Crystal of 
native protein.  
B:  Crystal of 
selenomethionine-
derivatized 
protein. 
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Dataset Native SeMet Peak 
X-ray source ID23-1 (ESRF) X06SA/PXI (SLS) 
Wavelengh in Å 0.9724 0.9792 
Space group P212121 I212121 
Cell dimensions  
a, b, c in Å 
α, β, γ  
 
47.79, 57.75 Å, 142.31  
90.00°, 90.00°, 90.00° 
 
48.17, 58.33 Å, 141.84  
90.00°, 90.00°, 90.00° 
Datarange in Å 70.9-2.2 70.9-1.9 
I/σI 14.99 
(2.48) 
12.19 
(5.27) 
Observations  78, 627 105, 665 
Unique observations  20, 282 30, 605 
Redundancy 3.9 3.5 
Completeness in % 99.0 
(97.6) 
98.7 
(95.5) 
Rsym in % 7.4 
(52.2) 
8.2 
(35.6) 
Table 2-3. Data collection for the crystal structure of B. burgdorferi Pur-
α . SeMet refers to the selenomethionine-derivatized crystal, Rsym refers to 
the unweighted R-value on I between symmetry mates. Numbers in 
parantheses indicate values for the highest resolution shell. 
 
 
Phase angles were determined by single wavelength anomalous dispersion (SAD) using 
the peak wavelength. The structural model was also build from this dataset. Refinement 
was performed with REFMAC (Murshudov et al., 1997) using non-crystallographic 
symmetry (NCS) with two molecules per asymmetric unit. Translation, Liberation, and 
Screw rotation (TLS) displacement tensors (Winn et al., 2001) were used and allowed to 
model anisotropic displacement of the atoms. Refinement resulted in final Rwork = 18.7 % 
and Rfree = 25.0 % (Table 2-4). The comparatively high difference of Rwork and Rfree can at 
least in part be explained with radiation damage of the selenium atoms. The structural 
model contains amino acids 3 to 79 as well as 161 water molecules. Although the DNA 
oligonucleotide hTel12 (Table 5-2) was present in the crystallization conditions 
(section 5.10.1), the DNA was not visible in the crystal structure. Bond lengths and 
angles are in good accordance with protein geometry as root mean square deviations 
(RMSD) from ideal values are very small (RMSD for bond length 0.012 Å, RMSD for 
bond angles 1.275 °). The Ramachandran plot visualizes possible conformations for the 
dihedral angle of a peptide bond in protein structures. For the structural model, 98 % of 
the amino acids lie in favored regions of the Ramachandran plot (Table 2-4). The B-
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factor gives a measure for the effective diameter of an atom’s electron density and 
reflects the fluctuation of the atom around its average position. The low B-facor (22.1 Å2) 
of the crystal structure corresponds to a high degree of order (Table 2-4). 
 
Dataset SeMet Peak 
Data range in Å 70.9-1.9 
Reflections 21, 157 
Rwork in % 18.5 
Rfree in % 23.0 
RMSD bond length in Å 0.010 
RMSD bond angles in deg 1.169 
Ramachandran plot in % 
           Favored 
           Allowed 
           Outlier 
 
98 
2 
0 
Average B-factor in Å2 23.5 
Table 2-4. Refinement statistics for the crystal structure of B. burgdorferi 
Pur-α . RMSD refers to root mean square deviation. 
 
 
Crystal structure of B. burgdorferi Pur-α  
The structural model of B. burgdorferi Pur-α revealed that it crystallized as a dimer. Each 
monomer is comprised of a 4-stranded anti-parallel β-sheet followed by an α-helix, as 
shown in the ribbon backbone model (Figure 2-6). One peptide chain intertwines with the 
other chain, resulting in a buried surface interface of 2058 Å2 per monomer 
(section 3.1.3).  
The part of the crystallized protein that is visible in the structural model (amino acids 3 to 79) 
nicely matches the homology region that was characterized as Borellia PUR (amino acids 3 
to 74) (Figure 2-2), thus indeed one PUR repeat corresponds to a structural entity. The 
interaction of two monomers results in a globular domain that is referred to as PUR domain. 
The PUR domain exhibits one side showing both α-helices (α-helical side) and one side 
showing both β-sheets (β-sheet side) (Figure 2-6). 
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The dimerization of B. burgdorferi Pur-α is mostly stabilized by hydrophobic interactions, as 
the assessment of the buried surface interface reveals a large number of aliphatic and 
aromatic residues. Hydrophobic amino acids on the inward oriented side of the α-helices 
include phenylalanine, leucine, alanine, isoluecines and valine (F62, L66, A69, I70, I73, 
V72). They are complemented by hydrophobic residues on the inner side of the β-sheets, 
including valines, tyrosines, phenylalanine, leucin, and isoleucines (V7, V24, V54, Y8, Y20, 
F22, L34, I36, I52). Phenylalanine 62 and tyrosine 20 may additionally contribute to stability 
by π-stacking interaction. Putative electrostatic interactions between the two chains are rare, 
as charged residues are generally oriented towards the solvent. At the interface between the 
α-helices, favourable electrostatic interaction may form between asparagine 60/lysine 74 and 
glutamate 63/lysine 74. At the edge between the α-helix and the adjacent β-sheet, hydrogen 
bonds may form between gluatamin 10/asparagine 65 and tyrosine 55/lysine 68.  
The submission of the B. burgdorferi Pur-α crystal structure to the RSCB protein data 
bank (PDB) is in preparation. 
 
Figure 2-6. Crystal 
structure of B. burgdorferi 
Pur-α .  
A: Ribbon backbone model 
of the PUR domain formed 
by two monomers, β-sheet 
side. One monomer is 
depicted in red, the other in 
gold. B: View from (A), 
rotated by 180° around the 
vertical axis, α-helical side. 
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Surface assessment  
A plot of the electrostatic potential on the surface of the crystal structure of B. burgdorferi 
Pur-α reveals differences concerning both sides of the PUR domain (Figure 2-7). 
The α-helical side of the PUR domain is rich in negative charge mainly due to glutamic acid 
residues (E57, E56, E61, E63) and bears only a few positively charged residues, like lysines 
(K68, K74). In contrary, the β-sheets of the PUR domain have a more pronounced positive 
surface charge, mainly due to arginine and lysine residues (R4, K11, R18, K25, R28, R29, 
R41, R49) and exhibit fewer negatively charged residues like aspartic acid (D31, D46) 
(Figure 2-7). 
This suggests the β-sheet side is a potential nucleic-acid binding surface, as nucleic-acid 
binding sites are typically enriched in positively charged residues and depleted in negatively 
charged residues (Bahadur et al., 2008). 
 
 
 
 
 
Figure 2-7. Electrostatic 
surface potential of 
B. burgdorferi Pur-α . A: 
Surface representation of the 
solvent-accessible surface of 
the PUR domain, β-sheet side. 
Dark blue coloration indicates 
positive charge, red indicates 
negative charge and white 
shows uncharged regions. B: 
α-helical side, view from (A), 
rotated by 180° around the 
vertical axis. Orientations are 
as given in the ribbon 
backbone model on the 
bottom.  
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Systematic structural comparison 
A systematic structural comparison using DaliLite (Holm, 2008) unveiled moderate 
similarity to a number of crystal structures, two of them from bacteriophage coat 
proteins, which are dimeric RNA-binding proteins. 
The highest score was obtained for bacteriophage coat protein from Pseudomonas phage 
pp7 (PDB-ID: 2QUD; Z-score: 5.2; RMSD: 4.8 for 68 α-carbon pairs) (Chao et al., 2008) 
(Figure 2-8). The other bacteriophage coat protein was from Enterobacterio phage ms2 
(PDB-ID: 1MSC; Z-score: 4.6; RMSD: 4.8 for 67 α-carbon pairs) (Ni et al., 1995) 
(Figure 2-8). 
The typical characteristics of bacteriophage coat proteins are a N-terminal β-hairpin, a 
five-stranded antiparallel β-sheet and two C-terminal α-helices. To form anti-parallel 
dimers, the α-helices of two protein chains intertwine into each other. On the opposing 
side, the dimer exhibits an extended β-sheet. The flat β-sheet is comprised of 10 β-
strands from both monomers and is reported to be the RNA binding surface for both 
bacteriophage coat proteins (Chao et al., 2008; Ni et al., 1995) (PDB-ID: 2QUX). 
 
Figure 2-8. Structures 
from the PDB with 
similarity to 
B. burgdorferi Pur-α .  
A: Coat protein from 
Pseudomonas phage 
pp7 (PDB-ID: 2QUD). 
B: View from (A) 
rotated by 180° around 
the vertical axis.  
C: Coat protein from 
enterobacterio phage 
ms2 (PDB-ID: 1MSC). 
D: View from (C) 
rotated by 180° around 
the vertical axis.  
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The structural model of B. burgdorferi Pur-α lacks the N-terminal β-hairpin, has only a 
four-stranded β-sheet and only one α-helix. However, the dimerization mode is similar: 
the α-helices intertwine and the β-sheets locate at the opposing side. Another pronounced 
difference is that in B. burgdorferi Pur-α, the β-sheets are positioned in a steep angle 
with respect to each other, resulting in a roof-like topology (Figure 2-6). In the 
bacteriophage coat proteins, the β-sheets form flat surface (Figure 2-8). 
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2.1.1.3 Drosophila melanogaster Pur-α   
Pur-α is the only member of the Pur family found in Drosophila (GeneID 43797). The 
protein is comprised of 274 amino acids (31.0 kDa). Sequence identity to human Pur-α is 
49 %, and sequence similarity is 66 %. 
The self-alignment of D. melanogaster Pur-α yielded the positions of its three PUR 
repeats (section 2.1.1.1) (Figure 2-2). PUR repeat I is comprised of amino acids 40-92, 
PUR repeat II of aminoa acids 116-190, and PUR repeat III of amino acids 193-242. The 
sequence identity of repeat I and II is 33 %, whereas the sequence similarity is 61 % 
(Table 2-5). Repeat III is slightly more divergent from repeat I and repeat II, with an 
identity of 25 % to repeat I (similarity 53 %) and an identity of 32 %  (similarity 56 %) to 
repeat II (Table 2-5).  
 
Identity/Similarity 
in % 
 
PUR Repeat I 
 
PUR Repeat II 
 
PUR Repeat III 
PUR Repeat I - 33 / 61 25 / 53 
PUR Repeat II 33/ 61 - 32 / 56 
PUR Repeat III 24 / 53 34 / 56 - 
Table 2-5. Sequence conservation between the three PUR repeats of 
D. melanogaster Pur-α . 
 
 
Crystallization of D. melanogaster Pur-α  repeats I-II 
In order to guide the design of D. melanogaster Pur-α expression constructs, the 
B. burgdorferi crystal structure was used to build a homology model of D. melanogaster 
Pur-α. The homology model of D. melanogaster Pur-α was done by J. Söding using the 
server HHpred (Söding et al., 2005) (Appendix 7-1). The computational model 
successfully predicted folded domains, as the protein fragments derived from it were 
stable and crystallizable (Table 2-6). The protein fragments were expressed in E. coli and 
purified using a GST-tag (section 5.7.1 and section 5.8.1). 
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Construct Tag Expression Purification/
Stability 
Initial  
Crystals 
Refined  
Crystals 
Comment 
dmPurA1-274 GST + +   a) 
dmPurA115-185 GST + -    
dmPurA181-260 GST + + + +  
dmPurA185-260 GST + + + +  
dmPurA188-258 GST + + + +  
dmPurA36-185 GST + -    
dmPurA40-105 GST -     
dmPurA40-185 GST ++ ++ ++ ++ b) 
dmPurA40-245 GST + -    
dmPurA40-255 GST + + -   
dmPurA40-274 GST + +/-    
dmPurA46-185 GST + -    
Table 2-6. Protein fragments of D. melanogaster Pur-α  for crystallization trials. dmPurA refers 
to D. melanogaster Pur-α , the numbers indicate the start and stop site of the amino acid 
sequence. a) Full length protein, b) used for structure determination and trials of heavy atom 
soaking, DNA soaking and co-crystallization with DNA.   
 
 
The crystallization experiments were performed at room temperature, unless stated 
otherwise (section 5.10). A fragment of D. melanogaster Pur-α 40-255, which comprises 
all three PUR repeats, did not yield any initial crystals in 384 conditions tested.  
Then crystallization of a fragment only containing PUR repeat I and PUR repeat II was 
tried. Pur-α 40-185 crystallized in 17 out of 480 conditions at 21 °C and in 5 out of 480 
conditions at 4 °C. Several conditions were refined and screened for single three-
dimensional crystals. Best crystals were found in solutions containing MES buffer and 
PEG 3350. It was found that the crystal size was dependent on the PEG content, as bigger 
crystals were grown at lower PEG concentration (Figure 2-9). Finally, D. melanogaster 
Pur-α 40-185 was crystallized at a concentration of 3-5 mg/ml at 21 °C. The 
crystallization solution contained 50 mM MES pH 5.9, 200 mM magnesium chloride, 
and 25 % PEG 3350. Cuboid crystals of approximately (100 x 50 x 50) µm appeared 
within 2-4 days and diffracted up to 2.1 Å.  
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Figure 2-9. Crystals of D. melanogaster Pur-α  repeats I-II. Pur-α  40-185 was 
crystallized in 50 mM MES pH 5.9, 200 mM magnesium chloride and 35 % (A), 30 % 
(B), respectively 25 % (C) PEG 3350. 
 
 
Selenomethionine-derivatized protein was produced and purified as described 
(section 5.7.1 and 5.8.1). The crystallized fragment of D. melanogaster Pur-α 40-185 
contains three methionines, so the mutational introduction of methionines was not 
necessary. The selenomethionine-derivatized protein crystallized in the same conditions 
as the native protein, however, crystals grew very big with the largest dimension up to 
600 µm. The crystals broke or cracked during transfer and cryo-protection. Thus 
crystallization solution and protein concentration had to be refined. Finally, crystals of 
selenomethionine-derivatized D. melanogaster Pur-α 40-185 were grown at a 
concentration of 2.7 mg/mL in buffer containing 200 mM magnesium chloride, 100 mM 
HEPES pH 7.8, and 22 % PEG 3350. They had a size of approximately 
(150 x 50 x 50) µm and diffracted up to 2.1 Å. 
 
Figure 2-10. Crystal of selenomethionine-derivatized D. melanogaster Pur-α  repeats I-II. 
Initial crystals of Pur-α  40-185 obtained with 200 mM magnesium chloride, 100 mM MES 
pH 6.8, and 22 % PEG 3350. B: Refined crystals of Pur-α  40-185 obtained with 200 mM 
magnesium chloride, 100 mM HEPES pH 7.2, and 22 % PEG 3350. C: Refined crystals of 
Pur-α  40-185 obtained with 200 mM magnesium chloride, 100 mM HEPES pH 7.8, and 
22 % PEG 3350. 
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Structure determination and refinement  
Synchrotron radiation diffraction data were collected at ESRF (Figure 2-11). The native 
crystals of D. melanogaster Pur-α repeats I-II belong to spacegroup P2 with cell 
constants a = 63.17 Å, b = 62.54 Å, c = 64.48 Å and angles α = γ = 90.00°, β = 90.01°. A 
native dataset was recorded at beamline ID14-1 (ESRF) with a wavelength of 0.934 Å 
(Table 2-7). A Q210 CCD ADSC detector was used to collect 600 frames with an 
oscillation angle of 0.5° each.  
Initially, molecular replacement was tried using the program PHASER (McCoy et al., 
2007) with the structural model of B. burgdorferi Pur-α as a search ensemble. 
Unfortunately, no convincing solution was found.  
Thus, selenomethionine-derivatized protein crystals were produced. An anomalous data 
set was recorded at beamline ID14-4 (ESRF) (Table 2-7). The crystals diffracted up to 
2.1 Å and are isomorphous to the crystals obtained with native protein (Figure 2-11). The 
beamline was equipped with a Q315r ADSC CCD detector. From one crystal, datasets at 
three different wavelengths (peak, inflection, and remote) were recorded (Table 2-7). For 
the peak wavelength, 720 frames with an oscillation angle of 0.5° per image were 
collected. Since the crystal showed signs of radiation damage, for the inflection and 
remote wavelengths, the number was reduced to 360 frames (oscillation angle 0.5° per 
image). Prior to data collection, a fluorescence scan determined the optimal wavelengths. 
Peak wavelength was 0.9789 Å (12.6656 keV, f’ = -7.95, f’’ = 6.20), inflection point was 
0.9791 Å (12.662679 keV, f’ = -10.33, f’’ = 2.39), and for high remote 0.9567 Å 
(12.9602 keV) was chosen. 
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Dataset 
 
Native SeMet  
Peak 
SeMet 
Inflection 
SeMet  
Remote 
X-ray source ID14-1 (ESRF) ID14-4 (ESRF) ID14-4  ID14-4  
Wavelength in Å 0.934 0.9789  0.9791 0.9567 
Spacegroup P2 P2   
Cell dimensions  
a, b, c in Å 
α, β, γ 
 
63.17,62.54, 64,48 
90.00°, 90.00°, 90.01° 
 
63.17,62.54, 64,48 
90.00°, 90.00°, 90.04° 
  
Data range in Å 64-2.1 
(2.23-2.1) 
64-2.1 
(2.23-2.1) 
64-2.1 
(2.23-2.1) 
64-2.1 
(2.23-2.1) 
I/σI 16.00 
(4.35) 
16.15 
(5.28) 
18.04 
(6.43) 
13.45 
(3.25) 
Observations  174, 369 212, 070 104, 025 112, 661 
Unique observations  28, 601 56, 933 54, 477 58, 851 
Redundancy 6.1 3.7 1.9 1.9 
Completeness in % 98.9 
(94.6) 
96.0  
(80.5) 
91.9  
(75.5) 
92.1  
(75.8) 
Rsym in % 7.0 
(40.3) 
5.4  
(20.8) 
2.9 
(10.7) 
3. 7  
(26.6) 
Table 2-7. Data collection for the crystal structure of D. melanogaster Pur-α  repeats I-II. SeMet 
refers to the selenomethionine-derivatized crystal, Rsym refers to the unweighted R-value on I 
between symmetry mates. Numbers in parentheses indicate values for the highest resolution 
shell. 
 
 
Phases were determined by multiple wavelength anomalous dispersion (MAD) and 
extended to 2.1 Å. The structural model was build from the native dataset. Refinement 
was done with REFMAC (Murshudov et al., 1997) using NCS and TLS. Final R-factors 
are Rwork= 22.3 % and Rfree= 24.0 %. Four copies of the protein fragment were found in 
the asymmetric unit. The structural model consists of amino acids 40 to 184, eight 
Figure 2-11. Diffraction 
images of 
D. melanogaster Pur-α  
repeats I-II. 
A: Crystal of native 
protein. 
B: Crystal of 
selenomethionine-
derivatized protein. 
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chloride ions, three ethylene glycol molecules (from the cryo-protectant), and 117 water 
molecules. In the Ramachandran plot, 95 % of the residues are in the allowed regions and 
bond lengths and bond angles comply with protein geometry (RMSD 0.016 Å, and 1.77°, 
respectively) (Table 2-8). 
 
Dataset Native 
Data range in Å 64.0-2.1 
Reflections 27, 900 
Rwork 22.3 
Rfree 24.0 
RMSD bond length in Å 0.016 
RMSD bond angles in deg 1.77 
Ramachandran plot in % 
           Favored 
           Allowed 
           Outlier 
 
95 
4.5 
0.5 
Average B factor in Å2 36.6 
Table 2-8. Refinement statistics for the crystal 
structure of D. melanogaster Pur-α  repeats I-II.  
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Crystal structure of D. melanogaster Pur-α  repeats I-II 
The structural model of D. melanogaster Pur-α repeats I-II shows that both PUR repeats 
adopt the same fold. Each repeat is comprised of a four-stranded anti-parallel β−sheet, 
followed by a C-terminal α-helix (Figure 2-12). A short linker region connects both 
repeats, which intertwine into each other to form an intra-molecular dimer. Therein, the 
α-helix from one repeat intercalates into the other repeat. This results in a large 
hydrophobic buried surface interface of approximately 33 % of each repeat’s surface 
(1830 Å2 per repeat). The globular domain formed by the intra-molecular dimer 
corresponds to one PUR domain, which was already described in this study for 
B. burgdorferi Pur-α (section 2.1.1.2). The PUR domain exhibits one β-sheet side 
(Figure 2-12, A) and one α-helical side (Figure 2-12, B). 
 
 
In the crystal structure, the PUR domain is formed by intra-molecular dimerization of 
PUR repeats I and II. Their attachment seems to be mainly stabilized by hydrophobic 
interactions. The inward oriented face of the α-helices is rich in aromatic and aliphatic 
side chains such as phenylalanines, leucines, and tyrosin (F93, F100, F171, F182, L97, 
L175, L178, Y107). They pack against the hydrophobic inside of the β-sheets, which 
Figure 2-12. Crystal structure of 
D. melanogaster Pur-α  repeats I-II, 
PDB-ID 3K44. A: Ribbon 
backbone model of the globular 
PUR domain formed by two PUR 
repeats. The first repeat is depicted 
in green, the second in blue. The 
linker in shown in grey. B: View 
from (A), rotated by 180° around 
the vertical axis. 
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includes leucines, phenylalanines, valines, isoleucines, and tyrosines (L44, L49, L58, 
L121, L135, L137, L146, L163, F56, V60, V71, V148, I69, I83, I161, Y133). A possible 
π-stacking interaction is seen between phenylalanines 97 and 171, which are located at 
the interface of the α-helices. Charged residues are generally oriented towards the solvent 
and seem to play a minor role in stabilizing the PUR domain. However, some potential 
hydrogen bonds are located at the solvent exposed interfaces of the secondary structure 
elements. The interaction between both α-helices is stabilized by hydrogen-bonds 
between serine 98 and arginine 172 and between arginine 94 and threonine 176. At the 
interface between the α-helices and the β-sheets, hydrogen bond form between: 
lysine 47/asparagine 177, lysine 47/glutamate 181, glutamine 52/glutamine 166, 
histidin 96/glutamate 124, and serine 99/lysine 122. 
The crystal structure of D. melanogaster Pur-α 40-185 has been submitted to the RSCB 
protein data bank, PDB-ID 3K44.  
 
Surface assessment 
The electrostatic surface potential of the crystal structure of D. melanogaster Pur-α 
repeat I and II reveals a different charge distribution for the α-helical and the β-sheet side 
of the PUR domain (Figure 2-13). The α-helical side shows moderate negative charge. In 
contrast, a number of positively charged residues is located at the opposing β-sheet side. 
The β-sheet formed by PUR repeat II (Figure 2-13, D) appears to bear more pronounced 
positive charge (K121, R132, K138, R142, R147, R155, R158) than the β-sheet formed 
by PUR repeat I (R55, K61, R65, K70, R80) (Figure 2-13, C). The clustering of positive 
charge on the β-sheets suggests that they are potential nucleic-acid binding surfaces 
(Bahadur et al., 2008). 
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Figure 2-13. Electrostatic surface potential of 
D. melanogaster Pur-α  repeats I-II. A: Surface 
representation of the solvent-accessible surface of 
the PUR domain, β-sheet side. Dark blue 
coloration indicates positive charge, red indicates 
negative charge and white shows uncharged 
regions. The dashed line indicates the unconserved 
rim (Figure 2-12). B: View from (A), rotated by 
180° around the vertical axis, α-helical side. C: 
Close-up of the β-sheet of PUR repeat I. D: Close-
up of the β-sheet of PUR repeat II. Orientations 
are as given in the ribbon backbone model above.  
 
 
Both sides of the PUR domain also reveal great differences in sequence conservation on 
the surface. The amino acid sequences of Pur-α from D. melanogaster, human, 
Caernohabditis elegans, and Arabidopsis thaliana were aligned and plotted on the 
surface of the crystal structure (Appendix 7-2 and Figure 2-14). Whereas the α-helical 
side is almost devoid of highly conserved residues, the opposing β-sheet side reveals 
considerable sequence conservation. Both conserved β-sheets are clearly separated by an 
un-conserved rim (dashed line in Figure 2-14). This suggests the two separated conserved 
regions might act independently from each other. 
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Figure 2-14: Surface conservation of 
D. melanogaster Pur-α  repeats I-II. A: Surface 
representation of sequence conservation at the 
solvent-accessible surface, β-sheet side. Dark 
green coloration indicates complete 
conservation, light green indicates partial 
conservation, white shows unconserved regions. 
B: View from (A), rotated by 180° around the 
vertical axis, α-helical side. C: Close-up of the 
β-sheet of PUR repeat I. D: Close-up of the β-
sheet of PUR repeat II. Orientations are as 
given in the ribbon backbone model above. The 
sequence alignment is given in (Appendix 7-2). 
 
 
 
Taken together, electrostatic potential and surface conservation hint at the β-sheet side 
for functional importance and nucleic-acid binding.  
 
Comparison with the crystal structure of B. burgdorferi Pur-α  
The crystal structures of B. burgdorferi Pur-α and D. melanogaster Pur-α repeats I-II 
show a pronounced structural conservation. Both proteins have the same ββββα-topology 
and superpose nicely (Figure 2-15). Pairwise comparison with DaliLite (Holm and Park, 
2000) delivers a Z-score of 6.1 and an RMSD of 2.3 Å for 68 α-carbon pairs. 
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The most prominent difference is that the PUR domain is constituted by inter-molecular 
dimerization in the B. burgdorferi structure, whereas is build from an intra-molecular 
interaction in D. melanogaster Pur-α. In the B. burgdorferi structure, β-strand 3 and β-
strand 4 are subtly distorted and slightly longer compared to their D. melanogaster 
counterparts. Also the α-helices are slightly longer in the B.  burgdorferi structure.  
The observed RMSD of about 2 Å is in the expectation range for evolutionary related 
proteins with a sequence identity of about 20 % (section 3.1.2) (Koehl and Levitt, 2002). 
 
Systematic structural comparison  
A systematic structural comparison was performed using DaliLite (Holm et al., 2008). 
Significant structural similarities were found to a set of proteins, while none of the 
proteins had a sequence identity higher than 16 %. 
Highest scores were obtained for two hypothetical proteins from cyanobacteria with 
unknown function (PDB-ID: 2IT9; Z-score: 11.4; RMSD: 3.5 Å for 116 α-carbon pairs / 
PDB-ID: 2NVN; Z-score: 10.9; RMSD: 3.7 Å for 118 α-carbon pairs).  
Among annotated proteins, highest scores were obtained for the Mitochondrial RNA-
Binding Protein-2 (MRP-2) (PDB-ID: 2GIA; Z-score: 8.2; RMSD: 4.7 Å for 114 α-
carbon pairs) and the Mitochondrial RNA-Binding Protein-1 (MRP-1) (PDB-ID: 2GJE; 
Z-score: 7.0; RMSD: 4.7 Å for 108 α-carbon pairs) from Trypanosoma brucei 
Figure 2-15. Superposition of the crystal 
structures of B. burgdorferi Pur-α  (red) and 
D. melanogaster Pur-α  repeats I-II (blue). 
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(Figure 2-16). A high score was also achieved by Plant Transcriptional Regulator PBF-2 
(P24) (PDB-ID: 1L3A; Z-score: 6.9; RMSD: 4.7 Å for 113 α-carbon pairs) from 
Solanum tuberosum (Figure 2-16).  
 
 
Figure 2-16. Structures 
from the PDB with 
similarity to 
D. melanogaster Pur-α  
repeats I-II.  
A: Mitochondrial RNA-
Binding Protein-1 (MRP1) 
(PDB-ID: 2GIA) and 
Mitochondrial RNA-
Binding Protein-2 (MRP2) 
(PDB-ID: 2GJE) from 
Trypanosoma brucei.  
B: Plant Transcriptional 
Regulator PBF-2 (P24) 
from Solanum tuberosum 
(PDB-ID 1L3A). 
 
 
All three proteins contain a Whirly domain that suits to the overall ββββα−ββββα 
topology of the PUR domain and nicely superposes with it (Figure 2-17). The main 
differences to the PUR domain are longer loop regions and a rotated orientation of the β-
sheets. In addition, MRP2 has a longer kinked a-helix at the C-terminus. It is intriguing 
that the structural similarity is accompanied by a functional correlation, as MRP-2 and 
MRP-1 are RNA-binding proteins (Schumacher et al., 2006), whereas P24 binds to 
dsDNA and ssDNA (Desveaux et al., 2002).  
Figure 2-17. Superposition of the PUR domain 
with a Whirly domain. A: Structure of Pur-α  
repeats I-II is depicted in grey, structure of 
MRP2 is shown in red. B: Close-up  showing 
the orientation  of the β-sheets from Pur-α  and 
MRP2. 
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To conclude, the systematic structural comparison revealed that Pur-α belongs to the 
Whirly class of nucleic-acid binding proteins (section 3.1.4). 
 
Crystallization trials of D. melanogaster Pur-α  repeat III 
To obtain structural information on the PUR repeat III of D. melanogaster Pur-α, 
crystallization trials with protein fragments consisting of the third repeat only were 
initiated. Again, the structural model made by J. Söding guided the design of expression 
constructs. Initial crystallization set ups were performed with Pur-α 185-260 and crystals 
formed in 15 out of 384 conditions. For refinement, also Pur-α 185-258, Pur-α 181-260 
and Pur-α 188-258 were employed. Best crystals were obtained for Pur-α 188-258. 
Mainly needle-shaped crystals were obtained (Figure 2-18, A). During crystal transfer 
and cryo-protection, many of them broke or cracked. The needles were tested at the 
ESRF and diffracted up to 4 Å. In some conditions, additional hexagonal and pentagonal 
crystal plates formed (Figure 2-18, B). 
 
 
Figure 2-18. Crystals of D. melanogaster Pur-α  repeat III. A: Pur-α  188-258 was 
crystallized at 4 °C A: Crystallization solution contained 100 mM sodium cacodylate pH 7.5, 
0.2 M ammonium acetate, 15 % PEG 3350, and 4 % MPD.  B: Crystallization solution 
contained 100 mM sodium cacodylate pH 7.5, 0.2 M sodium acetate, and 26 % PEG 3350. 
C: Crystallization solution contained 100 mM sodium cacodylate pH 7.5, 200 M sodium 
acetate, 22 % PEG 3350. 
 
Most of these plate-shaped crystals grow attached to the plastic surface of the 
crystallization plate and could not be transferred. However, the few that could be 
transferred and tested at the ESRF diffracted up to 3 Å. Therefore, it was aimed at 
refining the conditions in favor of the plate-shaped crystals. It was found that low protein 
concentration (0.3-0.5 mg/mL) promoted this crystal form and more crystals freely 
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floating in the crystallization drop were obtained. After optimization, crystals of 
D. melanogaster Pur-α 188-258 were grown at a concentrations of 0.3 mg/mL at 4 °C. 
The crystallization solution contained 22 % PEG 3350, 100 mM sodium cacodylate 
pH 7.5 and 200 mM sodium acetate. After 1-2 days, needle-shaped crystals appeared 
with a size of (300 x50 x 50) µm. After 2-3 weeks, additional pentagonal and hexagonal 
crystal plates of (100 x50 x 50) µm size formed, which diffracted up to 2.8 Å 
(Figure 2-18, C). 
A native dataset was recorded at 2.8 Å at the ESRF (ID14-1) (Figure 2-19). Crystals 
belong to spacegroup P212121 with cell constants a = 55.3 Å, b = 60.3 Å, c = 121.7 Å and 
angles α = β = γ = 90.00°. 
Molecular replacement was attempted using the program PHASER (McCoy et al., 2007). 
The structural models of D. melanogaster Pur-α repeats I-II respective B. burgdorferi 
Pur-α were used as search ensembles, but no convincing solution was found. To tackle 
the phase problem, the production of selenomethionine-derivatized protein crystals is in 
progress.  
 
 
 
 
 
 
 
Figure 2-19. Diffraction 
image of a native crystal 
of  D. melanogaster Pur-
α  repeat III. 
 
 
Co-crystallization trials of D. melanogaster Pur-α  repeats I-II with nucleic acids 
Crystals of D. melanogaster Pur-α repeats I-II were soaked with DNA and RNA 
oligonucleotides, as this fragment proved functional in nucleic acid binding 
(section 2.2.1.3 and section 5.14). Several datasets were recorded and after indexing, the 
same space group and unit cell constants were obtained as for the apo-structure. 
Molecular Replacement with the structural model revealed no extra-density in the unit 
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cell, so soaking was not successful. This is not surprising, since for these crystals, a 
Matthew’s coefficient of 1.9 Å3/Da was calculated, which corresponds to a solvent 
content of only 35 %. Therefore the unit cell seems already crowded in the apo-structure, 
leaving little space left for nucleic acids. In order to obtain a different crystal form, co-
crystallization was attempted (section 5.10.4). 
The protein fragment of D. melanogaster Pur-α repeats I-II, which was crystallized 
successfully (Figure 2-9), was further employed in co-crystallization trials with nucleic 
acids. As (GGN)n repeats constitute the consensus sequence of Pur-α (section 1.3) 
(Bergemann et al., 1992), (CGG)n repeat oligomers were chosen. To avoid that flexible 
parts of the nucleic acid disturb crystallization, its lengths was only 7 nucleotides 
(Table 5-2), as this matches the dimensions of the anticipated binding surface in the 
crystal structure of Pur-α repeats I-II. In order to distinguish crystals of a complex of 
protein and DNA from protein crystals, Cy3-labelled DNA was used (section 5.10.4).  
 
 
Figure 2-20. Crystals of 
D. melanogaster Pur-α  repeats I-
II and DNA. Pur-α  40-185 and 
Cy-3 labeled CGG 7mer ssDNA 
(1:2).  
A: Crystals of approximately 
(100 x 40 x 20) µm size, obtained 
with 50 mM MES pH 5.9 and 
20 % MPD. B: Crystals of 
approximately (80 x 20 x 20) µm 
size, obtained with 50 mM MES 
pH 5.9, and 30 % MPD,  
 
 
 
 
 
 
 
 
Figure 2-21. Diffraction 
image of crystals of 
D. melanogaster Pur-α  in 
complex with DNA. Pur-α  40-
185 with Cy-3 labelled CGG 
7mer ssDNA. 
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Initial crystals were obtained in 9 out of 480 conditions tested. After preliminary 
optimization, crystals of D. melanogaster Pur-α 40-185 and Cy3-CGG 7mer ssDNA 
(1:2) were grown at a concentration of 2.5-4 mg/mL. Crystallization solutions contained 
50 mM MES pH 6.5 and 30 % MPD or 50 mM MES pH 6.5 and 28 % PEG 400 
(section 5.10.4). Most crystals had a rice-grain shape of approximately 
(100 x 25 x 20) µm size. Individual crystals had a pointed shape with an approximate size 
of (100 x 40 x 20) µm. Crystals were tested for diffraction at SLS. The diffraction quality 
of the crystals is poor, as only individual spots were detected at a maximum resolution of 
15 Å, and many spots were enlarged and smeared (Figure 2-21). Refinement of the 
crystallization conditions is ongoing.  
Likewise, co-crystallization with short RNA oligonucleotides was tried. The affinity of 
D. melanogaster Pur-α repeats I-II to CGG 12mer RNA was shown in electrophoretic 
mobility shift assays (section 2.2.1.3 and Figure 2-33). Initial crystal screens were 
performed with Cy3-labeled CGG 7mer RNA, but no crystals were obtained. 
 51 
2.1.2 Solution structure of Pur-α  
2.1.2.1 Analytical size-exclusion chromatography 
To probe the oligomeric state of Pur-α, analytical size-exclusion chromatography was 
performed. After calibration of the column with proteins of known molecular weights, 
the molecular weight of the sample was calculated from the elution peak volume.  
For D. melanogaster Pur-α repeats I-II (amino acid 40 to 185), the peak appeared at 
15.0 mL (loaded concentration 5 µM), corresponding to a calculated molecular weight of 
17.4 kDa. Given the theoretical molecular weight of the protein fragment (16.8 kDa), 
Pur-α repeats I-II is monomeric in solution.  
D. melanogaster Pur-α repeats I-III (amino acids 40-255) eluted at 13.79 mL (loaded 
concentration 5 µM), corresponding to a calculated molecular weight of 36.5 kDa. This 
rather corresponds to a dimer, as the theoretical molecular weight of the protein fragment 
is 25.2 kDa. The difference between the calculated molecular weight from the calibration 
curve and the actual molecular weight of a dimer might hint at a monomer-dimer 
equilibrium. To assess if dimerization is concentration dependent, concentrations in the 
range of 5 µM to 200 nM were loaded (Figure 2-22). 
 
 
 
 
The estimated protein concentration on the column was calculated by multiplication of 
the loaded concentration with the dilution factor. The dilution factor was obtained by 
dividing the volume of the sample loaded by the volume of the elution peak. Leading as 
Figure 2-22. Analytical size-
exclusion chromatography with 
D. melanogaster Pur-α  repeats I-
III. The column was loaded with 
0.5 mL protein solution at five 
different concentrations as given 
above. 
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well as trailing portions of the peak were ignored by defining peak volumes to absorption 
areas above 10 % of the peak maximum. For each concentration, the molecular weight 
was calculated from the elution peak volume (Table 2-9). 
 
Loaded Protein 
conentration in nM 
Estimated concentration on 
column in nM 
Elution volume 
at peak in mL 
Calculated molecular 
weight in kDa 
5000 1140 13.79 36.5 
2000 420 13.56 41.9 
1000 150 13.59 41.2 
500 75 13.71 38.2 
200 30 13.71 38.2 
Table 2-9: Analytical size-exclusion chromatography with D. melanogaster Pur-α  repeats I-III at 
various concentrations. Theoretical molecular weight of one peptide chain is 25.2 kDa. 
 
 
There was a slight concentration-dependence of the observed elution volumes, as the 
elution volume was a little smaller for higher concentrations, yielding a higher molecular 
weight. The exception was the measurement for the highest concentration loaded (5 µM, 
corresponding to 0.126 mg/mL), which had a surprisingly high elution volume. However, 
the calculated molecular weight for each concentration rather corresponds to a dimer than 
to a monomer. Thus, dimerization occurs at concentrations on the column as low as 
30 nM and as high as 1.14 µM (Table 2-9). In conclusion, Pur-α repeats I-III dimerizes in 
solution and possibly exists in a monomer-dimer equilibrium. 
The physiological concentration of Pur-α has not been reported, but since dimers also 
form at a concentration as low as 30 nM, Pur-α is likely to dimerize also in vivo. 
The observation that Pur-α repeats I-II is monomeric, but Pur-α repeats I-III is dimeric, 
hinted at the fact that repeat III induces dimerization and led to further investigation of 
the solution structure via small angle X-ray scattering (SAXS). 
 
 
2.1.2.2 Small angle X-ray scattering  
To complement the crystal structure with a solution structure, small angle X-ray 
scattering (SAXS) experiments were performed. The main advantage of solution 
scattering over crystallography is that the protein is studied in nearly physiological 
conditions. Moreover, different conformations of flexible parts can be examined 
(Bernado et al., 2007; Putnam et al., 2007). However, SAXS only allows the 
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determination of the overall shape of the molecule, as the resolution limit is estimated to 
be 10 Å (Bernado et al., 2007; Putnam et al., 2007; Svergun et al., 2001). Furthermore, 
the molecular weight of the sample and thus the oligomeric state of the protein in solution 
can be determined (Mylonas and Svergun, 2007).  
In an SAXS experiment, a solution of the biological macromolecule of interest is exposed 
to X-rays and the scattered intensity is recorded in dependence of the scattering angle. 
The intensity is plotted as a function of the momentum transfer or scattering vector s 
(s = 4πλ-1sinθ, with the scattering angle 2θ). Due to the random orientation of the protein 
molecules, the scattering intensity is isotropic and proportional to the scattering intensity 
of one molecule averaged over all orientations (Svergun et al., 2001). To eliminate the 
contribution of the solvent to the scattering, blank measurements with buffer only are 
performed before and after each experiment. 
At lowest resolution, the scattering intensity is given by a single parameter, the radius of 
gyration (Rg). The radius of gyration is a measure for the size and shape of the scattering 
particles, as it is the square root of the average squared distances of each scattering atom 
from the center of each particle. For scattering angles near zero, the Guinier plot (ln(I(s) 
against s2) gives a linear function (Guinier and Fournet, 1955). Its slope can be used to 
calculate Rg. It should be noted that only homogenous samples with low attractive forces 
between the molecules give a linear Guinier plot. It can thus be used to monitor sample 
quality. To obtain a linear Gunier plot, only data for small scattering angles were used 
with the constraint Rg * s < 1.3.  
The intercept of the Guinier plot gives the scattering intensity at zero angle (I0). As I0 is 
only dependent on the amount of scattering electrons of the molecule, it can be used to 
calculate the molecular weight of the sample (Putnam et al., 2007). To this end, scattering 
curves for standard proteins (bovine serum albumin and lysozyme) with known 
molecular weight were recorded. Their scattering intensities were extrapolated to zero 
angle and provided a calibration curve (I0 versus M). The scattering intensity of the 
sample was extrapolated to zero angle and the molecular weight was calculated from the 
calibration curve. 
At high resolution, the scattering intensity is dependent on the shape of the scattering 
molecule. For a folded macromolecule, the scattering intensity I(s) falls off with s-4 
(Porods law). From Porod’s law, the Kratky plot (s2 * I(s) versus s) can be deduced, 
which shows typical characteristics for unfolded, partially folded and folded 
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macromolecules. For folded protein, Porod’s law applies, and the Kratky plot has a 
parabola-like shape. For partially unfolded and unfolded proteins, the Kratky plot shows 
a plateau for higher s values (Putnam et al., 2007).  
 
 
The pair-distribution function P(r) is the Fourier transform of the scattering curve I(s) and 
represents a real-space approximation of the scattering particles. It gives information 
about all distances (r) between the electrons in the protein. To obtain the pair-distribution 
function, the maximum linear dimension of the particle (Dmax) has to be iteratively 
determined. This was done by inspection of the pair-distribution function for different 
estimates of Dmax. P(r) should be zero at r = Dmax and at r = 0. The pair-distribution 
function also provides information on the shape of the scattering molecule, as it has the 
form of a parabola for globular proteins and a more skewed shape for elongated 
molecules (Putnam et al., 2007). 
From the scattering curves, a three-dimensional reconstruction of the scattering molecule 
can be calculated. For ab initio reconstruction, the program GASBORp was used 
(Svergun et al., 2001). It uses a chain-like ensemble of dummy residues that correspond 
to the distances between Cα-atoms in a peptide chain (Svergun et al., 2001). The 
obtained shape reconstructions from independent calculations were aligned with the 
program SUBCOMP to yield an averaged model with the most conceivable and reliable 
features (Kozin and Svergun, 2000).  
 
Figure 2-23. Kratky plot for folded, 
partially folded, and unfolded proteins. 
Figure taken from (Putnam et al., 2007). 
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SAXS of D. melanogaster Pur-α  repeats I-II 
In the crystal structure, D. melanogaster Pur-α repeats I-II appeared monomeric with 
both PUR repeats intertwining into each other (Figure 2-12). To assess if this 
conformation is also found in solution, the fragment that was crystallized (Pur-α 40-185) 
was employed in SAXS measurements.  
Synchrotron SAXS data was recorded at beamline X33 at European Molecular Biology 
Laboratory (EMBL, Hamburg, Germany) and at beamline ID14-3 at ESRF. The 
measurement was performed at three different concentrations in the same buffer that was 
used for analytical size-exclusion chromatography (500 mM sodium chloride, 20 mM 
HEPES) with the addition of 3 mM DTT (Table 2-10 and section 5.15).  
Data analysis was done with the ATSAS program package (Konarev et al., 2006).  
An Rg of 2.0-2.1 nm was obtained from the Guinier plot with a Dmax of 7.5-8.0 nm 
(Table 2-10). 
The molecular weight for each sample was obtained from the scattering intensity at zero 
angle (Table 2-10). An average molecular weight of (17.5 ± 1.2) kDa was calculated. 
Given the theoretical molecular weight of the fragment (16.8 kDa), this confirms that 
Pur-α repeats I-II is monomeric.  
 
 
Concentration  
in mg/mL 
Concentration  
in µM 
Rg 
in nm 
Dmax 
in nm 
Mol. weight 
in kDa 
Beamline 
4.55 270.8 2.0 7.5 17.4 ID14-3  
3.90 232.1 2.1 8.0 18.7 X33  
1.76 104.8 2.0 7.5 16.4 X33  
Table 2-10. SAXS measurements for D. melanogaster Pur-α  repeats I-II. Rg refers to radius of 
gyration, Dmax refers to maximum particle size.  
 
 
The Kratky plot of D. melanogaster Pur-α repeats I-II has the typical bell-shaped form of 
a folded protein (Figure 2-23 and Figure 2-24, A) (Putnam et al., 2007).  
The shape of the Pair-distribution function showed a rather symmetric peak that is typical 
for a globular molecule (Figure 2-24, B). Since the PUR domain seen in the crystal 
structure has an overall globular shape, this complies with its existence also in solution.  
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Using GASBORp, a bead model reconstruction was calculated from the SAXS data 
(Figure 2-25, A) (Svergun et al., 2001). The crystal structure could be fitted nicely into 
the envelope, further supporting the assumption that the PUR domain is also stable in 
solution (Figure 2-25, B) From the crystal structure, a theoretical scattering curve was 
calculated using CRYSOL (Svergun et al., 1995). The theoretical and the experimental 
scattering curve superpose nicely (Figure 2-25). This confirms that the structure of 
D. melanogaster Pur-α repeats I-II in aqueous solution equals the structure observed in 
the crystal.  
 
Figure 2-25. SAXS 
analysis for 
D. melanogaster 
Pur-α  repeats I-II.  
A: Bead model 
reconstruction. The 
crystal structure 
was fitted into the 
bead model with 
SUBCOMP.  
B: Overlay of the 
experimental 
scattering curve 
(black) with the 
theoretical 
scattering curve 
(blue) of the crystal 
structure. 
Figure 2-24. 
Analysis of SAXS 
data for 
D. melanogaster 
Pur-α  repeats I-II.  
A: Kratky plot.  
B: Pair-
distribution 
function. 
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SAXS of D. melanogaster Pur-α  repeats I-III 
By analytical size-exclusion chromatography, it was found that D. melanogaster Pur-α 
repeats I-III forms dimers (section 2.1.2.1 and Figure 2-22). This issue was further 
examined by SAXS.  
Synchrotron SAXS data was recorded at beamline X33 at EMBL and at beamline ID14-3 
at ESRF. The measurement was performed at three different concentrations in the same 
buffer that was used for analytical size-exclusion chromatography (500 mM sodium 
chloride, 20 mM HEPES) with the addition of 3 mM DTT (Table 2-11 and section 5.15). 
It should be noted that buffer conditions were not optimal. The examination of the 
Guinier plot for higher concentrations than 1.53 mg/mL showed that the protein 
aggregated. Therefore, only the lowest concentration was used for the bead model 
reconstruction. For future experiments, an extensive screening for improved buffer 
conditions (e. g. with dynamic light scattering) is recommended, to obtain scattering 
curves at higher concentrations and with an improved signal to noise ratio.  
Data analysis was done with the ATSAS program package (Konarev et al., 2006). An Rg 
value of 3.6-4.4 nm was obtained from the Guinier plot with a Dmax of 13.0-14.0 nm 
(Table 2-11). 
The molecular weight for each sample was obtained from the scattering intensity at zero 
angle, yielding an average molecular weight of (46.0 ± 4.6) kDa (Table 2-11). This 
corresponds to a dimer, as the theoretical molecular weight of the fragment Pur-α 
repeats I-III is 25.2 kDa. The dimerization of Pur-α repeats I-III is induced by PUR 
repeat III, as Pur-α repeats I-II is monomeric (Table 2-10). 
 
Concentration  
in mg/mL 
Concentration  
in µM 
Rg 
in nm 
Dmax 
in nm 
Mol. Weight 
in kDa 
Beamline 
1.53 60.5 4.4 14.0 50.3 ID14-3  
1.11 43.9 3.8 13.5 46.6 ID14-3  
0.9 35.6 3.6 13.0 41.1 X33  
Table 2-11. SAXS data of D. melanogaster Pur-α  repeats I-III. Rg refers to radius of gyration, Dmax 
refers to maximum particle size.  
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The Kratky plot shows that Pur-α repeats I-III is predominantly folded, but might contain 
some unstructured regions (Figure 2-23 and Figure 2-26, A) (Putnam et al., 2007). The 
Pair-distribution function shows the typical skewed shape of an elongated molecule 
(Figure 2-26, B). 
 
 
 
Figure 2-26: 
Analysis of SAXS 
data for 
D. melanogaster 
Pur-α  repeats I-
III.  
A: Kratky plot.  
B: Pair-
distribution 
function.  
 
 
 
Taken together, the analysis of the SAXS data confirmed the existence of the dimer, but 
also suggested that it might not be entirely stable. Firstly, the average molecular weight is 
lower than expected for a dimer (Table 2-10). This could arise from a monomer-dimer 
equilibrium, as suggested by the fact that a higher molecular weight was calculated for 
higher protein concentrations. Secondly, the Kratky plot indicates that there are 
unstructured regions (Figure 2-26, A). These are most likely due to the PUR repeat III, as 
the Kratky plot for Pur-α repeats I-II shows the typical form of a folded protein 
(Figure 2-24, A). An explanation would be that a fraction of Pur-α is monomeric. The 
third repeat might be unstructured, when it has no interaction partner.  
 
Dimerization is most likely achieved by interaction of PUR repeat III with another PUR 
repeat III from a second peptide chain (Figure 2-27). In this model, PUR repeats I and II 
of both Pur-α molecules form the globular PUR domain as seen in the crystal structure. 
The two PUR repeats III connect both peptide chains, yielding an elongated dimer 
(Figure 2-27).  
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PUR repeat III is nearly as homologous to the other two PUR repeats in D. melanogaster 
Pur-α, as they are to each other and to Borrelia PUR (section 3.1.6). Given that the latter 
three all adopt a very similar fold (Figure 2-15), it is tempting to speculate that also PUR 
repeat III might adopt a similar fold (section 3.1.6). The proposed interaction between 
two PUR repeats III (Figure 2-27) might then be constituted by PUR domain formation.  
 
To test this hypothesis, the surface envelope was calculated from the SAXS data using 
the program GASBORp (Figure 2-28) (Svergun et al., 2001). The calculated bead model 
had an unexpected Z-shape that can accommodate three PUR domains (Figure 2-28, B). 
For a good fit into the envelope, the PUR domain in the middle has to be oriented 
perpendicular to the two flanking PUR domains. Thus, although the overall shape of Pur-
α repeats I-III is elongated, the PUR domains are not arranged in a strictly linear way. It 
should be noted that the SAXS data do not prove that the dimerization model is correct, 
but they are in accordance with the model (section 3.1.6 and section 3.1.7).  
 
Figure 2-28. SAXS  
analysis for  
D. melanogaster Pur-α  
repeats I-III.  
A: Scattering curve.  
B: Bead model 
reconstruction for Pur-α  
repeats I-III. Three 
copies of the crystal 
structure of Pur-α  
repeats I-II were placed 
into the bead model.  
 
Figure 2-27. Dimerization model of 
Pur-α . One molecule is depicted in 
dark grey, the other in light grey. 
Two PUR repeats III interact with 
each other to dimerize Pur-α . 
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2.2 Functional studies  
2.2.1 Nucleic-acid binding of Pur-α  
2.2.1.1 Human Pur-α   
Filter binding assays were performed with the intention to find high-affinity 
oligonucleotides for co-crystallization trials with human Pur-α. The studies concentrated 
on previously known targets that included the recognition sequence (GGN)n. 
Krachmarov and colleagues demonstrated that Pur-α binds the major late promotor of 
human polyoma virus 2 (JCV) via the Tat-responsive DNA element upTAR. At the JCV 
upTAR element, transcription is synergistically enhanced by Tat protein and Pur-α 
(Krachmarov et al., 1996). The ssDNA oligonucleotide JCV upTAR was constructed by 
D. Niessing in previous work (Table 5-2). 
Chepenik and colleagues demonstrated binding of Pur-α to HIV-1 TAR RNA and 
suggested a role of Pur-α in the activation of transcription of HIV-1 (Chepenik et al., 
1998). Short RNA stem loops derived from HIV-1 TAR RNA (TAR14AU and 
TAR14GC) were constructed and tested for binding in previous work by D. Niessing 
(Table 5-2).  
The (GGN)n repeat motif is also present in the 3’-overhang of human telomeric DNA 
(Itoh et al., 1998). Thus short sequences derived from human telomeric DNA (hTel12 
DNA and hTel6 DNA) were also tested in previous work by D. Niessing (Table 5-2). 
Johnson and colleagues demonstrated binding of Pur-α to short sequences from BC200 
RNA and its functional rat homolog, BC1 RNA (Johnson et al., 2006; Kobayashi et al., 
2000). Thus in vitro transcribed BC200 RNA (200 nt) and BC1 RNA (152 nt), were 
included in binding experiments (Table 5-2). 
 
Filter binding assays 
For none of these targets, binding constants were previously determined. To evaluate 
which oligonucleotides might be most suitable for co-crystallization, filter binding assays 
with human Pur-α were performed. The oligonucleotides are radioactively labeled at 
their 5’-end, incubated with increasing amounts of protein and blotted on an activated 
nitrocellulose membrane (section 5.16.2 and section 5.16.3). The membrane retains the 
protein, but not the olignucleotide, unless it is bound to the protein. Radioactive signal on 
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the membrane is detected using a Phosphorimaging system. By plotting the relative 
bound fraction of radioactively labeled oligonucleotide against the protein concentration, 
saturation curves are obtained. The equillibrium dissociation constant (KD) is derived 
from the Langmuir isotherm. 
Filter binding assays were performed with human Pur-α 56-287 C272S, because this was 
the largest fragment of Pur-α that could be purified and it includes the entire nucleic-acid 
binding domain (White et al., 2009) (Table 2-1 and Table 2-12). 
 
 
Oligonucleotide Type Length KD in nM n 
JCVupTAR ssDNA 12 nt 232 ± 37  2 
hTel12 ssDNA 12 nt 443 ± 46 3 
TAR14AU Stem loop RNA 16 nt 38 ± 1 2 
TAR14GC Stem loop RNA 16 nt 85  2 
Cntrl1 ssDNA 12 nt no binding 3 
PolyC ssDNA 12 nt no binding 3 
BC1 Stem loop RNA 152 nt 724 ± 23 3 
BC200 Stem loop RNA 200 nt 621 ± 95 3 
Table 2-12. Filter binding assays with human Pur-α  56-287 C272S. 
nt = nucleotides, KD = equilibrium dissociation constant, n = number of 
experiments.  
 
 
Human Pur-α bound with good affinity to the tested DNA as well as RNA 
oligonucleotides, while preferring the latter (KD in the nanomolar range). The affinity was 
strongest for TAR14AU stem loop RNA (KD = 38 nM), followed by TAR14GC stem 
loop RNA  (KD = 85 nM) (Table 2-12 and Figure 2-29). 
The affinity to the DNA oligonucleotides was about 5-times weaker, as for JCVupTAR 
ssDNA (KD = 232 nM) and hTel12 ssDNA (KD = 443 nM). Binding to the in vitro 
transcribed RNA (BC1 and BC200) was also significantly lower, with a KD of 724 nM 
(612 nM, respectively) (Table 2-12 and Figure 2-29). 
In the following, TAR14AU stem loop RNA and JCVupTAR ssDNA were employed in 
co-crystallization assays (section 2.1.1.1).  
No significant binding was observed to the control oligonucleotides (Cntrl1 and PolyC) 
(Table 5-2), which do not contain the consensus sequence. This indicates a sequence-
specific mode of binding. 
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2.2.1.2 B. burgdorferi Pur-α   
To assess if the B. burgdorferi ortholog of Pur-α is indeed a functional Pur protein, its 
nucleic-acid binding properties were probed. The oligonucleotides previously employed 
for human Pur-α were used in filter binding assays with B. burgdorferi Pur-α full length 
(amino acids 1 to 122).   
 
Filter binding assays 
In filter binding assays, the binding of B. burgdorferi Pur-α to ssDNA was confirmed 
(JCVupTAR ssDNA KD = 480 nM and hTel12 ssDNA KD = 413 nM) (Table 2-13). The 
affinities were similar to those obtained with human Pur-α (KD = 200-400 nM) (Table 2-
12 and Figure 2-31, A). 
The binding seems to be specific, as no significant signal was observed for control 
ssDNA (Cntrl1) lacking the consensus sequence (Table 5-2). This indicated that the 
B. burgdorferi ortholog shares not only a sequence similarity, but also a functional 
conservation and encouraged the pursuit of its crystal structure (section 2.1.1.2).  
 
Figure 2-29. Representative 
filter binding curves for 
human Pur-α .  
A: Binding of Pur-α  56-287 
C272S to hTel12 DNA, 
KD = 438 nM.  
B: Binding of Pur-α  56-287 
C272S to TAR14GC RNA, 
KD = 85 nM. 
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Oligonucleotide Type Length KD in nM n 
JCVupTAR ssDNA 12 nt  480 ± 81 4 
hTel12 ssDNA 12 nt  413 ± 18 4 
TAR14AU Stem loop RNA 16 nt no saturation 3 
TAR14GC Stem loop RNA 16 nt no saturation 3 
Cntrl1 ssDNA 12 nt no binding 3 
MS2 Hairpin RNA 19 nt no saturation 3 
PP7 Hairpin RNA 25 nt no saturation 3 
Table 2-13. Filter binding assays with B. burgdorferi Pur-α  full length. KD = equilibrium 
dissociation constant, n = number of experiments.  
 
 
Binding to the RNA oligonucleotides could be not confirmed. The signal of bound RNA 
increased with higher protein concentration, but no saturation was observed even with 
protein concentrations as high as 8 µM (Table 2-13). This indicates a very weak affinity 
or even an unspecific mode of binding.  
Crystal structure determination of B. burgdorferi Pur-α revealed a structural similarity to 
bacteriophage coat proteins from Pseudomonas phage pp7 (Chao et al., 2008) and from 
enterobacterio phage ms2 (Ni et al., 1995) (section 2.1.1.2). These are RNA binding 
proteins, which bind a specific hairpin RNA (PP7 and MS2, respectively). It was 
speculated whether B. burgdorferi Pur-α binds to these hairpin RNA, therefore filter 
binding experiments with the respective oligonucleotides were performed.  
B. burgdorferi Pur-α full length showed some binding to the PP7 RNA and MS2 RNA 
oligonucleotides, as the signal of retained radioactivity increased with higher protein 
concentrations. Alas, no saturation of the signal was obtained with a protein 
concentration as high as 8 µM (Table 2-14). A KD would be even higher for this 
interaction. The binding is therefore very weak and/or unspecific (Table 2-13). 
In summary, B. burgdorferi Pur-α binds specifically to the PUR consensus sequence in 
DNA oligonucleotides, but only very weakly and/or unspecifically to the RNA targets 
tested. It is possible that species-specific RNA targets for B. burgdorferi Pur-α exist, but 
none are reported. 
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Filter binding assays with mutant Pur-α  
To map the binding surface on the crystal structure of B. burgdorferi Pur-α, mutational 
studies were performed. Surface assessment of the crystal structure of B. burgdorferi Pur-
α led to the identification of candidate amino acids that might be involved in nucleic-acid 
binding. Surface-exposed candidate amino acids were selected by their positive charge 
(preferably arginines) and their degree of conservation between species, as the DNA 
binding properties are conserved. The respective arginines were replaced by alanines 
(section 5.6.1). 
One point mutation (R18A) was introduced in the second β-strand of the β−sheet in the 
Borrelia PUR repeat. Two adjacent arginines (R28A, R29A) were mutated in the 
connector between the second and third β-strand. One mutation was introduced in the 
fourth strand of the β-sheet (R49A) (Figure 2-30).  
The B. burgdorferi Pur-α full length mutant proteins were tested in filter binding assays 
and the results were compared to the binding affinities of the wild type protein (Table 2-
13 and Table 2-14). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-30. Position of the 
mutations which affect nuleic acid 
binding in B. burgdorferi Pur-α . 
Backbone Ribbon model of the 
crystal structure, one monomer is 
shown in red, the second monomer 
is depicted in gold. Arginines that 
were mutated to alanines are 
highlighted in blue. 
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Protein Oligonucleotide Type Length KD n 
bbPurA1-122 wt JCV upTAR ssDNA 12 nt 480 ± 81 3 
bbPurA1-122 wt hTel12 ssDNA 12 nt 413 ± 18 3 
bbPurA1-122 R18A JCV upTAR ssDNA 12 nt Appr. 1 µM 3 
bbPurA1-122 R18A hTel12 ssDNA 12 nt No saturation  3 
bbPurA1-122 R28A hTel12 ssDNA 12 nt No saturation 3 
bbPurA1-122 R28A, R29A hTel12 ssDNA 12 nt no binding 3 
bbPurA1-122 R49A JCV upTAR ssDNA 12 nt no binding 3 
bbPurA1-122 R49A hTel12 ssDNA 12 nt No binding 3 
Table 2-14. Filter binding assays with mutants of B. burgdorferi Pur-α . KD = equilibrium 
dissociation constant, n = number of experiments, wt = wild type. No saturation at 8 µM. 
 
The B. burgdorferei Pur-α 1-22 R18A bound JCVupTAR ssDNA with an approximate 
KD of 1 µM (Table 2-14), thus the mutation R18A only weakly affected binding. The 
affinity to hTel12 ssDNA was more strongly impaired. The signal of retained 
oligonucleotide increased with higher protein concentrations, but no saturation of the 
signal was obtained with a protein concentration as high as 8 µM (Table 2-14). A KD 
would be even higher for this interaction. 
The same effect was observed for the mutation R28A, as for the binding of 
B. burgdorferi Pur-α 1-122 R28A to hTel12 ssDNA, no saturation was achieved at a 
protein concentration of 8 µM (Table 2-14). 
Because of their immediate vicinity, arginine 29 was also mutated and the double mutant 
was assessed. B. burgdorferei Pur-α 1-22 R28A R29A showed a total loss of affinity to 
both ssDNA oligomers tested (Table 2-14). 
An abolishment of ssDNA binding was also seen for B. burgdorferei Pur-α 1-22 R49A 
In summary, the effects of the point mutations support the hypothesis that the β-sheets 
are the nucleic-acid binding surfaces of B. burgdorferi Pur-α.  
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2.2.1.3 D. melanogaster Pur-α  
The binding affinities of D. melanogaster Pur-α to nucleic acid targets previously 
described for human Pur-α were assessed. Further, two additional sequences were 
probed. 
Bergemann and colleagues assessed the binding of human Pur-α to zones of replication 
and suggested (GGAGG) ssDNA as the minimal requirement for binding. MF0677 
ssDNA is a 24mer containing this consensus sequence and flanking regions (Table 5-2). 
This oligonucleotide was previously employed in mobility shift competition assays 
(Bergemann et al., 1992). 
Jin and colleagues reported that D. melanogaster Pur-α binds to r(CGG)n repeats in the 
Fmr1 mRNA in a Drosophila model of Fragile X Tremor/Ataxia Syndrome. For pull-
down experiments, r(CGG)105 RNA was employed (Jin et al., 2007).  
In this study, the binding of Pur-α to shorter repeat oligonucleotides (CGG 12mer ssRNA 
and CGG 25mer ssRNA) was probed (Table 5-2). 
 
 
 
Figure 2-31. 
Representative 
filter binding 
curves for 
B. burgdorferi 
Pur-α . 
A: Binding to 
hTel12 DNA with 
wild type Pur-α  
full length. 
B: Binding to 
hTel12DNA with 
mutant protein 
Pur-α  full length 
R28A. 
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Filter binding assays with Pur-α  repeats I-III 
Filter binding assays with D. melanogaster Pur-α and the previously described target 
oligomers of human Pur-α was assessed in filter binding assays. The fragment of Pur-α 
used contained the core region (PUR repeats I-III) and was comprised of amino acids 40 
to 255.  
The obtained binding affinities (Table 2-15 and Figure 2-32) were similar compared to 
those for human Pur-α (Table 2-12).  
Noticeably, unlike for human Pur-α, the standard deviations for this set of experiments 
were high, reaching 28 % of the measured KD value (Table 2-15). This reduces the 
reliance of the data and might arise from precipitation of the protein on the membrane. 
Thus, another approach to assess nucleic-acid binding was followed, that is 
electrophoretic mobility shift assay (EMSA).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Oligonucleotide Type Length KD in nM n 
hTel12 ssDNA 12 nt  873 ± 241 4 
CGG 12mer ssRNA 12 nt 675 ± 134 2 
TAR14AU Stem loop RNA 16 nt 376 ± 91 2 
TAR14GC Stem loop 16 nt 311 1 
Table 2-15. Filter binding assays with D. melanogaster Pur-α  40-255. 
KD = equilibrium dissociation constant, n = number of experiments.  
 
Figure 2-32. Representative filter binding 
curve for D. melanogaster Pur-α  repeats I-
III. Binding of Pur-α  40-255 to TAR14AU 
RNA.  
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Electrophoretic mobiliy shift assays with full length Pur-α  
Nucleic-acid binding of full length D. melanogaster Pur-α was assessed by EMSA with 
RNA and DNA oligonucleotides. Oligonucleotides were radioactively labeled at their 5’-
end, incubated with increasing amounts of protein and resolved on 6 % TBE gels. Gels 
were read out using a Phosphorimaging system (section 5.16.2 and section 5.16.4). The 
KD was estimated from the gels as the protein concentration, which shifted half the 
amount of labeled oligonucleotide. 
The nucleic-acid binding properties of D. melanogaster Pur-α full length (amino acids 1 
to 274) were examined in EMSAs. Full length Pur-α strongly bound to MF0677 ssDNA 
with a KD of about 5 nM. In the control experiment, no binding to Oligo-A ssDNA was 
observed (Figure 2-33, A). 
Binding to the RNA target was considerably weaker. Pur-α full length bound CGG RNA 
12mer with a KD of about 1 µM (Figure 2-33, B).   
The binding of Pur-α to CGG 12mer ssRNA was weaker than expected from previous 
work (Jin et al., 2007). Jin and colleagues pulled down Pur-α from fly extracts with 
notably longer RNA - r(CGG)105 RNA – therefore it was speculated if Pur-α would 
exhibit a more pronounced affinity to longer repeats. To test this, binding experiments 
were performed with CGG 25mer ssRNA, but no increase in affinity was observed, as the 
KD is approximately 1 µM (Figure 2-33, C). 
Taken together, the EMSAs showed strong and reproducible binding of D. melanogaster 
full length Pur-α to DNA as well as RNA. 
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Figure 2-33. EMSAs with 
D. melanogaster Pur-α  full 
length.  A: Binding to 
MF0677 ssDNA and to 
Oligo-A control DNA. 
B: Binding to CGG 12mer 
ssRNA. C: Binding to CGG 
25mer RNA. 
 
 
 
EMSAs with Pur-α  repeats I-II 
With the motivation to assess whether the crystallized fragment of Pur-α is indeed a 
functional nucleic-acid binding domain, EMSAs were performed with Pur-α repeats I-II 
(amino acids 40 to 185) (Figure 2-35). 
Strong binding was observed with MF0677 ssDNA, indicating a dissociation constant 
(KD) of at least 5 nM (Figure 2-35). Binding to CGG RNA 12mer was considerably 
weaker and indicated a KD around 1 µM (Figure 2-35).  
The measured affinities for Pur-α repeats I-II were analogous to those for full length Pur-
α. The crystallized PUR domain is thus indeed a functional nucleic-acid binding domain. 
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EMSAs with mutant Pur-α  repeats I-II 
To probe the hypothesis that the β-sheets are the nucleic-acid binding surface of the PUR 
domain (section 2.1.1.3), point mutations were introduced and their effect on DNA and 
RNA binding was assessed. As sites of mutagenesis, positively charged, conserved 
residues on the surface of D. melanogaster Pur-α repeats I-II were chosen. Due to the 
repetitive structure of Pur-α, point mutations were introduced in pairs, replacing both 
homologous amino acids in each repeat. The respective arginines were replaced by 
alanines (section 5.6.1). Double mutants were R80A, R158A and R65A, R142A 
(Figure 2-34). 
 
Figure 2-34. Position of the 
mutations which affected nucleic-
acid binding in D. melanogaster Pur-
α  repeats I-II. A: Ribbon backbone 
model of the PUR domain, the first 
repeat is depicted in green, the 
second in blue. Arginines that were 
mutated to alanines are highlighted 
in red (R80, R142) or orange (R80, 
R158). The residue highlighted in 
magenta (R55) is homologous to a 
residue in mouse Pur-α  that was 
found to be crucial for nucleic-acid 
binding in a previous study 
(Wortman et al., 2005). B: Close-up 
on the concave surface of β-sheet of 
repeat II. 
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The mutations R65A and R142A are located in the fourth β-strand of the β-sheet of each 
repeat (Figure 2-34). The double mutant Pur-α 40-185 R65A R142A showed the same 
affinity to ssDNA as the wild type protein, but its affinity to RNA was moderately 
decreased (Figure 2-35). 
 
 
 
 
 
 
Figure 2-35. EMSA with 
D. melanogaster Pur-α . A: Wild type 
Pur-α  repeats I-II and double mutant 
Pur-α  repeats I-II R65A, R142A with 
MF0677 ssDNA, and control Oligo-
A ssDNA.  
B: Wild type Pur-α  repeats I-II and 
double mutant Pur-α  repeats I-II 
R65A, R142A with CGG 12mer 
ssRNA.  
 
 
To further examine the contribution of single amino acids, fragments of Pur-α with single 
mutations were constructed. The point mutation R65A had no considerable effect on 
ssDNA or ssRNA binding (Figure 2-36). It shall be mentioned that the clone used had a 
spontaneous mutation at position 66 (S66G). However, since it showed no effect on 
binding, it can nevertheless be concluded that the mutation R65A has no effect on 
binding, either. 
 
 
 
Figure 2-36. EMSA with 
D. melanogaster Pur-α . A: Wild 
type Pur-α  repeats I-II and 
double mutant Pur-α  repeats I-
II R65A, S66G with MF0677 
ssDNA, and control Oligo-A 
ssDNA.  
B: Wild type Pur-α  repeats I-II 
and double mutant Pur-α  
repeats I-II R65A, S66G with 
CGG 12mer ssRNA.  
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The point mutation R142A had no effect on ssDNA binding, but moderately impaired 
ssRNA binding (Figure 2-37). 
 
 
 
 
Figure 2-37. EMSA with D. melanogaster 
Pur-α . A: Wild type Pur-α  repeats I-II 
and point mutant Pur-α  repeats I-II 
R142A, with MF0677 ssDNA, and control 
Oligo-A ssDNA. B: Wild type Pur-α  
repeats I-II and point mutant Pur-α  
repeats I-II R142A with CGG 12mer 
ssRNA. 
 
 
 
The mutations R80A and R158A are located in the loop that connects β−strand 2 with β−
strand 3 in both β-sheets (Figure 2-34). Pur-α 40-185 R80A R158A showed a total loss 
of affinity to ssDNA as well as to ssRNA binding (Figure 2-38). 
 
Figure 2-38. EMSA with 
D. melanogaster Pur-α . A: Wild type 
Pur-α  repeats I-II and double mutant 
Pur-α  repeats I-II R80A, R158A with 
MF0677 ssDNA.  
B: Wild type Pur-α  repeats I-II and 
double mutant Pur-α  repeats I-II 
R80A, R158A with CGG 12mer 
ssRNA.  
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The point mutation R80A decreased both ssDNA as well as ssRNA binding 
(Figure 2-39). The point mutation R158A had no effect on ssDNA binding, but ssRNA 
binding was decreased (Figure 2-40). 
 
 
 
Figure 2-39. EMSA with 
D. melanogaster Pur-α .  
A: Wild type Pur-α  repeats I-II 
and point mutant Pur-α  
repeats I-II R80A with MF0677 
ssDNA, and control Oligo-A 
ssDNA.  
B: Wild type Pur-α  repeats I-II 
and point mutant Pur-α  
repeats I-II R80A with CGG 
12mer ssRNA.  
 
 
In summary, the mutational studies show that surface-exposed amino acids located in the 
β-sheets are involved in nucleic-acid binding. This is further confirmed by the previously 
described mutation of arginine 71 to glutamic acid in mouse Pur-α (Wortman et al., 
2005). This mutation reduced binding to ssDNA as well as unwinding of dsDNA. The 
homologous residue in D. melanogaster Pur-α is arginine 55, which is located in the 
second β-strand of the β-sheet of PUR repeat I (Figure 2-34). 
 
 
Figure 2-40. EMSA with 
D. melanogaster Pur-α . A: Wild 
type Pur-α  repeats I-II  and 
point mutant Pur-α  repeats I-II 
R158A with MF0677 ssDNA, 
and control Oligo-A ssDNA.  
B: Wild type Pur-α  repeats I-II 
and point mutant Pur-α  repeats 
I-II R158A with CGG 12mer 
ssRNA.  
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Circular dichroism spectra of mutant Pur-α  repeats I-II 
Circular dichroism (CD) was used to confirm that the mutant proteins employed in 
binding studies are not defective in folding. CD measures the difference in absorption of 
left-handed polarized light and right-handed polarized light. In the far-UV region (190-
250 nm), a peptide bond gives rise to characteristic shape and magnitude of CD spectra, 
dependent on its structural environment (e.g. α-helix, β-sheet or random coil).  
CD spectra were recorded for native D. melanogaster Pur-α repeats I-II and for double 
mutants Pur-α repeats I-II R65A, R142 as well as Pur-α repeats I-II R80A, R158A 
(Figure 2-34). Overlay of the CD spectra for native protein and mutant proteins 
demonstrates a nice superposition (Figure 2-41). Thus the conformation of the mutant 
proteins and the native protein seems to be equivalent. It is concluded that the reduced 
nucleic-acid binding affinities of the mutant proteins are due to loss of functional amino 
acids that constitute the binding.  
 
 
 
 
Figure 2-41. CD spectra of 
D. melanogaster Pur-α  repeats I-II. 
The spectra for the wild type protein 
is depicted in green, for the double 
mutant R80A, R158A in red, and for 
the double mutant R65A, R142A in 
blue.  
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EMSAs with Pur-α  repeat III 
The observation that Pur-α repeats I-II does not show any significant difference in 
binding affinity compared to full length Pur-α, suggests that repeat III does not strongly 
contribute to nucleic-acid binding (Figure 2-33 and Figure 2-35) 
To examine this, EMSAs were performed with a fragment of Pur-α comprising the third 
repeat only (amino acids 185 to 260). 
Pur-α repeat III does bind with approximately 8-fold lower affinity to MF0677 ssDNA 
(KD = 40 nM) (Figure 2-42) than Pur-α repeat I-II. For Pur-α repeat I-II, the KD was 
5 nM (Figure 2-35). Binding to CGG 12mer ssRNA was also drastically reduced 
(KD = 5 µM) (Figure 2-42). For Pur-α repeats I-II, it was 1 µM (Figure 2-35). The third 
repeat thus only weakly contributes to nucleic-acid binding (section 3.2.2). 
 
 
 
 
 
 
 
 
Figure 2-42. EMSA with 
D. melanogaster Pur-α .  
A: Pur-α  repeat III with 
MF0677 ssDNA. B: Pur-
α  repeat III with CGG 
12mer ssRNA. 
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EMSA with quadruplex RNA and full length Pur-α  
In the 5’-untranslated region of Fmr1 mRNA, r(CGG)n repeats were reported to form 
quadruplex structures, which are recognized and bound by Fmr protein (Bole et al., 2008; 
Schaeffer et al., 2001). Therefore it was speculated if Pur-α prefers quadruplex structures 
as well.  
Quadruplexes can form in DNA and RNA sequences rich in guanine (G) content. They 
are formed by planar G tetrads, which are held together by reverse Hoogsteen base 
pairing. Several G tetrads can stack together and form quadruplex structures, which 
depend on the presence of monovalent cations. Potassium and sodium ions stabilize 
quadruplexes, whereas lithium ions do not, due to their small size (Burge et al., 2006; 
Williamson, 1994).  
It was examined if Pur-α prefers quadruplex structures using EMSAs under quadruplex-
promoting and -destabilizing conditions. Besides their dependence on potassium, 
quadruplexes can be destabilized by interacalation of a cationic porphyrin. In gel shift 
experiments, the cationic porphyrin 5,10,15,20-tetra(N-methyl-4-pyridyl)porphin 
(TMPyP4) was used as described (section 5.16.4) (Ofer et al., 2009).  
 
 
 
 
Figure 2-43. EMSA 
with D. melanogaster 
Pur-α  full length and 
CGG 25mer ssRNA. 
A: Potassium 
containing conditions. 
B: Potassium-free 
conditions. TMPyP4 
refers to the 
quadruplex-
destablizing drug 
5,10,15,20-tetra(N-
methyl- 
4-pyridyl)porphin. 
 
 
EMSAs were performed with D. melanogaster Pur-α full length and CGG RNA 25mer 
with gels and protein buffer containing potassium chloride. The observed KD is about 1-
1.5 µM (Figure 2-43, A). The addition TMPyP4 in the control lane without protein 
altered the running behavior of the RNA and no deposit band was observed. It is thus not 
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possible to compare the KD with and without the quadruplex-destablizing drug 
(Figure 2-43, A). 
Therefore, the same experiment was performed with gels and protein buffer containing 
no potassium, but lithium chloride. Quadruplexes cannot form under these conditions. 
The binding Pur-α to the CGG RNA 25mer exhibited a KD of about 0.5 µM (Figure 2-43, 
B). With the addition of TMPyP4, the shifted band remained, whereas the deposit was 
smeared as in the control lane containing TMPyP4 and RNA (Figure 2-43, B). 
If the binding affinities of Pur-α between quadruplex-promoting (Figure 2-43, A) and 
quadruplex-preventing (Figure 2-43, B) conditions are compared, the binding appears 
stronger in the latter case. This could hint a preference of Pur-α for non-quadruplex 
RNA.  
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2.2.2 Protein binding of Pur-α  
2.2.2.1 Yeast-two-hybrid screen 
To identify protein binding partners of Pur-α, a yeast-two-hybrid screen was 
commissioned to Hybrigenics (Paris, France). This technique allows for the assessment 
of non-covalent protein-protein interactions and is based on the modular structure of 
transcription factors. A bait protein is fused to the DNA-binding domain of a 
transcription factor and a number of prey proteins are fused to its activation domain. 
Yeast strains containing plasmids carrying either one of the two hybrid proteins are 
mated with each other. When bait and prey proteins interact with each other, the domains 
of the transcription factor come together. This stimulates specific transcription of the 
reporter gene, allowing for growth under selective conditions. Positive clones are then 
sequenced to reveal the identity of the prey protein. 
As bait protein, a fragment of D. melanogaster Pur-α comprised of amino acids 40 to 254 
was cloned in vectors pB27 (LexA system) and pB66 (Gal4 system) (Formstecher et al., 
2005; Fromont-Racine et al., 1997). Prey proteins were derived from a complex library of 
randomly primed cDNA fragments from poly(A)+RNA that was isolated from adult fly 
heads (Formstecher et al., 2005). No auto-activation with the bait alone was observed in 
either system. In the LexA system, 103 million interactions were tested and in the Gal4 
system 71 million interactions were probed. This refers to 10-fold (respectively 7-fold) 
the library complexity and indicates that screening was exhaustive. Positive clones were 
then sequenced at their 5’- and 3’-ends. With the longest continuous sequence a BLAST 
search was performed against GenBank, yielding the protein reference (Altschul et al., 
1997; Benson et al., 1994). A positive interaction is often detected with several preys that 
correspond to fragments of the same protein. The common sequence shared by 
overlapping fragments is referred to as selected interacting domain (SID) (Rain et al., 
2001). For each interaction, Hybrigenics calculates a biological score (PBS), which 
annotates its reliance. The PBS is based on a statistical model for the competition for 
bait-binding between fragments and represents the probability that the interaction is due 
to random noise or false positives (Rain et al., 2001). Interactions that are most probable 
to be specific are ranked in category A. Interactions with a decreased reliance are ranked 
in categories B and C. Category D includes interactions most probable due to artifacts. 
Category E reflects unspecific interaction due to highly connected prey domains that 
have a tendency to yield false positives.  
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Interactions with known proteins 
The yeast-two-hybrid screen identified seven interaction partners, which correspond to 
known proteins. These are Arrestin1 (Arr1), Btb VII, CG5758, Connector of AP to 
kinase (Cka), Eye, Lamin C (LamC), and Pur-α (Table 2-16). Among these proteins, it is 
noticeable that all interactions except one are based on only one prey fragment. This 
results in the classification in category D for most of them and hampers the correct 
assignment of the interaction domain (Table 2-16).  
 
 
Protein AA full 
length 
SID PBS Number of 
clones 
Screen 
Arr1 364 183-347 D 1 Gal4 
Btb VII 743 460-743 E 1 LexA 
CG5758 625 223-426 D 1 Gal4 
Cka 730 407-730 D 1 Gal4 
Eye 838 300-493 D 1 Gal4 
LamC 621 555-621 C 2 Gal4 
Pur-α 260 146-260 D 1 LexA 
Table 2-16. Interactions of Pur-α  with known proteins found in the yeast-two-hybrid screen. 
D. melanogaster Pur-α  40-254 was used as a bait. AA refers to amino acids, SID refers to selected 
interaction domain, PBS is the biological score assigned by Hybrigenics. 
 
Arrrestin1 
Arrestin1 (Arr1) was found as an interaction partner in the Gal4 system and was assigned 
to category D (Table 2-16). Arrestin1 is specifically expressed in the retina and functions 
as a multifunctional adaptor and transducer molecule (Lefkowitz and Shenoy, 2005). It 
regulates and mediates the signal transduction via G-protein coupled receptors. Arrestin1 
silences the receptor by binding to the light-activated phosphoryllated rhodopsin, leading 
to receptor endocytosis and desensitizing of the cell (Satoh and Ready, 2005). Arrestins 
shuttle between nucleus and cytoplasm. They have a dipartite structure with an N-
terminal and a C-terminal domain. The found interacting region for Pur-α (Table 2-16) 
maps to the C-terminal domain (amino acids 179-352), which is also involved in 
rhodopsin binding (Hirsch et al., 1999) (section 3.3.2.2).  
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Btb VII 
Btb VII was found in the LexA screen and was listed in category E, since it represents a 
highly connected, “sticky” protein (Table 2-16). The Btb protein-protein interaction 
domain is conserved throughout eukaryotes and exposes a large, versatile interaction 
surface. Btb proteins exert diverse functions, and are frequently included in 
transcriptional regulation and protein degradation (Perez-Torrado et al., 2006) 
(section 3.3.2.1).  
 
CG5758 
In the Gal4 screen, and interaction to CG5758 was found and assigned to category D 
(Table 2-16). The protein CG5758 was first discovered in a DNA microarray screen 
searching for genes with potential roles in the development of the wing disc of the 
Drosophila embryo (Butler et al., 2003). Butler and colleagues found that the CG5758 
transcript was enriched in the dorsal hinge and predicted a role in cell adhesion for the 
gene product (Butler et al., 2003; Jacobsen et al., 2006). The selected interaction domain 
of CG5758 with Pur-α (Table 2-16) is a predicted extracellular Fas domain 
(section 3.3.2.1). 
 
Cka 
The interaction with Connector of kinase to AP-1 (Cka) was found in the Gal4 screen and 
assigned to category D (Table 2-16). Cka is a regulatory kinase involved in the JUN N-
terminal kinase signal transduction pathway in Drosophila embryogenesis. This pathway 
controls the epithelial cell sheet movement during dorsal closure in the embryo. Cka 
regulates AP-1 activity and thus controls the spatial-temporal expression of AP-1 
regulated genes (Chen et al., 2002). The found fragment (Table 2-16) corresponds to a 
known protein-protein interaction domain that is a WD40-repeat domain 
(section 3.3.2.2).  
 
 81 
Eye 
The interaction to Eye protein was observed in the Gal4 screen and scored in category D 
(Table 2-16). The eyeless (eye) gene is a master regulatory gene for eye development in 
the Drosophila embryo. Eye, which is the Drosophila homolog of human Pax6, is also 
essential to control differentiation and function of neurons of the adult brain (Callaerts et 
al., 2001). It acts as a transcription factor and is suggested to regulate several genes 
involved in learning and memory (Callaerts et al., 2001). Eye is composed of four 
domains: at the N-terminus the paired domain, followed by the linker region connecting 
to the homeodomain, and the C-terminal domain. The paired domain and the 
homeodomain are DNA-binding regions, whereas the C-terminal domain is the 
transactivating domain of the transcription factor (Clements et al., 2009; Walther and 
Gruss, 1991). The fragment interacting with Pur-α in the yeast-two-hybrid screen 
(Table 2-16) contains the homeodomain (amino acids 398-470) (section 3.3.2.2).  
 
Lamin C 
In the Gal4 screen, the interaction to Lamin C (LamC) was scored in category C, because 
it was observed for two clones. However, the two LamC fragments were identical 
(Table 2-16). Lamin C belongs to the lamin familiy of intermediate filaments, which 
localize to the inner surface of the nuclear envelope (Schulze et al., 2005). It was 
previously believed that lamins do solely serve as mechanical support, but today there are 
hints that lamins also regulate tissue-specific gene expression (Worman and Courvalin, 
2002). Of particular interest are laminopathies, which are caused by mutations in lamin 
proteins and cause disorders of muscle, fat and nerve cells (Worman and Courvalin, 
2002). A-type lamins (Lamin C and Lamin A) are composed of a N-terminal rod domain 
followed by a C-terminal globular domain. The latter exhibits an Ig-like structure and 
contains mutation sites for several inheritable laminopathies (Krimm et al., 2002). The 
proposed interaction domain for Pur-α (Table 2-16) corresponds to a part of the C-
terminal domain (amino acids 465 to 582), but is not identical with it (section 3.3.2.2).  
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Pur-α  
The self-interaction of Pur-α was confirmed in the LexA screen and assigned to category 
D (Table 2-16). Only one clone was positive, bearing a fragment of Pur-α comprised of 
amino acids 146 to 260. This corresponds to a part of PUR repeat II in addition to the 
entire PUR repeat III (section 2.1.1.3 and section 3.3.2.2). 
 
Interactions with non-existing proteins 
A significant proportion of positive preys does not correspond to existing proteins 
(Table 2-17). Sequencing of those clones yields out-of-frame fragments, antisense 
fragments, and fragments located in untranslated regions of the mRNA. Because such 
preys do not correspond to existing proteins, no confidence score was given by 
Hybrigenics.  
 
Protein minimal 
Start/Stop 
(nt) 
Comment Number of clones Screen 
Argk 1675-345 antisense 4 Gal4 
Cac 7659-6257 antisense, fully in 3’-UTR 5 Gal4 
Camta 351-32 out-of-frame 1 Gal4 
Ced-6 1839-1362 antisense 3 Gal4 
E(Pc) 5225-6849 out-of-frame 1  Gal4 
GstS1 998-1232 out-of-frame, fully in 3’-UTR 1 Gal4 
inaF 674-1363 out-of-frame 9 Gal4 
ND75 1469-2303 out-of-frame 1 Gal4 
Pcm 2140-1856 antisense 1 Gal4 
Pde1c 3910-3355 out-of-frame, fully in 3’-UTR 2 Gal4 
Rab5 789-128 out-of-frame 1 Gal4 
scrt 610-1004 out-of-frame 1 Gal4 
Socs16D …-2476 antisense 1 Gal4 
Table 2-17. Interactions of Pur-α  with non-existing proteins found in the yeast-two-hybrid 
screen. D. melanogaster Pur-α  40-254 was used as a bait. nt refers to nucleotides. 
  
 
Interaction with so-called non-existing proteins do not yield a coding region when their 
sequence is used as a query for a BLAST search against GenBank (Altschul et al., 1997; 
Benson et al., 1994). In some cases, the sequence aligns with chromosomic DNA. These 
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are referred to as GenMatches by Hybrigenics (Table 2-18). The highest PBS (category 
A) was achieved for a GenMatch (GID 158246), which was found in as much as 32 
different fragments (Table 2-18).  
 
Gene minimal Start/Stop 
(nt) 
Number of 
clones 
Screen 
GID 112980799 1-… 1 Gal4 
GID 113193577 1-107 3 Gal4 
GID 113194556 1-638 1 Gal4 
GID 113194865 1-551 1 Gal4 
GID 113194944 1-314 1 Gal4 
GID 113194944 1-352 1 Gal4 
GID 158246 36-231 32 Gal4 
GID 55380579  1-391 1 Gal4 
GID 55380579 1-856 1 Gal4 
Table 2-18. GenMatch interaction partners of Pur-α  found in the yeast-two-hybrid 
screen. D. melanogaster Pur-α  40-254 was used as a bait. nt refers to nucleotide. 
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Chapter 3 Discussion 
3.1 Structure of Pur-α   
3.1.1 PUR repeats are highly conserved structural units  
Amino acid sequence analysis of metazoan Pur-α reveals that it is composed of three 
repetitive units, which are referred to as PUR repeats. J. Söding, employing the HHrepID 
server, did the assignment of the repeats, whose accuracy is confirmed by structural 
characterization. In the crystal structure of B. burgdorferi Pur-α as well as in the crystal 
structure of D. melanogaster Pur-α repeats I-II, the folded domains superpose exactly 
with the predicted repeat boundaries (Figure 2-6, Figure 2-12, and Appendix 7-2).  
The PUR repeats are located in the core region of Pur-α, which is required and sufficient 
for nucleic-acid binding and mediates many protein interactions (White et al., 2009). 
However, they are not identical to the previously described three class I and two class II 
repeats, which were also mapped in this region (Gallia et al., 2000). The detection of 
PUR repeats was made possible by advances in bioinformatic analysis, such as the 
HHrepID server. This program is very sensitive to distant homology, especially for repeat 
proteins (Biegert and Söding, 2008). The PUR repeats in D. melanogaster share an 
overall amino acid sequence identity of approximately 30 % (Table 2-5). Amino acid 
sequence alignment shows that the PUR repeats are conserved in orthologs from different 
species. Pur-α from Caernohabditis elegans, Arabidopsis thaliana, and human bear also 
three PUR repeats, whereas B. burgdorferi Pur-α has only one PUR repeat (Figure 2-2 
and Appendix 7-2). 
 
3.1.2 B. burgdorferi Pur-α  is a functional PUR protein 
The detection of PUR repeats enabled the identification of a distant bacterial homolog, 
B. burgdorferi Pur-α. Its core region (Borrelia PUR) shares an identity of about 20 % 
with the PUR repeats of D. melanogaster Pur-α (Figure 2-2). 
In addition to sequence identity, experimental evidence confirmed that B. burgdorferi 
Pur-α is indeed a functional PUR protein. Nucleic-acid binding properties were examined 
in filter binding assays with DNA and RNA targets that were previously reported to bind 
human Pur-α (section 2.2.1). Binding to DNA oligomers was specific (KD = 400-
500 nM), and showed affinities comparable to human Pur-α (KD = 200-400 nM). This 
suggests a conserved functionality and therefore encouraged the pursuit of the 
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B. burgdorferi Pur-α crystal structure (section 2.1.1.2). However, no binding was 
detected to the RNA oligomers. It cannot be judged if this result means that 
B. burgdorferi Pur-α has no RNA-binding ability, since there may exist unknown, 
species-specific RNA targets.  
Because B. burgdorferi Pur-α is annotated as a hypothetical protein, no comment on its 
in vivo functionality is attempted. However, one might speculate if parasitic Borrelia has 
adopted this gene from a metazoan host, as PUR proteins are generally conserved in 
metazoan, but only found in very few bacterial families.  
B. burgdorferi Pur-α was crystallized and its structure was solved at 1.9 Å 
(Rwork = 18.7 %, Rfree = 25.0 %) (section 2.1.1.2 and Figure 2-6). Based on the crystal 
structure and the sequence alignment, a homology model of D. melanogaster Pur-α was 
build by J. Soeding, employing the HHpred server (Appendix 7-1) (Söding et al., 2005). 
The domain boundaries predicted by the model allowed for the design of crystallizable 
metazoan Pur-α fragments, apparently for the first time.  
 
3.1.3 Two PUR repeats form a PUR domain 
A fragment of D. melanogaster Pur-α composed of the first two PUR repeats was 
crystallized and its structure was solved at 2.1 Å (Rwork = 22.3 %, Rfree = 24.0 %). The 
comparison with the structural model of B. burgdorferi Pur-α reveals a highly conserved 
fold with a ββββα-topology for each PUR repeat. In both crystal structures, two PUR 
repeats intertwine into each other to form a globular PUR domain. The PUR domain is 
structurally conserved in both homologs with an RMSD of 2.3 Å (Figure 2-15). In the 
case of B. burgdorferi Pur-α, PUR domain formation is achieved by inter-molecular 
dimerization, whereas the fragment of D. melanogaster Pur-α bears two PUR repeats and 
forms an intra-molecular dimer (Figure 2-6 and Figure 2-12). 
To distinguish between a nonspecific crystal contact and a specific interaction with 
biological relevance, the interaction surface of proteins in a crystal is analyzed. The 
combination of size, shape and complementary of the contact area allows for the 
prediction, if the crystallized state reflects the solution structure of the protein (Bahadur 
and Zacharias, 2008). The buried surface interface is 1830 Å2 per repeat in the 
D. melanogaster case, and 2058 Å2 in the B. burgdorferi structure (section 2.1.1.2 and 
2.1.1.3). These values are typical for heterodimers and significantly exceed those 
obtained by average crystal packing (Bahadur and Zacharias, 2008). Moreover, the shape 
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of the contact surface is typical for a specific interaction, as it is formed by one large 
patch without cavities and does not include water molecules. Typical is also the high 
number of aromatic and aliphatic residues on the buried surface and its depletion in 
charged residues, with a clear separation of hydrophobic core residues and polar rim 
residues (Bahadur and Zacharias, 2008). Taken together, the nature of the interaction 
surface indicates that the PUR domain is not a crystallographic artifact, but stable and 
specific.   
This conclusion is further confirmed by the assessment of the oligomeric state of Pur-α in 
solution. In analytical size-exclusion chromatography, the crystallized fragment of 
D. melanogaster Pur-α repeats I-II eluted at a volume corresponding to a monomer. 
From the calibration curve, a molecular weight of 17.4 kDa was calculated. This is in 
good accordance with the theoretical molecular weight (16.8 kDa) of the fragment. Since 
the size-exclusion column was calibrated with globular protein, the good accordance also 
hints at a globular shape of the fragment, as given by PUR domain formation.  
The monomeric state was also confirmed by molecular weight calculation from SAXS 
data, yielding 17.2 kDa (section 2.1.2.2 and Table 2-10). Moreover, the experimental 
scattering curve nicely superposes with the theoretical scattering curve calculated from 
the structural model. Consistently, the crystal structure fits into the bead model calculated 
from SAXS data (section 2.1.2.2 and Figure 2-25).  
It is thus concluded that the PUR domain also constitutes the solution state of PUR 
repeat I and PUR repeat II of D. melanogaster Pur-α. 
 
 
3.1.4 The PUR domain is similar to bacteriophage coat and Whirly proteins 
The crystal structure of a protein often reveals previously unknown relationships to other 
proteins, from which a functional correlation can be deduced.  
Systematic structural comparison for the B. burgdorferei Pur-α crystal structure yielded a 
similarity to bacteriophage coat proteins from Pseudomonas phage pp7 and 
Enterobacterio phage ms2. Both coat proteins show a similar dimerization mode as 
B. burgdorferi Pur-α. The dimers have α-helices on one side and an extended β-sheet on 
the opposing side (Figure 2-8). The bacteriophage coat proteins have a similar topology 
as PUR repeats. However, a pronounced difference is that they form a flat β-sheet 
surface, not a roof-like structure as a PUR domain. Interestingly, the β-sheet sides of both 
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bacteriophage coat proteins have been previously shown to bind RNA (Chao et al., 2008; 
Ni et al., 1995). The present study found that the β-sheet side of the PUR domain is 
required for DNA and RNA binding. Both bacteriophage proteins are evolutionary 
related, as reflected by their amino acid sequence identity (similarity) of 24 % (50 %). 
The lack of significant sequence similarity to B. burgdorferi Pur-α speaks for a 
convergent evolution of the nucleic-acid binding surfaces. 
Surprisingly, the DaliLite server (Holm et al., 2008) identified different structural 
neighbors for the highly homologous structure of D. melanogaster Pur-α repeats I-II. 
This might reflect a limitation of the DaliLite search method, as the only significant 
difference between both structures is that one is formed by an inter-molecular dimer and 
the other one by an intra-molecular dimer (Figure 2-15). 
The identified structural neighbors revealed that Pur-α belongs to the Whirly class of 
nucleic-acid binding proteins. This structural relationship is more pronounced than the 
one to the bacteriophage coat proteins, as the PUR domain shares topology as well as 
overall orientation with the Whirly domain and nicely superposes with it (Figure 2-15). 
However, Pur-α shows no significant sequence homology to the Whirly proteins 
MRP1/MRP2 and P24. Furthermore, the proteins differ in their quaternary structure. 
Whereas the Whirly proteins tetramerize via interactions of their α-helical sides, such an 
orientation is not seen in the crystal lattice of Pur-α repeats I-II. The analysis of the 
oligomeric state of D. melanogaster Pur-α demonstrates that it does not tetramerize in a 
comparable fashion, but dimerizes via PUR repeat III (section 2.1.2).  
Intriguingly, Pur-α also shares a functional similarity with Whirly proteins. MRP1/MRP2 
was previously reported to bind ssRNA, whereas P24 has been shown to bind ssDNA as 
well as dsDNA (Desveaux et al., 2002; Schumacher et al., 2006). Pur-α combines the 
functions of both proteins as it binds both types of nucleic acids (section 2.2.1). As a 
recurrent feature, the β-sheets of the Whirly proteins have been shown to mediate 
nucleic-acid binding. However, the mode of binding is presumably different in Pur-α. On 
the one hand, both β-sheets of the PUR domain are involved in nucleic-acid binding, 
whereas in MRP1/MRP2 only one of the two β-sheets is a functional RNA-binding 
motif. Moreover, MRP1/MRP2 binds RNA unspecifically, and in the co-complex with 
gRNA (PDB-ID 2GJE), the nucleobases are oriented away from the protein surface. For 
sequence-specific binding of Pur-α, an orientation of the bases towards the protein 
surface is more likely. 
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As for Pur-α, ATP-independent nucleic acid unwinding properties were reported for the 
Whirly proteins (Darbinian et al., 2001a). As seen in the crystal structure, the binding of 
MRP1/MRP2 to hairpin RNA requires unwinding of the latter (Schumacher et al., 2006). 
P24 has been suggested to exploit melted regions of DNA and to intercalate the entire 
tetramer between the two strands (Desveaux et al., 2002). Similarly, one might speculate 
that the Pur-α dimer intercalates into a DNA duplex by binding each strand with one of 
its binding domains (section 3.2.1 and Figure 3-2, A). 
 
 
3.1.5 Dimerization of Pur-α  is mediated by PUR repeat III  
This study demonstrates that D. melanogaster Pur-α form dimers in solution, as 
established by analytical size-exclusion chromatography and SAXS experiments. The use 
of truncation mutants of D. melanogaster Pur-α demonstrated that dimerization requires 
PUR repeat III.  
A fragment of Pur-α composed of repeats I-II is monomeric in solution, as demonstrated 
by analytical size-exclusion chromatography and SAXS analysis (section 2.1.2 and 
section 3.1.3). In contrast, analytical size-exclusion chromatography with a fragment 
bearing PUR repeats I-III yielded an elution volume more consistent to a dimer. From the 
elution peak volume, a molecular weight of 36.5 kDa was calculated and theoretical 
molecular weight is 25.2 kDa. Dimerization was observed over a wide range of 
concentrations (5 µM to 200 nM) (Figure 2-22). The deviation from the ideal value for a 
dimer is most likely due to the fact that the protein exists in a dynamic monomer-dimer 
equilibrium. Equivalent results were obtained when the molecular weight of the fragment 
was calculated from SAXS analysis, giving a molecular weight of 46.0 kDa (Table 2-11). 
The deviation from the ideal volume might be due to a slight instability of the dimer. A 
portion of Pur-α might be present in monomeric form. This could also explain that the 
Kratky plot of the Pur-α repeats I-III hints at some unstructured regions (Figure 2-23 and 
Figure 2-26). One might speculate that the third repeat is unstructured, unless it has an 
interaction partner (section 3.1.6). 
In summary, size-exclusion chromatography and SAXS analysis showed that the third 
repeat induces dimerization of Pur-α. Therefore, a dimerization model was proposed that 
links two Pur-α molecules via the third repeat (Figure 2-15).  
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In the present study, dimerization of Pur-α was independent of nucleic acid and its 
absence was confirmed by the absorption spectra at wavelengths 260 nm and 280 nm 
(section 5.8). 
Gallia and colleagues reported that self-association of Pur-α requires RNA (Gallia et al., 
1999). They used GST-tagged human Pur-α coupled to glutathione-sepharose beads to 
pull down Pur-α. They showed that RNAse, but not DNAse, abolished self-association of 
Pur-α and that binding was restored by the addition of specific PU-RNA. The 
disagreement could be explained by the dimerization of Pur-α. One might assume that 
Pur-α could not be pulled down in the absence of nucleic acid, because all Pur-α 
molecules in the pull down assay are already dimeric. There are no free PUR repeats III 
left to form additional interactions. The putative fraction of monomeric Pur-α that is 
discussed above is presumably too small to pull down significant amounts of the protein. 
One might speculate that the self-association they observed in the presence of PU-RNA 
(Gallia et al., 1999) is indeed due to the cross-linking of Pur-α by RNA. The present 
study shows that one PUR domain is sufficient to bind nucleic acids hence one Pur-α 
dimer has (at least) two independent binding surfaces (section 2.2.1). Large complexes 
could form by the simultaneous interaction of the RNA with two or more different Pur-α 
dimers (Figure 3-2, C). In accordance, the 290 nt PU-RNA includes at least two putative 
Pur-α binding sites with the consensus sequence (GGN) (Tretiakova et al., 1998). It 
should be noted that Gallia and colleagues do not comment on the oligomeric state of the 
observed self-association (Gallia et al., 1999).  
Ramsey and colleagues investigated the quarternary structure of recombinant mouse Pur-
β, which shares a sequence identity of 70 % with Pur-α (Ramsey et al., 2007). They 
subjected nucleic-acid free Pur-β to dynamic light scattering and analytical 
ultracentrifugation and ascertained a dynamic monomer-dimer equilibrium. Moreover, 
their molecular shape calculations resulted in an elliptical shape for the homodimer 
(Ramsey et al., 2007). This is in good accordance with the SAXS analysis and the 
proposed dimerization model of the present work (section 2.1.2.2 and Figure 2-27). 
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3.1.6 PUR repeat III is predicted to form a PUR domain 
Although there is no direct proof, several lines of evidence suggest that the third PUR 
repeat in D. melanogaster Pur-α also forms a PUR domain – potentially with another 
repeat III from a different peptide chain. 
Firstly, the amino acid sequence of D. melanogaster PUR repeat III is homologous to the 
three other PUR repeats described in this study. Its identity (similarity) to 
D. melanogaster PUR repeat I, and D. melanogaster repeat II and B. burgdorferi PUR is 
24 % (53 %), 34 % (56 %), respective 13 % (38 %). The degree of conservation between 
the latter three is similar, ranging from 19 % (47 %) between PUR repeat I and 
B. burgdorferi PUR to a maximum of 33 % (61 %) between PUR repeat I and PUR 
repeat II (section 2.1.1.3 and 2.1.1.2). Since D. melanogaster PUR repeat I, 
D. melanogaster PUR repeat II and B. burgdorferi PUR adopt the same fold with an 
RMSD of only 2.3 Å (section 2.1.1.3 and Figure 2-15), is seems reasonable to assume 
that PUR repeat III also complies with their overall fold. Consistently, secondary 
structure prediction with the NPS server (Combet et al., 2000) confirms the assumption 
of a ββββα-topology for the third repeat of D. melanogaster Pur-α. The position of the 
α-helix is predicted exactly at the position that is expected by the sequence homology to 
PUR repeat I and II. The number of β-strands is less clear, however their predicted start 
site coincides with the beginning of the conserved region.  
Secondly, the third repeat bears conserved hydrophobic residues that could stabilize a 
PUR domain. The anticipated driving force of PUR domain formation is hydrophobic 
interaction and a number of hydrophobic residues was identified in the respective buried 
surface in the crystal structures of B. burgdorferi Pur-α and D. melanogaster Pur-α 
repeats I-II (section 2.1.1.2 and section 2.1.1.3). Amino acid sequence alignment shows 
that the positions of these residues are highly conserved (Figure 3-1). In total, 39 
hydrophobic residues are located in the buried surfaces of both crystal structures. The 
great majority, 33 residues, is found in corresponding positions in each repeat, yielding 
11 conserved amino acid positions likely involved in dimerization. It is striking that the 
third PUR repeat of D. melanogaster Pur-α offers hydrophobic residues in all of these 11 
positions (Figure 3-1).  
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Figure 3-1. Amino acid sequence alignment of D. melanogaser PUR repeats I, II and III and Borellia PUR. 
Hydrophobic amino acids are depicted in light green, hydrophobic residues located in the buried surface of 
the respective PUR domain are shown in dark green.  
 
 
Finally, the experimentally observed dimerization of Pur-α repeats I-III hints at PUR 
domain formation of repeat III. Dimerization of Pur-α in dependence of the third repeat 
was confirmed by analytical size-exclusion chromatography and SAXS analysis 
(section 2.1.2 and 3.1.5). In this study, the most intuitive and simple dimerization mode is 
proposed (section 2.1.2.2 and Figure 2-27). In the model, PUR repeats I and II interact 
with each other as seen in the crystal structure, whereas PUR repeat III interacts with 
another PUR repeat III from a second Pur-α molecule (Figure 2-27). The hypothesis that 
both repeats III attach to each other by PUR domain formation is in accordance with the 
surface envelope calculated from SAXS data. The Z-shaped bead model is able to 
accommodate three PUR domains, while for a good fit, the one potentially formed by the 
repeats III has to be placed perpendicular to the other two (Figure 2-28).  
In conclusion, the sequence homology to the other PUR repeats, the conservation of 
residues of presumed structural importance, and the experimentally observed 
dimerization speak for a PUR domain formation of PUR repeat III in D. melanogaster 
Pur-α.  
 
 
3.1.7 Interaction of the PUR repeats is likely specific 
Given the above elaborations about the homology of the third repeat (section 3.1.6), the 
immediate question arises if PUR domain formation is specific. It should be noted that 
there is no direct evidence for specific interaction of two repeats III and for their PUR 
domain formation.  
The PUR repeats in D. melanogaster Pur-α may also have some promiscuity in binding, 
meaning that the interaction observed in the crystal structure is not the only possible 
combination of repeats. In the crystal structure, PUR repeat II interacts with PUR repeat I 
(Figure 2-12), thus the proposed dimerization model includes their interaction and the 
interaction of two PUR repeats III (Figure 2-27). One could speculate that PUR repeat II 
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may also interact with PUR repeat III, leaving PUR repeat I to bridge to another peptide 
chain by binding to another PUR repeat I. By analytical size-exclusion chromatography 
or SAXS analysis, this dimerization mode would be indistinguishable from the proposed 
one (section 2.1.2).  
However, if the repeats were freely interchangeable, also cross-links of more than two 
Pur-α molecules could be possible. In the analytical size exclusion chromatography 
(maximum concentration 0.126 mg/mL) and in the SAXS analysis (maximum 
concentration 1.53 mg/mL) no species with a higher molecular weight than the dimer 
were observed. Therefore mutually exclusive interaction of the PUR repeats and the 
proposed dimerization mode appear most plausible (Figure 2-27). 
Specific PUR domain formation may be driven by some structural peculiarity of the third 
repeat. To gain understanding of this issue, crystallization trials of the D. melanogaster 
Pur-α repeat III are ongoing (section 2.1.1.3). There might well be specific contacts on 
the interface between the PUR repeats III that help to discriminate between the other 
repeats. It is also possibly that the length of the linker between the PUR repeats has an 
influence on specificity. In D. melanogaster Pur-α, the linker between PUR repeats I and 
PUR repeat II has a length of 24 amino acids, whereas between PUR repeat II and PUR 
repeat III, it is only 3 amino acids long (Appendix 7-2).  
 
 
3.1.8 The PUR domain is likely conserved in different orthologs 
Based on the high degree of sequence conservation, it can be speculated that Pur-α from 
different species share a common fold, as it is the case for B. burgdorferi and 
D. melanogaster Pur-α (Figure 2-6 and Figure 2-12). 
The amino acid sequence alignment for D. melanogaster, Caernohabditis elegans, 
Arabidopsis thaliana and human Pur-α shows the high degree of conservation between 
them (Appendix 7-2). The secondary structure prediction is based on the sequence 
alignment and the crystal structure of D. melanogaster Pur-α repeats I-II (Appendix 7-2). 
Notably, sequence conservation follows a typical pattern. As expected, the degree of 
conservation correlates with structured regions and is high in the predicted PUR domains 
and low in linker regions. This may indicate that the domain boundary assignment is 
correct for the orthologs. Moreover, in a PUR repeat, sequence conservation is typically 
higher around the β-sheets than in the α-helices. On the one hand, this could denote that 
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the β-sheets are of functional importance, as confirmed by nucleic-acid binding 
experiments and mutational studies (section 2.2.1). On the other hand, this could hint at 
the point that the β-sheets are required for fold stabilization, as supported by the 
assessment of the buried surface interfaces (section 2.1.1). 
 
 
3.2 Interaction with nucleic acids  
3.2.1 The PUR domain binds nucleic acids 
The crystallized PUR domain (D. melanogaster Pur-α repeats I-II) was found to be a 
functional nucleic-acid domain by EMSAs and filter binding assays (section 2.2.1.3). 
Assessment of the degree of conservation and the electrostatic potential of the surface of 
the PUR domain led to the hypothesis that the β-sheets form the nucleic-acid binding 
surface (Figure 2-13 and Figure 2-14). For the PUR domain of B. burgdorferi Pur-α, this 
was confirmed by filter binding assays. It was found that ssDNA binding was abolished 
when arginines located in the fourth β-strand (R49) of the β-sheet or in the connector 
between its second and third β-strand (R28, R29) were replaced by alanines (Figure 2-30 
and Table 2-14). Thus the β-sheets of B. burgdorferi Pur-α are involved in DNA-binding. 
The corresponding amino acids conserved in D. melanogaster Pur-α were subjected to 
mutagenesis and EMSAs were performed with wild type and mutant PUR domains (see 
2.3.1.3). In the β-sheet formed by the first PUR repeat, the mutation of arginine 80 to 
alanine (R80) had only moderate effect on ssDNA and ssRNA binding. The same was 
observed for the corresponding mutation (R158A) in the β-sheet of the second PUR 
repeat. In contrary, the double mutant R80A, R158A showed a total loss of affinity to the 
nucleic acid probes (section 2.2.1.3). This demonstrates that both β-sheets are 
functionally important.  
However, one might speculate if both β-sheets bind simultaneously to one nucleic acid, 
or if they independently bind two distinct nucleic acids. In the first scenario, the loss of 
binding affinity of the double mutant can be explained with a cooperative binding that 
needs both arginines for full affinity. In the second scenario, the observed higher KD 
would indeed not refer to a loss in affinity, but to a reduced number of active binding 
sites. 
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The separation of the two conserved β-sheets by an unconserved rim rather suggest that 
they act as independent binding surfaces (Figure 2-14). Furthermore, the differences of 
PUR repeat I and PUR repeat II in surface conservation and electrostatic surface potential 
suggest that they might have evolved to bind distinct nucleic acids (section 2.1.1.3, 
Figure 2-13 and Figure 2-14). Even if both β-sheets denote independent binding surfaces, 
it is still unknown if the PUR domain can bind two nucleic-acid chains simultaneously. 
Provided this is the case, this would mean that the Pur-α dimer has even four nucleic-acid 
binding surfaces (section 3.2.4, Figure 3-2). One might speculate if DNA duplex 
destabilization by Pur-α (Darbinian et al., 2001a) is achieved by intercalation of the PUR 
domain into the dsDNA. In this scenario, each β-sheet might bind one strand of the DNA 
(section 3.2.4 and Figure 3-2, A).  
One should note that even if both β-sheets have autonomous binding properties, it is still 
likely that one PUR repeat alone is not functional, but requires an interaction partner for 
fold stabilization by PUR domain formation. The curved β-sheets of a PUR domain have 
a shape that seems to be well suited to accommodate a nucleic-acid stretch. Shape 
complementarity is a common feature of RNA-protein recognition, with the typical 
interplay between a convex RNA that fits into a concave protein surface (Bahadur et al., 
2008).  
For a deeper insight into the nucleic-acid binding mode of Pur-α, a more detailed 
mutational analysis and, importantly, the assessment of binding stoichiometry are 
required. A crystals structure of a co-complex with RNA or DNA is highly desired. 
Therefore, crystallization trials with D. melanogaster Pur-α repeats I and II and DNA 
oligonucleotides (section 2.1.1.3) are ongoing. A co-structure would also contribute to 
the understanding of the determinants of specific affinity of Pur-α.  
 
 
3.2.2 PUR repeat III only weakly contributes to nucleic-acid binding 
It was then assessed if the PUR repeat III, which was not in the crystal structure, has also 
nucleic-acid binding properties. For D. melanogaster Pur-α repeat III, binding affinities 
for ssDNA and ssRNA were 8fold, respectively 5fold decreased compared to Pur-α 
repeats I-II (Figure 2-42). Since Pur-α repeats III was stable in solution and also 
crystallized (section 2.1.1.3 and Figure 2-18), it seems unlikely that the weaker affinity is 
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due to a folding defect. Furthermore, full length Pur-α had no increased affinities 
compared to the fragment containing only PUR repeats I-II (section 2.2.1.3).  
Interestingly, the previously mapped nucleic-acid binding region of human Pur-α (amino 
acid 54-250) (White et al., 2009) does not include the entire PUR repeat III (amino acids 
218-278) (Appendix 7-2). This suggest that the decreased binding capacity of PUR 
repeat III is not due to the limited number of oligonucleotides tested in this study, but is a 
general feature and conserved throughout species. It is likely that PUR repeat III is not 
required for nucleic acid binding, but may have adopted a different function. As shown in 
this study, the third repeat is required for dimerization (section 2.1.2). In addition, the 
assessment of previously mapped binding regions (White et al., 2009) reveals that the 
third repeat mediates many protein interactions (section 3.3.1).  
 
 
3.2.3 Pur-α  binds DNA as well as RNA 
One intriguing feature of Pur-α is its affinity to DNA as well as to RNA. By filter 
binding assays, strong affinities of human Pur-α to ssRNA as well as ssDNA 
oligonucleotides were measured (Table 2-12). A comparable affinity (KD = 15 nM) was 
previously reported for human Pur-α and ssDNA from the bovine papilloma virus (BPV-
1) minimal origin of replication (Jurk et al., 1996). 
For B. burgdorferi Pur-α, a functional conservation was observed, as it bound to the 
same DNA oligomers as human Pur-α, though its affinity was decreased (Table 2-13). 
No affinity was observed for B. burgdorferi Pur-α to the RNA oligomers tested (Table 2-
13). This does not imply that B. burgdorferi Pur-α has no RNA binding capacity, as there 
might exist unknown, species-specific RNA targets (section 2.2.1.2). 
Filter binding assays with D. melanogaster Pur-α resulted in similar equilibrium 
dissociation constants as for human Pur-α, but their reproducibility was reduced 
(Table 2-15). This might be due to protein precipitation on the membrane 
(section 5.16.3). Thus another experimental set up was chosen, that is EMSA. It should 
be said that at this point of the thesis, the motivation to perform nucleic-acid binding 
studies changed and therefore different oligomers were tested, enabling direct 
comparison of both techniques. In the beginning, it was searched for small 
oligonucleotides with strong affinity, which could be used for co-crystallization assays. 
But when the crystal structure of D. melanogaster Pur-α was solved, it became critical to 
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confirm functionality of the crystallized fragment with previously described oligomers, 
e. g. MF0677 ssDNA 24mer (Bergemann et al., 1992).  
Somewhat surprisingly, the affinity to r(CGG) repeat RNA (KD =  1 µM) was lower than 
expected. Jin and colleagues pulled down Pur-α from cell lysate with bead-coupled 
r(CGG)105 RNA (Jin et al., 2007). Furthermore, they propose that in the pathogenesis of 
FXTAS, cellular Pur-α is sequestered from its normal functions by its binding to the 
r(CGG)55-200 repeats in premutation Fmr1 mRNA (Jin et al., 2007). It seems unlikely that 
such a weak affinity can account for these effects. Maybe there is an unknown factor 
involved that stabilizes the interaction of Pur-α and the RNA. Possibly the length of the 
r(CGG) repeats is crucial and the 12mer and 25mer tested in this study were too short for 
full affinity. A longer stretch of RNA could increase the affinity by back-folding 
(Figure 3-2, B) or by cross-linking of Pur-α (Figure 3-2, C). 
 
There are other transcription factors known that bind both types of nucleic acids, but little 
is known about the structural basis for their dual nucleic-acid specificity (Cassiday and 
Maher, 2002). It would be interesting to address if Pur-α binds DNA and RNA via the 
same binding mode, that means if the same binding surface and the same amino acid 
contacts are employed. Structure-guided mutagenesis of D. melanogaster Pur-α 
(section 2.2.1.3) suggests that both DNA and RNA are bound via the β-sheet side of the 
PUR domain, as the double mutant R80A, R158A abolished binding for both types of 
nucleic acids. On the other hand, the double mutant R65A, R142A did not affect DNA 
binding, but reduced the affinity to RNA. Possibly more extended mutational studies and 
the assessment of various oligomers of each type of nucleic acid can pin down the 
individual amino acids involved. Furthermore, it is interesting to examine if RNA and 
DNA are bound competitively. Consistent with this speculation, Tretiakova and 
colleagues reported that interaction of Pur-α with a specific RNA, named PU-RNA, 
prevented its binding to the MB1 regulatory motif of the myelin basic protein gene 
(Tretiakova et al., 1998).  
The secondary and tertiary structure of RNA and DNA strands with the same sequence 
are expected to be very different. Thus the question arises whether specificity is achieved 
in the same way. One might speculate that the RNA mimics the secondary structure of 
the DNA to exploit the same binding mode (Cassiday and Maher, 2002). For a different 
binding mode speaks the comparison of protein data bank entries of protein interactions 
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with DNA or RNA, which reveals similarities, but also differences in binding (Bahadur et 
al., 2008). Bahadur and colleagues reported that unique features of the RNA are essential 
in their contribution to protein binding. Typical RNA-protein interactions are formed by 
the 2’-OH of the sugar, the main chain NH groups, and arginine as well as lysine side 
chains. In DNA binding, the phosphate backbone is more frequently involved, but not the 
sugar (Bahadur et al., 2008). Notably, in sequence-specific RNA binding, interactions are 
often mediated by stacking of aromatic residues with the nucleobases (Auweter et al., 
2006). The solvent-accessible surface of the crystal structure of D. melanogaster Pur-α 
repeats I-II bears the conserved tyrosines 57 and 134 as well as the conserved 
phenylalanines 68 and 145. It would be interesting to assess if mutation of these amino 
acids would affect specifically RNA binding, but not DNA binding. 
 
 
3.2.4 The Pur-α  dimer bears two nucleic-acid binding domains 
Dimerization of Pur-α (section 3.1.5) implies that each Pur-α molecule possesses two 
nucleic-acid binding PUR domains. This allows for a variety of potential binding modes 
for nucleic acids (Figure 3-2). 
The Pur-α dimer may bind two nucleic-acid strands simultaneously, each with one PUR 
domain (Figure 3-2, A). It is tempting to speculate that this binding mode might account 
for DNA duplex destabilizing properties of Pur-α (Darbinian et al., 2001a). The dimer 
might exploit melted regions of DNA and intercalate between the strands (Figure 3-2, A). 
A similar intercalation was previously proposed for the tetramer of the structural 
homolog of Pur-α, P24 (section 2.1.2.3) (Desveaux et al., 2002). Admittedly, in this 
scenario, not only a PUR consensus sequence, but likewise the complement strand would 
have to be bound. As only a preference for (GGN)n, not for the complement (CCN)n is 
reported, this interaction would be presumably unspecific. Interestingly, Darbinian and 
colleagues report that Pur-α destabilizes DNA helices independently of its recognition 
motif (Darbinian et al., 2001a).  
The Pur-α dimer could also employ both its PUR domains to bind one nucleic-acid strand 
bidentally with both binding surfaces and thereby increasing its affinity (Figure 3-2, B). 
This seems to be a well suiting binding mode for the interaction with long repetitive 
sequences, as Pur-α has been shown to bind to repetitive single-stranded nucleic acids, 
such as (GGN)n or r(CGG)n repeats (Gallia et al., 2000; Jin et al., 2007). Alas, if the Z-
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shaped arrangement of the Pur-α dimer were stable also when nucleic acid is bound, 
multidendate binding would require extreme bending of the nucleic acid (Figure 3-2, B). 
Consistent with this idea, Chao and colleagues recently proposed that binding of β-Actin 
mRNA to ZBP1 induces a 180° loop in the RNA (Chao et al., 2010). Still, the required 
flexibility might be well possible for RNA, but it is more unlikely in the case of dsDNA. 
However, conformational flexibility may be achieved by the duplex unwinding properties 
of Pur-α (Darbinian et al., 2001a). On the other hand, it cannot be ruled out that Pur-α 
itself undergoes conformational changes upon nucleic-acid binding. 
 
 
 
 
 
Figure 3-2. Potential binding modes 
for Pur-α  and nucleic acids. The Z-
shaped Pur-α  dimer is depicted in 
grey, with one peptide chain in light 
grey, the other in dark grey. Single 
stranded nucleic acid is shown in 
orange, double stranded DNA is 
shown in red. A: Simultaneous 
binding of two distinct nucleic acid 
chains by one Pur-α  dimer. 
B: Bidentate binding of the Pur-α  
dimer to an individual nucleic acid. 
C: Cross-linking of several Pur-α  
dimers by an elongated nucleic acid.  
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The Pur-α dimer might also be connected by long nucleic acids that have multiple 
interaction sites, and interact with several Pur-α molecules (Figure 3-2, C). This would 
lead to cross-linked Pur-α complexes. This binding mode might play a role in the 
pathogenesis of the neurodegenerative disease Fragile X Tremor/Ataxia syndrome 
(FXTAS) (section 1.3). The patients carry a premutation that leads to prolonged stretches 
of r(CGG) repeats (55-200) in the Fmr1 mRNA (Berry-Kravis et al., 2007). Jin and 
colleagues have shown that Pur-α binds r(CGG) repeat RNA and propose that the loss of 
functional Pur-α by this affinity is the underlying cause for FXTAS (Jin et al., 2007). 
Interestingly, a pathological characteristic of FXTAS is the formation of inclusions in 
nerve cells, which contain Fmr1 premutation RNA and Pur-α together with additional 
proteins (Greco et al., 2002; Iwahashi et al., 2006; Jin et al., 2007). In these inclusions, 
Pur-α might be cross-linked by the Fmr1 premutation RNA (Figure 3-2, C). 
An even higher complexity of binding modes and cross-linking can be envisioned, if both 
β-sheets of a PUR domain can bind two distinct nucleic acids simultaneously 
(section 3.2.1).  
 
 
3.2.5 The nucleic-acid binding surface of a PUR domain is reminiscent of an RRM 
domain  
The modular structure of Pur-α is a common feature of RNA-binding proteins. Many 
RNA-binding proteins are composed of small RNA binding domains, which perform 
sequence-specific binding. Examples are Pumilio (PUF) repeats, zinc-finger domains, K-
homology (KH) domains, and RNA-recognition motifs (RRM). They have a length of 35 
to 90 amino acids and are often found in multiple copies in one protein (Auweter et al., 
2006). By their versatile combination, these RNA-binding domains can satisfy diverse 
functional needs (Lunde et al., 2007). Affinity, as well as specificity of the binding can be 
increased by the interaction of one nucleic-acid strand with two or more binding modules 
(Lunde et al., 2007).  
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Intriguingly, the proposed nucleic-acid binding surface of a PUR domain is reminiscent 
of the binding surface of an RRM domain. The RRM domain, also known as RNA-
binding domain (RBD) or ribonucleoprotein domain (RNP) is found in all kingdoms of 
life (Maris et al., 2005). The RRM fold is one of the most abundant protein domains in 
eukaryotes and found is in a variety of RNA- and DNA-binding proteins with a wide 
range of specifities and affinities (Maris et al., 2005).  The RRM fold is composed two α-
helices that are sandwiched against a four-stranded antiparallel β-sheet (Figure 3-3). As 
shown in this study, one PUR repeat bears an α-helix that is packed against a four 
stranded antiparaell β-sheet. RRM domains typically bind nucleic acids via the central β-
strands of the β-sheet (Maris et al., 2005) (Figure 3-3). Likewise, this study identified the 
β-sheet side of a PUR domain as its nucleic-acid binding surface (section 3.2.1). Another 
functional similarity between RRM domains and the PUR domain is that they do not only 
bind both types of nucleic acids, but also interact with proteins (Maris et al., 2005) 
(White et al., 2009). However, there is a striking discrepancy in topology. A PUR domain 
is constituted of two ββββα-units, whereas a RRM domain is build from a βαββαβ-
topology. Therefore, albeit a drastically different topology, a similar binding surface 
might be achieved. One might speculate if sequence-specific nucleic-acid binding follows 
a similar mechanism for PUR domains and RRM domains.  
Figure 3-3. Example of 
an RRM domain. 
Crystal structure of 
hnRNPA1 (UP1) 
RRM2 in complex with 
single stranded 
telomeric DNA (PDB-
ID 2UP1) (Ding et al., 
1999). 
A: The RRM domain is 
depicted in a color 
gradient from blue (N-
Terminus) to red (C-
terminus), the ssDNA is 
depicted in gray. 
B: View from A, 
rotated by 180° around 
the vertical axis. 
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3.3 Interaction with proteins 
3.3.1 Protein interactions are mediated by PUR repeats  
Structural characterization of Pur-α gives insight not only into nucleic-acid binding, but 
also in protein-protein interactions. The functional role of the PUR repeats is highlighted 
by previous efforts to map the binding regions of human Pur-α to various protein 
interaction partners. Interestingly, many binding regions overlap with the PUR repeats 
and predicted structural domains in human Pur-α (Figure 1-3 and Appendix 7-2). For 
human Pur-α, PUR repeat I comprises amino acids 59 to 123. It interacts with the 
polyomavirus large T-antigen, as the mapped binding region includes amino acids 72 to 
123. (Gallia et al., 1998). Similarly, the minimal binding region of YB1 and CyclinT1 
(amino acids 167-216) is part of the second PUR repeat (amino acids 137-209) 
(Darbinian et al., 2001c; Safak et al., 1999). Intriguingly, the mapped binding region for 
Rb, Cdk2, and Cdk9 superposes almost exactly with the PUR repeat III (amino acids 
218-278), with a deviation of not more than four amino acids (Darbinian et al., 2001c; 
Johnson et al., 1995; Liu and Johnson, 2002).  
It was previously known that the binding region for many proteins coincides with the 
nucleic-acid binding region of Pur-α (Gallia et al., 2000). From a structural point of view, 
one might wonder if also the same surface areas are involved. Ma and colleagues 
reported that the protein-protein binding surface of a protein can be predicted by the 
degree of conservation of its solvent-exposed residues (Ma et al., 2003). Especially 
conserved tryptophanes, and, to a lesser extend, phenylalanines and methionines, are 
frequently responsible for protein-protein contacts (Ma et al., 2003). Surface assessment 
of the crystal structure of D. melanogaster Pur-α repeats I-II reveals that the β-sheet side 
of the PUR domain shows more pronounced conservation than the α-helical side 
(Figure 2-14). This suggests that the β-sheet side might also be employed in protein 
binding. In the crystal structure, the conserved and solvent-accessible residues 
phenylalanine 68 and phenylalanine 145 located in the β-sheets are putative candidates to 
probe this hypothesis with mutational studies. 
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3.3.2 Yeast-two hybrid screen 
The yeast-two hybrid with D. melanogaster Pur-α (amino acids 40 to 254) yielded seven 
interaction partners corresponding to known proteins. After their inspection, only five of 
them (Arr1, LamC, Eye, Cka and Pur-α ) appear credibly.  
A yeast-two hybrid system bears inherent limitations due to false-positive and false-
negative results. In general, an observed interaction requires further examination, e. g. by 
pull-down assays, to confirm its specificity. A specific positive interaction is ideally 
expected to arise in several different protein fragments of the library. However, in the 
screen of this study, only interactions based on unique fragments were found. This means 
an increased probability that the results are due to random noise and leads to low 
confidence scores (section 2.2.2). Therefore the data has to be handled with caution, 
unless confirmed by supplementing techniques. In addition to background noise, false 
positive results can also derive from interactions without any biological relevance, e. g if 
the interacting proteins reside in distinct cellular compartments.  
The inconsistency between the Gal4 screen and the LexA system might hint at a 
systematic problem. The more sensitive Gal4 screen yielded 5 putative protein 
interactions, 13 interactions with non-existing proteins, and 9 GenMatches 
(section 2.2.2). On the other hand, only 2 putative protein interactions were found in the 
LexA system (section 2.2.2). The fact that the expected self-interaction of Pur-α was only 
observed in the LexA system, but not in the Gal4 system, suggests that the bait protein in 
the latter screen might have a folding problem. This idea is supported by the high number 
of interactions that refer to non-existing proteins and GenMatches, which were found in 
the Gal4 system. If the bait is not correctly folded, these interactions are likely false 
positives. Improper folding is possibly due to steric hinderance by the N-terminal DNA-
binding domain. Therefore an independent confirmation of the interactions is absolutely 
required. The lack of trust in the Gal4 system is exceptionally unfortunate, since all of the 
putative new binding partners for Pur-α were found in this screen (section 2.2.2 and 
Table 2-16). 
The failure to observe physiologic interactions is referred to as false negative results. As 
a general principle, one should note that the absence of proof is not proof of absence. 
Consequently, the absence of previously known interaction partners in the yeast-two-
hybrid screen does not necessarily discredit them. The demonstration of direct physical 
interaction of two proteins, e. g. by pull-down assays, seems to be more reliable than a 
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yeast-two-hybrid system. False negative results can be caused by improper folding of the 
bait as discussed above and by the fact that the N-terminal part of the protein of interest is 
not available for the interaction because it is fused to the DNA-binding domain. 
Furthermore, the protein fragment chosen as a bait might not be optimal. In the yeast-
two-hybrid screens, D. melanogaster Pur-α 40-254 was employed because it was 
stable in in vitro experiments and contains the main protein interaction region of Pur-α 
(White et al., 2009).  
Another reason for false negative results might be that the targeting of the transcription 
factor domains to the nucleus might be prevented by the bait or prey proteins fused to 
them. Kinetics might also explain missing interactions, as an interaction can not be 
detected if its KD is significantly higher than the hybrid protein concentration in the yeast 
cell.  
 
 
3.3.2.1 Potential artifacts 
The observed interaction of Pur-α and BtbVII is likely to be an artifact, as this protein is 
known to be highly promiscuous in its protein interactions. Therefore, BtbVII tends to 
produce false positive results (Table 2-16). 
The interaction to CG5758 is most likely an artifact, since the mapped interaction domain 
is a predicted extracellular Fas domain, which is inapplicable to the intra-cellular 
localization of Pur-α (Table 2-16). The biological relevance of this interaction has thus to 
be questioned.  
The found interactions with so-called non-existing protein does not inevitably go back to 
random noise (Table 2-17). The preys do not represent existing proteins, but they can be 
helpful to identify a consensus motif for protein binding. If multiple independent clones 
are observed for one given prey (as it is the case for antisense Cac and out-of-frame 
inaF), then a cryptic peptide is likely to bind Pur-α (Table 2-17). In contrast, an 
interaction based on only one prey fragment has a higher probability to be caused by 
random noise, as it is the case for most other found interactions with non-existsing 
proteins (Tab. 2-17).  
The interactions with proteins whose sequences do not correspond to translated regions 
of the genome, but to chromosomic regions are referred to as GenMatches by 
Hybrigenics (Table 2-18). Possibly, they represent so far uncharacterized genes whose 
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expression is not know. Alas, this is increasingly unlikely with today’s high quality of 
genome annotation, especially for Drosophila. They may also correspond to untranslated 
poly-adenylated RNA or may derive from poly-adenylated mRNA not yet fully spliced. 
As a consequence, the clone contains both exonic and intronic regions and does not align 
with previously identified mRNA, but rather with chromosomic regions. An interaction 
observed in multiple independent clones (as it is for GID 158246) likely represents a 
cryptic peptide preferred by Pur-α. The other GenMatches found are only represented by 
unique clones and are probably caused by residual background (Table 2-18). 
 
 
3.3.2.2 Arr1, LamC, Eye and Cka are putative binding partners of Pur-α  
The fact that the yeast-two-hybrid screen yielded only one fragment per protein 
interaction partner, indicates a low reliability and hampers the correct assignment of the 
interaction domain. Since a full domain is most likely properly folded and functional, the 
reliance of an interaction is increased, when the fragment corresponds to a known protein 
domain. This is the case for Arrestin1 and Cka, where the interaction fragment is 
identical with the C-terminal domain or the protein-binding WD40-repeat domain, 
respectively (Table 2-16). For LaminC, Eye, and Pur-α the fragments are longer but 
contain a known domain that is likely to be folded. Of course, in the evaluation of one 
interaction, the biological context has to be considered.  
 
Arrestin1 
The putative interaction of Pur-α with Arrestin1 (Table 2-16) leads to tempting 
speculations, since upon activation of photosensitive cells, arrestins translocate from the 
cell cytoplasm to the plasma membrane to activate G-protein coupled receptors (GPCRs) 
(Nair et al., 2005). The interaction of Arrestin1 and Pur-α might hint at yet another role 
of Pur-α in active transport. Arrestin1 translocates from the soma of the rod cell to the 
light-sensitive microvilli. There it is recruited to photoactivated rhodopsin in order to 
quench the exitation of the photoreceptor (Nair et al., 2005). The nature of this 
translocation is not sufficiently elucidated. A diffusion mechanism was proposed based 
on the observation that the transport is energy independent (Nair et al., 2005). Satho and 
colleagues supported the diffusion model by demonstrating that the translocation of 
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Arrestin1 is independent of the motor protein Eye-enriched Myosin-III (NINAC). On the 
other hand, Lee and Montell showed a requirement of NINAC for the transport of 
Arrestin2, which is the major arrestin with a 7-fold higher abundance than Arrestin1 (Lee 
and Montell, 2004; Satoh and Ready, 2005). Furthermore, Marszalek and colleagues 
found that Kinesin-II is essential for the selective transport of arrestin in mammalian 
photoreceptors (Marszalek et al., 2000). If Arrestin1 is indeed actively transported, it is 
intriguing to speculate if there is a conserved core complex that is responsible for a 
variety of different transport processes. Kanai and colleagues proposed a functional core 
complex might exist for mRNA localization in dendrites and named Pur-α as a likely key 
factor (Kanai et al., 2004).  
 
LaminC  
The interaction of LaminC and Pur-α might also have some functional relevance 
(Table 2-16). LaminC is located at the inner membrane of the nucleus (Worman and 
Courvalin, 2002). Pur-α is shuttling between cytoplasm and nucleus, and is therefore 
accessible to LaminC (Itoh et al., 1998; Osugi et al., 1996). A functional link between 
Pur-α and LaminC might be transcriptional regulation, as both proteins are involved in 
this process (White et al., 2009). The role of lamins in tissue-specific gene expression is 
not yet understood (Worman and Courvalin, 2002). It was observed that mutations in 
lamins have an effect on gene expression pattern and RNA-Polymerase II-dependent 
transcription (Spann et al., 2002; Tsukahara et al., 2002). A further link between both 
proteins is Fragile X Temor/Ataxia Syndrome (FXTAS), as the inclusions present in the 
brains of FXTAS patients contain LaminC together with 19 other proteins (Arocena et 
al., 2005; Iwahashi et al., 2006). Aroncena and colleagues showed that r(CGG)-repeat 
RNA disrupts the lamin A/C structure and leads to the formation of inclusions (Arocena 
et al., 2005). In a Drosophila model of FXTAS, Jin et al. demonstrated that Pur-α binds 
to CGG-repeat RNA and is also present in these inclusions (Jin et al., 2007). Possibly 
Pur-α is precipitated together with its interaction partner LaminC in these inclusions.  
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Eye 
The possible interaction with Eye (Table 2-16) is interesting because of its functional link 
to Pur-α in brain development. Eye is a transcription factor and the Drosophila homolog 
of Pax6. A role for Eye was suggested in terminal differentiation and the maintenance of 
cell-type specific expression profiles in neurons. Eye was shown to control the expression 
of insulin-like peptides (Dilps) in insulin-producing neurons (Clements et al., 2008). By 
its expression-pattern overlap with genes involved in learning and memory, a role of Eye 
in the transcription of those genes was also suggested (Callaerts et al., 2001). Similarly, 
Pur-α was also shown to be essential for brain development and neuronal differentiation 
(Khalili et al., 2003).  
 
Cka 
The kinase Cka is involved in the signal transduction pathway regulating the dorsal 
closure of the Drosophila embryo (Chen et al., 2002). Interestingly, the examination of 
Cka mutant flys hinted at an additional role for Cka in neuronal differentiation during eye 
development (Weng and Wei, 2002). This might constitute a functional link to Pur-α, as 
it is essential for neuronal differentiation (Khalili et al., 2003). Furthermore, Pur-α is 
involved in the pathogenesis of FXTAS (Berry-Kravis et al., 2007; Jin et al., 2007) and in 
the Drosophila model of FXTAS, an eye neurodegeneration phenotype is observed (Jin et 
al., 2007). The fragment of Cka that interacted with Pur-α in the yeast-two-hybrid screen 
(Table 2-16) comprises a WD40 repeat region. WD40 repeats are conserved in a variety 
of proteins (Smith et al., 1999). They form a β-propeller structure which serves as a 
versatile interaction platform for protein-protein contacts (Smith et al., 1999).  
 
Pur-α  
As demonstrated by this study, Pur-α is dimeric in solution (section 2.2.2). Size-
exclusion chromatography and SAXS analysis support the model that dimerization is 
induced via the third PUR repeat in full length Pur-α. In accordance with this model, the 
self-interaction of Pur-α in the yeast-two-hybrid screen involved a fragment of Pur-α that 
included PUR repeat III (Table 2-16). Since the interaction was only observed with a 
unique clone, a precise mapping of the interaction domain was not possible. As discussed 
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above, when taking the Pur-α self-interaction as a positive control, the quality of the 
yeast-two-hybrid screen seems poor. Most prominently, the interaction was only found in 
the LexA system, but not in the Gal4 system, reducing the confidence of the latter screen. 
Since the Gal4 screen identified the putative interaction partners Arrestin, LamC, Eye, 
and Cka, it is absolutely required to revise them, e. .g. by pull-down assays.  
 
 
Chapter 4 Conclusion 
This study structurally and functionally characterizes Pur-α. It shows that Pur-α adopts a 
Whirly-like fold, identifies a novel nucleic-acid binding surface and proposes a 
dimerization model with direct functional implications. 
Furthermore, the present work represents a case study how the bottleneck of X-ray 
structure analysis, that is crystallization, was overcome by crystal structure determination 
of a bacterial homolog and iterative use of sensitive bioinformatic tools. 
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Chapter 5 Materials and Methods  
5.1 Consumables and chemicals 
All chemicals were purchased in reagent grade or better from Merck (Darmstadt, 
Germany), Roth (Karlsruhe, Germany), Roche (Mannheim, Germany), or Sigma Aldrich 
(Hamburg and Seezle, Germany) unless stated otherwise. Enzymes for molecular biology 
and electrophoresis products were obtained from Fermentas (St. Leon-Rot, Germany) or 
New England Biolabs (Frankfurt, Germany). Media for bacterial cultures were prepared 
from reagents from Becton, Dickinson & Co (Heidelberg, Germany) and Sigma Aldrich. 
Media for insect cell culture were obtained from Sigma Aldrich. Chromatographic 
materials and columns were purchased from GE Healthcare (Munich, Germany), with the 
exception of amylose resin, which was obtained from New England Biolabs. 
Crystallization tools and screens were obtained from Hampton Research (Aliso Viejo, 
USA) and Qiagen (Hilden, Germany). DNA oligonucleotides were synthesized by 
Thermo Fisher Scientific (Schwerte, Germany). RNA oligonucleotides were ordered 
from Dharmacon/Perbio Science (Bonn, Germany) or Metabion (Martinsried, Germany). 
Radioactive nucleotides were purchased from Hartmann Analytik (Braunschweig, 
Germany). 
 
 
5.2 Oligonucleotides 
5.2.1 DNA oligonucleotides for molecular biology 
No.  Name Sequence 5’-3’ 
1 hPurA60 BamHI for 
 
ATG GGA TCC GAG CTG GCC TCC AAG CGG GTG G 
2 hPurA56 BamHI for 
 
ATG GGA TCC CAC GAG ACG CAG GAG CTG GCC 
4 bbPur1 BamHI for 
 
ATG GGA TCC ATG GGA GAG AGA GGG GAA GTA 
TAC 7 bbPurA3 BamHI for 
 
ATG GGA TCC GAG AGA GGG GAA GTA TAC 
8 bbPurA5 BamHI for 
 
ATG GGA TCC GGG GAA GTA TAC TCT GAA AAA C 
11 bbPurA1 L12M, F22M for ATG GGA GAG AGA GGG GAA GTA TAC TCT GAA 
AAA ATG TTT ACA GAG TCT GAG AGA ACT TAT TTT 
ATG AAT GTC AAG GAA AA 12 bbPurA55 I59M for TAT GAA GAG AAT ATG AAT GAG TTT GAA TCC 
16 hPurA 245 XhoI rev 
 
GCA CTC GAG CTA TCG CAT AAA CAC GCC GTA CTT 
C 17 hPurA287 XhoI rev 
 
GCA CTC GAG CTA CTC CCT CTG CTT CTC TTG AAT 
CTT C 18 hPurA 274 XhoI rev 
 
GCA CTC GAG CTA GTA CTT GCA GAA GGT GTG TCC 
GAA C 22 bbPur122 XhoI  rev 
 
C  TC GAG CTA ATA ATC CTT CTT TTT AAA TCG 
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25 bbPurA120 XhoI rev 
 
GCA CTC GAG CTA CTT CTT TTT AAA TCG 
26 bbPurA105 XhoI rev 
 
GCA CTC GAG CTA TCT AGA ATC GTC TAA TTT 
27 bbPurA100 XhoI rev 
 
GCA CTC GAG CTA TTT AGA TCT CTC CCC ATA 
28 bbPurA110 XhoI rev 
 
GCA CTC GAG CTA AGA TTT CTT ATC AAA TCT 
29 bbPurA64 I59M rev 
 
GGA TTC AAA CTC ATT CAT ATT CTC TTC ATA 
30 bbPurA95 XhoI rev 
 
GCA CTC GAG CTA ATA TTC ACC ATA CCC TTT 
45 bbPurA70 XhoI rev 
 
GCA CTC GAG CTA TAT TGC CTT AAG CAA 
46 bbPurA74 XhoI rev 
 
GCA CTC GAG CTA CTT AAT AAC CGC TAT 
47 bbPurA78XhoIrev 
 
GCA CTC GAG CTA AGA TAC TTT CTG CTT 
48 bbPurA82 XhoI rev 
 
GCA CTC GAG CTA AAC GGA CCC CGT AGA 
51 bbPurA90 XhoI rev 
 
GCA CTC GAG CTA ATA CCC TTT ATT ATG 
52 hPurA42 BamHI for 
 
AAA GGA TCC GGC AGT GGC GGC GGC 
53 hPurA259 XhoI rev 
 
GCA CTC GAG CTA CAC GGT GAT GGA GTT 
55 hPurA191 BamHI for 
 
AAA GGA TCC CCC GCG CAG GGG CTC 
60 hPurA105 XhoI rev 
 
GCA CTC GAG CTA TGA CAT GGA GAG 
61 hPurA186 XhoI rev 
 
GCA CTC GAG CTA ATG GCC CTG CGT 
62 bbPurA23 R28A, K29A for 
 
AAT GTC AAG GAA AAT GCA GCA GGA GAT TAT TTT 
TTA 63 bbPurA34 R28A, K29A rev 
 
A  AAA ATA ATC TCC TGC TGC ATT TTC CTT GAC 
ATT 64 bbPurA44 R49A for 
 
G  GGA GAT TTT GAA GCA CAT TCT ATT TTT GTA 
65 bbPurA54 R49A rev 
 
TAC AAA AAT AGA ATG TGC TTC AAA ATC TCC ACT 
66 bbPurA1 R18A for AAAGGATCCATGGGAGAGAGAGGGGAAGTATACTCT
GAAAAACTATTT 
ACAGAGTCTGAGGCAACTTATTTTTTTAATGTC 78 dmPurA40 BamHI for 
 
AAA GGA TCC GTC GAA CAG GAA TTG GCT 
79 dmPurA115 BamHI for 
 
AAA GGA TCC CCG GAA GAT GGT AAA CTT 
82 dmPurA105 XhoI rev 
 
GCA CTC GAG CTA AGA AGC GTA GTA ATC 
83 dmPurA185 XhoI rev 
 
GCA CTC GAG CTA ATC ATT AGC TCC AAA C 
84 dmPurA245 XhoI rev 
 
GCA CTC GAG CTA AAT ATC ACG AAA GCG 
85 hPurA140 BamHI for 
 
AAA GGA TCC CGC CGG GCG CTC AAA AGC 
87 hPurA202 XhoI rev 
 
GCA CTC GAG CTA CAG AGC GTC ACG GAA 
88 hPurA268 XhoI rev 
 
GCA CTC GAG CTA TCC GAA CTT GGC CCA 
93 dmPurAa70 R65A XhoI rev GCA CTC GAG CTA CTT TAT AAA ACG GCT TGC TCT 
ATT TTG TTT TAC 
95 dmPurAa1 BamHI for AAA GGA TCC ATG TCC GAT TTG GGA ATG 
96 dmPurAa274 XhoI rev GCA CTC GAG CTA TTT AAG ACT ATT TGA AGA 
97 bbPurA24 R28A BamHI for AAA GGA TCC GTC AAG GAA AAT AGA GCA GGA 
GAT TAT TTT TTA 98 dmPurAa152 R158A BamHI for A A GGA TCC ACA AGA GGG GGG CCT GCA TCT CAA 
ATC GCT TTA 
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100 dmPurAa136 R142A BamHI for AAA GGA TCC TTA AAA GAA AAT GCG GCT GGC CGA 
TTT TTA CGG 102 bbPurA34 R28A XhoI rev GCA CTC AG CTA TAA AAA ATA ATC TCC TGC TCT 
ATT TTC CTT GAC 
103 dmPurA162 R158A XhoI rev GCA CTC GAG CTA ATC ATT AGC TCC AAA GAT TTG 
AGA TGC AGG CCC CCC TCT TGT 
106 dmPurA146 R142A XhoI rev GCA CTC GAG CTA CCG TAA AAA TCG GCC AGC CGC 
ATT TTC TTT TAA 
117 dmPurAa36 BamHI for AAA GGA TCC GGA AGA AGC GGC GTC GAA CAG 
118 dmPurAa46 BamHI for AAA GGA TCC ACG AAA ATG TTG CAA ATA CAA 
124 dmPurA260 XhoI rev GCA CTC GAG CTA AAT TGA GTC GGA CGA TTT 
129 dmPurA60 R65A BamHI for neu AAA GGA TCC AAA CAA AAT AGA GCA GCC CGT TTT 
ATA AAG 130 dmPurA85 R80A XhoI rev neu GC  CTC GAG CTA CAA GTA AAT TTG ACT TGC TCT 
ACC ATC AGC GCC 
131 dmPurA75 R80A BamHI for neu AAA GGA TCC GGC GCT GAT GGT AGA GCA AGT CAA 
ATT TAC TTG 
159 dmPurA181 BamHI for AAA GGA TCC GAG TTT GGA GCT AAT GAT GGA 
160 dmPurA188 BamHI for AAA GGA TCC GGG TTT AAA GGA GAT TTA CCG 
161 dmPurA258 XhoI rev GCA CTC GAG CTA GTC GGA CGA TTT TTT CAT 
162 dmPurA185 BamHI for neu AAA GGA TCC AAT GAT GGA GGG TTT AAA GGA 
Table 5-1. Oligonucleotides for molecular biology. dmPurA refers to D. melanogaster Pur-α , bbPurA 
refers to B. burgdorferi Pur-α , hPurA refers to human Pur-α . The numbers in the column “name” 
indicate the start site respective stop site of the amino acid sequence. 
 
 
4.2.2 DNA and RNA oligonucleotides for binding assays and crystallization 
Name  Sequence 5’-3’ Length in nt Type 
CGG 6 mer DNA CGG CGG 6 ssDNA  
CGG 7 mer DNA G CGG CGG 7 ssDNA  
CGG RNA 12mer r(CGG)4 12 ssRNA 
CGG RNA 25mer r(CGG)8C 25 ssRNA 
Cntrl1 CCT CCG CCT CCG 12 ssDNA 
Cy3-CGG DNA Cy3-G CGG CGG 7 ssDNA labeled 
with Cy3 
Cy3-CGG RNA Cy3-G CGG CGG 7 ssRNA labeled 
with Cy3 
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hTel12 AGG GTT AGG GTT 12 ssDNA 
hTel12-bromo AGG GTT AGG GXT , X=Bromo-dU 12 ssRNA 
hTel6 GTT AGG 6 ssDNA 
JCVupTAR GGA GGG GGA GGC 12 ssDNA 
MF0677 GGA GGT GGT GGA GGG AGA GAA 
AAG 
24 ssDNA 
MS2 ACA UGA GGA UUA CCC AUG U 19 Hairpin RNA 
Oligo-A DNA A24 24 ssDNA 
Oligo-A RNA A12 12 ssRNA 
Poly C C12 12 ssDNA 
pp7 GGC ACA GAA GAU AUG GCU UCG 
UGC C  
25 Hairpin RNA 
TAR14AU AGA GCC UGG GAG CUC U  16 Stemloop RNA 
TAR14GC GGA GCC UGG GAG CUC C  16 Stemloop RNA 
Table 5-2. RNA and DNA oligonucleotides for binding assays and crystallization. 
 
5.3 Plasmids 
5.3.1 Commercial plasmids 
Name Application Tag Antibiotic Source 
pGEX-6P-1 Recombinant protein 
expression in E. coli 
GST Amp GE Healthcare  
(Munich, Germany) 
pET28a Recombinant protein 
expression in E. coli 
His6 Kan Novagen (Schwalbach, 
Germany) 
PETM40 Recombinant protein 
expression in E. coli 
MBP Kan EMBL 
(Heidelberg, Germany) 
pFastBac1-
GST 
Bac-to-Bac Baculovirus 
expression system 
GST Amp, Gen Invitrogen  
(Karlsruhe, Germany) 
modified (GST-tag) by D. 
Niessing (Gene Center, 
Munich, Germany) 
Table 5-3. Commercial plasmids for recombinant protein expression. 
 
 
5.3.2 Plasmids for recombinant protein expression in E. coli  
No.  Insert Vector Restriction 
sites 
Primer Template Note 
AG25 bbPurA1-100 
 
pGEX-6P-1 BamHI/XhoI 4, 27 AG21  
AG28 bbPurA1-120 
 
pGEX-6P-1 BamHI/XhoI 4, 25 AG21  
AG21 bbPurA1-122 pGEX-6P-1 BamHI/XhoI 4, 22  a) 
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AG97 bbPurA1-122 R18A 
 
pGEX-6P-1 BamHI/XhoI 66, 22 AG21  
AG130 
 
bbPurA1-122 R28A pGEX-6P-1 BamHI/XhoI 97, 102, 4, 22 AG21  
AG94 
 
bbPurA1-122 R28A, 
K29A 
pGEX-6P-1 BamHI/XhoI 62, 63, 4, 22 AG21  
AG96 
 
bbPurA1-122 R49A pGEX-6P-1 BamHI/XhoI 64, 65, 4, 22 AG21  
AG32 bbPurA3-100 
 
pGEX-6P-1 BamHI/XhoI 7, 27 AG21  
AG41 bbPurA3-100  
L12M,F22M,I59M 
pGEX-6P-1 BamHI/XhoI 7, 27, 11, 12, 
29, 22 
AG21  
AG33 bbPurA3-105 
 
pGEX-6P-1 BamHI/XhoI 7, 26 AG21  
AG34 bbPurA3-110 
 
pGEX-6P-1 BamHI/XhoI 7, 28 AG21  
AG29 bbPurA3-120 
 
pGEX-6P-1 BamHI/XhoI 7, 25 AG21  
AG75 bbPurA3-70 
 
pGEX-6P-1 BamHI/XhoI 7, 45 AG21  
AG76 bbPurA3-74 
 
pGEX-6P-1 BamHI/XhoI 7, 46 AG21  
AG77 bbPurA3-78 
 
pGEX-6P-1 BamHI/XhoI 7, 47 AG21  
AG78 bbPurA3-82 
 
pGEX-6P-1 BamHI/XhoI 7, 48 AG21  
AG81 bbPurA3-90 
 
pGEX-6P-1 BamHI/XhoI 7, 51 AG21  
AG31 bbPurA3-95 
 
pGEX-6P-1 BamHI/XhoI 7, 30 AG21  
AG42 bbPurA3-95  
L12M, F22M, I59M 
pGEX-6P-1 BamHI/XhoI 7, 30, 11, 12, 
29, 22 
AG21  
AG59 bbPurA5-100 
 
pGEX-6P-1 BamHI/XhoI 8, 27 AG21  
AG35 bbPurA5-95 
 
pGEX-6P-1 BamHI/XhoI 8, 30 AG21  
AG104 dmPurA1-274 
 
pGEX-6P-1 BamHI/NotI -  - b) 
AG156 dmPurA1-274 
 
pGEX-6P-1 BamHI/XhoI 95, 96 AG104   
AG110 dmPurA115-185 
 
pGEX-6P-1 BamHI/XhoI 79, 83 AG156  
AG172 dmPurA181-260 
 
pGEX-6P-1 BamHI/XhoI 159, 124 AG104  
AG146 dmPurA185-260 
 
pGEX-6P-1 BamHI/XhoI 162, 124 AG156  
AG176 dmPurA188-258 
 
pGEX-6P-1 BamHI/XhoI 160, 161 AG156  
AG128 dmPurA36-185 
 
pGEX-6P-1 BamHI/XhoI 117, 83 AG156  
AG108 dmPurA40-105 
 
pGEX-6P-1 BamHI/XhoI 78, 82 AG156  
AG109 dmPurA40-185 
 
pGEX-6P-1 BamHI/XhoI 78, 83 AG156  
AG155 dmPurA40-185 R142A pGEX-6P-1 BamHI/XhoI 95, 96, 78, 83, 
1100, 106 
AG156  
AG158 dmPurA40-185 R158A pGEX-6P-1 BamHI/XhoI 95, 96, 78, 83, 
98, 103 
AG156  
AG154 dmPurA40-185 R65A, 
R142A 
pGEX-6P-1 BamHI/XhoI 95, 96, 78, 83, 
129, 93, 100, 
106 
AG156  
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AG162 dmPurA40-185 R65A, 
S66G 
pGEX-6P-1 BamHI/XhoI 95, 96, 78, 83, 
129, 93 
AG156 C 
AG161 dmPurA40-185 R80A pGEX-6P-1 BamHI/XhoI 95, 96, 78, 83, 
131, 130 
AG156  
AG155 dmPurA40-185 R80A, 
R158A 
pGEX-6P-1 BamHI/XhoI 95, 96, 78, 83, 
98, 103, 131, 
130 
AG156  
AG111 dmPurA40-245 
 
pGEX-6P-1 BamHI/XhoI 78,79 AG104  
AG13 dmPurA40-255 
 
pGEX-6P-1 BamHI/XhoI - - d) 
AG145 dmPurA40-274 
 
pGEX-6P-1 BamHI/XhoI 78, 96 AG156  
AG129 dmPurA46-185 
 
pGEX-6P-1 BamHI/XhoI  118, 83 AG156  
AG54 hPurA1-322 
 
pGEX-6P-1 EcoRI/XhoI  - e) 
AG115 hPurA140-268 
 
pGEX-6P-1 BamHI/XhoI 85, 88 AG54  
AG103 hPurA191-259 
 
pGEX-6P-1 BamHI/XhoI 55, 53 AG54  
AG91 hPurA42-186 
 
pGEX-6P-1 BamHI/XhoI 52, 61 AG54  
AG19 hPurA56-245 
 
PETM40 BamHI/XhoI 2, 16 AG19  
AG19 hPurA56-245 
 
pGEX-6P-1 BamHI/XhoI - - d) 
AG17 hPurA56-274  
 
pET28a BamHI/XhoI 2, 18 AG9  
AG9 hPurA56-274 
 
pGEX-6P-1 BamHI/XhoI - -- d) 
AG138 hPurA56-287  
 
pGEX-6P-1 BamHI/XhoI 2, 17 AG54  
AG20 hPurA56-287 C272S 
 
PETM40 BamHI/XhoI 2, 17 AG10  
AG10 hPurA56-287 C272S 
 
pGEX-6P-1 BamHI/XhoI - - d) 
AG113 hPurA60-105 
 
pGEX-6P-1 BamHI/XhoI 1, 60 AG54  
AG114 hPurA60-202 
 
pGEX-6P-1 BamHI/XhoI 1, 87 AG54  
AG16 hPurA60-245 
 
pET28a BamHI/XhoI 1, 16 AG10  
AG6 hPurA60-245 
 
pGEX-6P-1 BamHI/XhoI - b d) 
AG4 hPurA96-287 
 
pGEX-6P-1 BamHI/XhoI - - d) 
Table 5-4. Plasmids for recombinant protein expression in E. coli. a) Obtained from U. Schulte-
Spechtle, Nationales Referenzzentrtum für Borrelien (Munich, Germany), b) obtained from K. 
Förstemann, Gene Center (Munich, Germany), c) spontanenou mutation S66G, d) obtained from 
D. Niessing, Gene Center (Munich, Germany), e) obtained from E. Johnson, Mount Sinai School 
of Medicine (New York, USA). 
 
 
5.3.3 Plasmids for baculovirus-based recombinant protein expression in insect cells 
No.  Insert Vektor Restriction sites Primer Template 
AG60 hPurA56-245 pFastBac1-GST BamHI/XhoI 2, 16 AG54 
AG61 hPurA56-287 pFastBac1-GST BamHI/XhoI 2, 17 AG54 
Table 5-5. Plasmids for baculovirus-based recombinant protein expression in insect cells. 
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5.3.4 Plasmids for in vitro RNA transcription 
Name Gene Organism Length in nt Antibiotic Source 
pBCX607 BC1 RNA rat 152 nt Amp Obtained from J. Brosius 
(University Münster, Germany) 
pBC200 BC200 RNA human 200 nt Amp Obtained from J. Brosius 
(University Münster, Germany) 
Table 5-6. Plasmids for in vitro RNA transcription. 
 
 
5.4 Bacterial strains 
Name Essential genotype Source 
XL-1 Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac  
[F’ proAB laclq ZΔM15Tn10 (Tetr)] 
Stratagene  (La Jolla, 
USA) 
BL21 Star (DE3) B F– ompT hsdS(rB- mB-) dcm+ Tetr galλ (DE3) 
EndA Hte  [argU ileY leuW Camr] 
Stratagene  (La Jolla, 
USA) 
B834 (DE3) F– ompT gal met rBmB Novagen 
(Schwalbach, 
Germany) 
DH10Bac F- mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacX74 recA1 
endA1 araD139 ∆(ara, leu)7697 galU galK λ-
rpsLnupG/bMON14272/pMON7124  
 
Invitrogen (Karlsruhe, 
Germany) 
Table 5-7. Bacterial strains. 
 
 
5.5 Media for cell culture 
Medium Composition 
Luria-Bertani 
medium  
1 % (w/v) bacto tryptone, 0.5 % (w/v) bacto yeast extract, 0.5 % (w/v) NaCl 
for  plates + 1.5 % (w/v) agar 
DH10Bac medium  
 
1 % (w/v) bacto tryptone, 0.5 % (w/v) bacto yeast extract, 0.5 % (w/v) NaCl, 1 M IPTG, 
100 µg/mL bromo-chloro-galactopyranoside (X-Gal), 7 mg/mL gentamycin, 10 mg/mL 
tetracycline, 50 mg/mL kanamycin 
for  plates + 1.5 % (w/v) agar 
SOC 
 
2 % (w/v) bacto tryptone, 0.5 % (w/v) bacto yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 
mM MgCl2, 10 mM MgSO4, pH 7.0 
Minimal medium 7.5 mM (NH4)2SO4, 8.5 mM NaCl, 55 mM KH2PO4, 100 mM K2HPO4, 1 mM MgSO4, 
20 mM glucose, 1 mg/L CaCl2, 1 mg/L FeCl2, 1 mg/L Thiamine, 1 mg/L Biotin,1 µg/L 
trace elements as follows: Cu2+, Mn2+, Zn2+, MoO42+,  100 mg/L amino acids as follows: 
L-alanine, L-arginine, L-aspartic acid, L-cysteine, L-glutamate, L-glycine, L-histidine, 
L-isoleucine, L-leucine, L-lysine, L-phenylalanine, L-proline, L-serine, L-threonine, L-
tyrosine, L-valine, L-selenomethionine 
Table 5-8. Media for cell culture. 
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5.6 Molecular biology 
5.6.1 Standard cloning and site-directed mutagenesis 
Genes of interest were cloned by standard methods as described (Sambrook and Russell, 
2001). The protocol includes amplification of the target gene by PCR, digestion of the 
PCR product with restriction enzymes, digestion of vector DNA with restriction enzymes 
and ligation of DNA fragments. DNA fragments were separated by agarose 
gelelectrophoresis and purified with the NucleoSpin-Extract II kit (Macherey-Nagel, 
Düren, Germany). Point mutations were inserted by PCR-based site-directed mutagenesis 
(Ho et al., 1989). Cloning strategies for all plasmids and the oligonucleotides employed 
are summarized above (Table 5-1 and Table 5-4). 
 
 
5.6.2 Transformation of E. coli and isolation of plasmid DNA 
Plasmid DNA was transformed in chemically competent E. coli XL-1 Blue cells as 
indicated (Hanahan, 1983; Sambrook and Russell, 2001). Isolation of plasmid DNA was 
performed with the NucleoSpin Plasmid kit (Macherey-Nagel, Düren, Germany). DNA 
sequencing was commissioned to Eurofins MWG Operon (Ebersberg, Germany). 
 
 
5.7 Protein expression 
5.7.1 Recombinant protein expression in E. coli 
Affinity-tagged Pur-α fusion proteins were recombinantly expressed in E. coli BL21 Star 
(DE3) cells. Typically, a 3 L scale of LB media was used. Media was supplemented with 
the appropriate antibiotic and cells were grown at 37 °C to an OD600 of 0.3-0.4. The 
medium was cooled to 18 °C within 1 h and then recombinant protein expression was 
induced by the addition of 0.25 mM IPTG. After 12-16 h, cells were harvested by 
centrifugation (15 min, 4000 rpm, 3500 g) at 4 °C, partitioned in 2 aliquots, flash frozen 
in liquid nitrogen, and stored at 80 °C. 
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Expression of selenomethionine-substituted protein 
L-selenomethionine-substituted protein was expressed as described (Doublie, 1997). The 
E. coli methionine auxotrophic strain B834 (DE3) was grown in minimal medium 
essentially as elaborated above. 
 
 
5.7.2 Baculovirus-based recombinant protein expression in insect cells 
The Bac-to-Bac baculovirus expression system (Anderson et al., 1996) was applied 
according to the manufacturer’s instructions (Invitrogen, Karlsruhe, Germany). The 
commercial pFastBac1 vector was modified to carry the gene for a GST-tag, yielding 
pFastBac1-GST vector (D. Niessing, Gene Center, Munich, Germany). The gene of 
interest was cloned into pFastBac1-GST and the plasmid was amplified in XL-1 Blue 
cells (section 5.6).  
For transposition, the pFastBac1-GST plasmid was transformed into DH10Bac E. coli 
cells (Anderson et al., 1996; Luckow et al., 1993) and regenerated in 1 mL SOC medium 
for 6 h. DH10Bac cells were streaked on DH10Bac medium agar plates and grown at 
37 °C for 48 h. Successful clones were identified using blue/white selection. Liquid 
cultures (5 mL LB medium with 7 mg/mL gentamycin, 10 mg/mL tetracycline, 50 
mg/mL kanamycin) were inoculated with colonies with a white phenotype. Bacmid DNA 
was isolated from 5 mL culture with a Nucleospin Plasmid kit (Macherey-Nagel, Düren, 
Germany), but using isopropanol precipitation of DNA instead of the provided columns.  
High Five insect cells (Davis et al., 1992; Wickham et al., 1992) were cultured at 27 °C 
in HyClone SF medium (Thermo Fisher Scientific, Schwerte, Germany) according to the 
provider’s instructions (Invitrogen, Karlsruhe, Germany). For transfection, 2 µg bacmid 
DNA and 3 µL FuGeneHD reagent (Roche, Basel, Switzerland) were mixed with 300 µL 
Hyclone SF medium and incubated for 45 min at room temperature. The formed complex 
was added to 2 mL of High Five cell suspension (0.25 million cells per mL). Cells were 
incubated at 27° C for 3-4 days and then inspected for signs of infection under the 
microscope. After infection, cells were centrifuged (10 min, 3000 rpm, 1000 g) and the 
supernatant (P1 virus) was stored at 4 °C. 
Virus amplification was done in 50 mL cell culture (1 million cells per mL) with the 
addition of 2 mL P1 virus. After incubation at 27 °C for 48 h, cell density was 
determined with the help of a counting chamber and the culture was diluted to 1 million 
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cells per mL. This procedure was repeated until cells stopped growing. After additional 
24 h, the cells were centrifuged (10 min, 3000 rpm, 1000 g) and the supernatant (P2 
virus) was stored at 4 °C. 
For protein expression, 1 L of cell culture (1 million cells per mL) was infected with 
100 mL of P2 virus and cultured at 27 °C for 3-4 days. The culture was diluted every day 
to 1 million cells per mL and checked for protein expression via SDS-PAGE 
(section 5.9). At the peak of protein production, cells were harvested by centrifugation 
(15 min, 3000 rpm, 1000 g) and frozen in liquid nitrogen.  
 
 
5.8 Protein purification  
5.8.1 Purification of GST-tagged proteins 
Cell pellets were thawed and resuspended in 25 mL buffer A containing 500 mM NaCl, 
50 mM HEPES pH 7.5. After the addition of ½ tablet Roche complete protease inhibitor 
and 10 mM PMSF, cells were disrupted by sonication on ice. The lysate was cleared by 
centrifugation (45 min, 15 000 rpm, 27000 g) at 4 °C. All subsequent purification steps 
were carried out at 4 °C. The lysate was loaded on a GSTrap 5 mL column equilibrated 
with buffer A. After washing with 100 mL buffer A, the fusion protein was eluted from 
the column with 5 column volumes buffer B (500 mM NaCl, 20 mM HEPES pH 8.0, 
25 mM Glutathion). Protein containing fractions were identified by their absorption at 
wavelength 280 nm (A280) and pooled. GST was cleaved off by the addition of 50 µg 
PreScission Protease (GE Healthcare, Munich) prior to dialysis against buffer C (250 mM 
NaCl, 20 mM HEPES pH 8.0) for 12 h at 4 °C. GST was subtracted using a GSTrap 
column and contaminating nucleic acids were removed by a HiTrapQ column. Pur-α was 
further purified by a Heparin column and was eluted with buffer D (2 M NaCl, 20 mM 
HEPES pH 8.0). After concentration using a centrifugal filter device (Amicon Ultra, 
Millipore, Billerica, USA), the protein was centrifuged (20 min, 13 000 rpm, 16 000 g, 
4 °C) and finally purified by size-exclusion chromatography.  
For B. burgdorferi Pur-α and D. melanogaster Pur-α repeats I-II, size-exclusion 
chromatography was performed in buffer C with a Superose 12 10/300 GL column. 
For D. melanogaster full-length protein, size-exclusion chromatography was carried out 
on a Superdex S200 16/60 column in buffer C.  
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D. melanogaster Pur-α repeats I-II double mutant (R80A, R158A) did not bind to 
Heparin column, thus flow-through from GSTrap and HiTrapQ column was directly 
subjected to size-exclusion chromatography on Superdex S200 16/60 column with buffer 
C. 
Since D. melanogaster Pur-α repeats I-III and fragments of human Pur-α were 
unstable in low salt conditions, dialysis and all further purification steps for these protein 
fragments were carried out in buffer E (500 mM NaCl, 20 mM HEPES pH 8.0). 
Selenomethionine-substituted protein was purified analogous to native protein with the 
addition of 2 mM DTT in all buffers.  
Protein fragments of human Pur-α were purified analogously, with buffer A (500 mM 
KCl, 100 mM TRIS pH 8.4), buffer B (500 mM KCl, 100 mM TRIS pH 8.4, 25 mM 
Glutathion), buffer C same as buffer A, buffer D (2 M KCl, 100 mM TRIS pH 8.4) and 
size-exclusion chromatography on a Superdex S200 16/60 column in buffer A.  
 
 
5.8.2 Purification of His-tagged proteins 
The cell pellet was resuspended in 30 mL buffer N1 containing 50 mM potassium 
phosphate buffer pH 8.0, 300 mM NaCl, 0.5 mM PMSF. Cells were disrupted by 
sonication followed by centrifugation as described (section 5.8.1). The lysate was loaded 
on a 5 mL HisTrap column pre-equillibrated with buffer N1. The column was washed 
with buffer N2 (50 mM potassium phosphate buffer pH 8.0, 2 M NaCl) until the A280 
absorption baseline appeared stable. The protein was eluted by buffer N3 (50 mM 
potassium phosphate buffer pH 8.0, 1 M NaCl, 500 mM Imidazol) with a gradient over 
10 column volumes. Protein containing fractions were identified via the A280 absorption. 
The fractions were pooled and dialyzed for 12 h against buffer N4 (50 mM potassium 
phosphate buffer pH 7.5, 200 mM NaCl, 0.5 mM EDTA, 2 mM DTT). The solution was 
loaded on a Heparin column pre-equillibrated with buffer N4 and eluted with buffer N5 
(50 mM potassium phosphate buffer pH 7.5, 2 M NaCl, 0.5 mM EDTA, 2 mM DTT). 
Finally, size-exclusion chromatography was carried out on a Superdex S200 16/60 
column in buffer N4. 
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4.8.3 Purification of MBP-tagged proteins 
Cells were resuspended in 30 mL buffer M1 containing 200 mM NaCl, 20 mM TRIS 
pH 7.4 and 1 mM EDTA. After the addition of ½ tablet Roche complete protease 
inhibitor and 10 mM PMSF, cells were disrupted and centrifuged as described 
(sesction 5.8.1). Pre-equillibrated (buffer M1) amylose resin (2 mL) was incubated with 
the lysate for 1 h while shaken gently. The resin was washed with 150 mL buffer M1 and 
loaded on a column. The protein was eluted with 10 mL buffer M2 (200 mM NaCl, 
20 mM TRIS pH 7.4, 1 mM EDTA 20 mM maltose). The solution was diluted with 
20 mL buffer M0 (20 mM TRIS pH 7.4 and 30 mM MgCl) and 100 µL RNAse A 
(10 mg/mL) as well as 5 µL DNAseI (10 U/µL) were added and incubated for 14 h.  The 
solution was passed through a HiTrapQ column and directly loaded on a Heparin column 
pre-equillibrated with buffer M1. The protein was eluted from the Heparin column with 
buffer M3 (2 M NaCl, 20 mM TRIS pH 7.4, 1 mM EDTA). The final purification step 
was carried out on a Superdex S200 16/60 column in buffer M4 containing 100 mM 
NaCl and 10 mM TRIS pH 7.4. 
 
 
5.9 Protein analysis  
Efficiency of purification steps and purity of the final sample was monitored by sodium 
doceylsulfate polyacrylamide gelelectrophoresis (SDS-PAGE) as described (Laemmli, 
1970).  Electrophoretic separation was carried out on 16-19 % polyacrylamide gels 
followed by staining with Coomassie Blue staining solution. For purified protein 
samples, absence of contaminating nucleic acids was confirmed by measuring the ratio of 
absorption at wavelengths 260 nm and 280 nm. Only samples with a ratio A260/A280 of 0.6 
or lower were used.  
 
 
5.9.1 Analytical size-exclusion chromatography 
Analytical size-exclusion chromatography was performed with a Superose 12 10/300 GL 
column standardized with a size-exclusion calibration kit (BioRad, Munich, Germany). 
The column was equilibrated with buffer E and 0.5 mL of Pur-α was loaded with a flow 
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rate of 0.9 mL/min. Peak fractions were identified by A280 and the presence of Pur-α was 
confirmed by SDS-PAGE.  
 
5.9.2 Circular dichroism spectroscopy 
To assess proper folding of the mutant proteins, Circular Dichroism (CD) spectra were 
recorded using a Jasco 810 Spectropolarimeter. Protein samples at a concentration of 
0.5 mg/mL in buffer containing 150 mM KCl and 20 mM HEPES pH 8.0 were measured 
in a 0.1-cm cuvette at 4 °C. Spectra were recorded from wavelength 190 nm to 260 nm 
with a scan speed of 200 nm per minute.  
 
 
5.10 Crystallization  
For all crystallization experiments, only freshly prepared protein samples were used and 
centrifuged before set ups (20 min, 13 000 rpm, 16 000 g, 4 °C). Initial crystallization 
conditions were screened robotically by using the crystallization facility of the Max-
Planck-Institute for Biochemistry (Martinsried, Germany). Equipment included a 
Phoenix nanodispenser robot (Art Robbins Instruments, Sunnyvale, USA) and an Xtal-
focus visualization system (Tecan, Männedorf, Switzerland and Leica, Wetzlar, 
Germany). The system used a 0.5 µL drop size and a 1:1 mixture of protein and 
crystallization solution. Refinement was done manually using hanging-drop vapor 
diffusion technique with a drop size of 2 µL and a 1:1 mixture of protein and 
crystallization solution. 
 
 
5.10.1 Crystallization and structure determination of B. burgdorferi Pur-α  
Diverse protein constructs were concentrated in buffer C (250 mM NaCl, 20 mM HEPES 
pH 8.0) and initial screening was performed with a protein solution of 3 mg/mL. Initial 
crystals appeared in various conditions. After optimization, crystals of a fragment of 
B. burgdorferi Pur-α comprising amino acids 3 to 100 were grown at 4 °C from a protein 
solution of 2.2 mg/mL and a crystallization solution containing 100 mM HEPES pH 7.2 
and 20 % PEG 3350. Cuboid crystals of approximately (200 x 100 x 30) µm size 
appeared after 2-4 days.  
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For selenomethionine-substituted protein, 1 mM DTT and 1 mM TCEP were added prior 
to crystal set up. After optimization, crystals were grown at 4 °C in 2.8 M sodium 
formate with a protein concentration of 1.2 mg/mL and the stoichiometric addition of a 
short DNA oligomer (hTel12 ssDNA), albeit the latter was not visible in the structural 
model. Cubic and spindle shaped crystals of  (100 x 50 x 50) µm size appeared within 2-5 
days. 
Prior to data collection, crystals were cryo-protected in mother liquor plus 20 % ethylene 
glycol in 3 steps and frozen in liquid nitrogen.  
Multiple wavelength anomalous dispersion (MAD) experiments were recorded at 
beamline X06SA/PXI (SLS, Villingen) and native datasets were recorded at beamline 
ID23-1 (ESRF, Grenoble). The data were integrated and scaled with the XDS program 
package (Kabsch, 1993). Matthews coefficient was calculated with MATTHEWS_COEF 
(Kantardjieff and Rupp, 2003; Matthews, 1968). Phases were obtained by SAD using 
SHELX (Sheldrick, 2008). The model was build manually from the selenomethionine-
dataset using COOT (Emsley and Cowtan, 2004). Refinement was performed with 
REFMAC (Murshudov et al., 1997; Terwilliger, 2002). The final model was analyzed 
using SFCHECK (Vaguine et al., 1999).  
 
 
5.10.2 Crystallization and structure determination of D. melanogaster Pur-α  
repeats I-II 
Diverse protein constructs were concentrated in buffer C (250 mM NaCl, 20 mM HEPES 
pH 8.0) and initial screening was performed with protein solutions of 1-5 mg/mL, 
yielding initial crystals in various conditions. After optimization, crystals of a fragment 
of D. melanogaster Pur-α comprising amino acids 40 to 185 were grown at 21 °C with a 
protein solution of 3-5 mg/mL. The crystallization solution contained 50 mM MES 
pH 5.9, 200 mM MgCl2, and 25 % PEG 3350. Cuboid crystals of approximately 
(100 x 50 x 50) µm size appeared within 2-4 days. For the selenomethionine-derivatized 
protein, 1 mM DTT and 1 mM TCEP were added to the protein solution. After 
optimization, crystals of selenomethionine-derivatized D. melanogaster Pur-α 40-185 
were grown at a concentration of 2.7 mg/mL. The crystallization solution contained 
200 mM MgCl2, 100 mM HEPES pH 7.8, and 22 % PEG 3350. The crystals had a cuboid 
shape and a size of approximately (150 x 50 x 50) µm.  
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For cryo-protection, native crystals were shortly incubated in reservoir solution 
containing 20% glycerol in 2 steps. Selenomethionine-derivatized crystals were shortly 
incubated in reservoir solution containing 20% ethylene glycol in 2 steps. Then crystals 
were frozen in liquid nitrogen.  
Multiple wavelength anomalous dispersion (MAD) experiments were performed at 
beamline ID14-4 (ESRF, Grenoble) and native datasets were collected at beamline ID14-
1 (ESRF, Grenoble). The data were integrated and scaled with the XDS program package 
(Kabsch, 1993). Phases were obtained with Crank (Crunch2/BP3/Solomon) 
(Collaborative Computational Project, 1994; Ness et al., 2004), and extended to 2.1 Å 
resolution. Parts of the final model were build automatically with Buccaneer (Cowtan, 
2006). The final model was build from the native dataset and manually completed using 
COOT (Emsley and Cowtan, 2004). Refinement was performed with REFMAC 
(Murshudov et al., 1997; Terwilliger, 2002). The final model was analyzed using 
SFCHECK (Vaguine et al., 1999).  
 
 
5.10.3 Crystallization of D. melanogaster Pur-α  repeat III 
Several protein fragments were concentrated in buffer C (250 mM NaCl, 20 mM HEPES 
pH 8.0) and initial screening was performed with protein solutions of 3.0-5.7 mg/mL. 
Initial crystals were obtained in several conditions. After optimization, crystals of a 
fragment of D. melanogaster Pur-α comprising amino acids 188 to 258 were grown at a 
concentrations of 0.3 mg/mL at 4 °C. The crystallization solution contained 22 % PEG 
3350, 100 mM sodium cacodylate pH 7.5 and 200 mM sodium acetate. After 1-2 day, 
needle-shaped crystals appeared. After 2-3 weeks, additional pentagonal and hexagonal 
crystal plates of (100 x 50 x 50)µm size appeared. This crystal form had improved 
diffraction properties and individual crystals diffracted up to 2.8 Å. 
 
 
5.10.4 Co-crystallization with nucleic acids 
A fragment of D. melanogaster Pur-α comprising amino acids 40 to 185 was mixed with 
Cy3-CGG 7mer DNA in a ratio 1:2 in buffer C (250 mM NaCl, 20 mM HEPES pH 8.0). 
After incubation on ice for 30 min, size-exclusion chromatography was performed in 
buffer C using a S12 10/300 GL column. The co-elution of protein and DNA was 
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confirmed by absorption spectra as well as SDS-PAGE. The complex was concentrated 
and initial screens were set up with solution of approximately 3.6 mg/mL. Initial crystals 
were obtained in a few and related conditions.  
After preliminary optimization, crystals diffracted up to 15 Å. Crystals of approximately 
(20 x 20 x 40) µm size were grown at 4 °C at a concentration of 3.1 mg/mL in 0.05 MES 
pH 6.5 and 30 % MPD or 28 % PEG 400, resp. Rice grain shaped crystals appeared after 
2-4 days. 
Initial crystallization trials with Cy3-CGG 7mer RNA (3.3 mg/mL) yielded no crystals.  
 
 
5.11 Limited proteolysis 
Protein samples in buffer containing 125 mM NaCl and 100 mM TRIS pH 8.0 were 
supplied with protease (trypsin or chymotrypsin) in a ratio of 50:1 (w/w) and incubated at 
room temperature or on ice. Probes of 15 µL were taken at time points 0 s, 30 s, 1 min, 
2 min, 5 min, 10 min, 30 min, 60 min, 90 min and the reaction stopped by the addition of 
5 µL SDS-gel loading dye. Samples were resolved by SDS-PAGE, defined bands were 
cut out, blotted on a PVFD membrane (Immobilon P, Millipore, Billerica, USA) via 
passive absorption and subjected to Edman sequenzing (Messer et al., 1997).  
 
 
5.12 Lysine methylation 
Reductive methylation of lysine residues was performed as described (Walter et al., 
2006).  Freshly prepared 1 M dimethylborane complex (ABC) and 1 M formaldehyde 
was cooled on ice. 20 µL of 1 M ABC and 40 µL 1 M formaldehyde were added to 1 mL 
protein solution (1 mg/mL) in buffer containing 50 mM HEPES pH 7.5 and 250 mM 
NaCl. After incubation at 4 °C for 1.5 h, additional 20 µL of 1 M ABC and 40 µL 1 M 
formaldehyde were added and the reaction was carried out 14 h at 4 °C. Then, 100 µL 
1 M ammonium sulfate were added followed by size-exclusion chromatography on a 
Superdex S200 16/60 column in buffer containing 20 mM TRIS pH 7.5, 200 mM NaCl, 
and 1 mM DTT.  
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5.13 Heavy atom derivatization by soaking  
Solutions of heavy atom salts with a concentration of 10 mM, 5 mM and 1 mM were 
prepared. 0.1 µL of the respective solution was added to the crystallization drop and 
incubated for 10 min, 30 min, 1 h and 12 h.  
Heavy atom salts tested for crystals of a fragment of B. burgdorferi Pur-α comprising 
amino acids 3 to 100 included K2PtCl4, K2Pt(CN)4, (NH4)2PtCl4, K2PtCl6, and K2PtI6. 
For crystals of a fragment of D. melanogaster Pur-α comprising amino acids 40 to 185, 
additionally 5-Amino-2,4,6-triiodoisophtahalic acid (JBS Magic Triangle) and 
Hexatantalum tetradecabromide (JBS Tantalum Cluster) were tested (Beck et al., 2008; 
Knablein et al., 1997) (Jena Bioscience, Jena, Germany). 
 
 
5.14 DNA soaking experiments 
Crystals of a fragment of B. burgdorferi Pur-α comprising amino acids 3 to 100 were 
grown as described (section 5.10.1). DNA oligonucleotides Bromo-hTel12 DNA, hTel6 
DNA or JCVupTar DNA (Table 5-2) were added to the crystallization drop to a final 
concentration of 0.3-0.8 µg/mL. Crystals were incubated for 1 or 2 days before they were 
cryo-protected and frozen in liquid nitrogen. 
Crystals of D. melanogaster Pur-α repeats I-II were grown as described (section 5.10.2). 
In a hanging-drop vapor diffusion chamber, a drop of mother liquor with the addition of 
1.95 µg/µL CGG7mer DNA was prepared and equilibrated against the reservoir for 1 h. 
Crystals were transferred to the soaking solution and incubated for 2 h. 3 h, and 12 h. 
Crystals were tranferred, shortly incubated in 20 % glycerol and flash frozen in liquid 
nitrogen.  
 
 
5.15 Small angle X-ray scattering  
Small angle X-ray scattering (SAXS) data were collected at the ID14-3 beamline (ESRF, 
Grenoble, France) and the X33 beamline (EMBL/DESY, Hamburg, Germany). Scattering 
curves were measured in 20 mM HEPES pH 8.0, 500 mM NaCl, and 3 mM DTT with 
exposure times of 2 min (X-33) and ten times 30 seconds (ID14-3), respectively. Protein 
concentration was 0.9-4.55 mg/mL. Before and after each measurement, a blank 
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measurement with sample buffer was taken. Primary analysis of the data was done with 
PRIMUS (Konarev et al., 2003) and data evaluation and processing was performed using 
the ATSAS program package (Konarev et al., 2006). The averaged blank measurements 
were subtracted from the scattering curves. The measurements were scaled to their 
respective protein concentration and merged in one dataset. The Kratky plot was used to 
inspect correct folding of the protein sample. For molecular-mass determination, 
scattering intensities were extrapolated to zero angle (I0), using bovine serum albumine 
and lysozyme as references. The Guinier approximation was used with the constraint 
s*Rg < 1.3 to calculate the radius of gyration Rg (Guinier and Fournet, 1955). The 
maximum dimension of the particle Dmax was iteratively determined by evaluating the 
resulting Rg value and the shape of the pair-distribution function P(r) using GNOM 
(Svergun, 1992). Ab initio models were calculated with GASBORp (Svergun et al., 2001) 
assuming P2 symmetry for Pur-α repeats I-III and P1 symmetry for Pur-α repeats I-II. In 
each case, 10 bead models were averaged using DAMAVER (Volkov and Svergun, 
2003). For Pur-α repeats I-II, the final bead model was overlaid with the crystal structure 
using SUPCOMB (Kozin and Svergun, 2000). CRYSOL (Svergun et al., 1995) was used 
to determine the theoretical scattering curve based on the Pur-α repeats I-II crystal 
structure. 
 
 
5.16 Nucleic-acid binding assays 
5.16.1 In vitro transcription of RNA 
All RNA experiments were carried out in buffers made from RNAse free water and using 
RNAse free chemicals and equipment. RNAse free water was produced by adding 0.05 % 
diethylpyrocarbonate (DEPC) to Millipore-purified water and incubating for 8-12 h at 
38 °C, then autoclaving for 20 min at 121 °C.  
In vitro transcription was performed with the MEGAshortscript T7 Kit (Ambion, Austin, 
USA) according to the manufacturer’s instruction. Plasmid DNA was linearized with 
DraI and purified by ammonium acetate/ethanol precipitation. In a 20 µL standard 
reaction, 2 pmol of template DNA were used. The transcription reaction was carried out 
at 37 °C for 3-4 h. Then, 1 U of calf intestine alkaline phosphatase (CIAP) was added and 
incubated for additional 30 min. The template was digested by the addition of 2 U Turbo 
DNAse (Ambion, Austin, USA) prior to purification by native polyacrylamide 
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electrophoresis (PAGE). Electrophoresis was carried out at room temperature at 80 V 
using a 5 %-gel and 1 x TBE running buffer (90 mM TRIS pH 8.3, 90 mM boric acid, 
2 mM EDTA). RNA was visualized by UV shadowing and then extracted from the gel by 
crush & soak technique. The band was cut into small pieces and incubated with 400 µL 
crush & soak solution (0.3 M NaCl, 0.5 mM EDTA) for 12 h at 37 °C. The probe was 
filtered through an Ultrafree MC centrifugal filter device (Ambion, Austin, USA). RNA 
was concentrated and buffer was exchanged using a Ultrafree-0.5 centrifugal filter device 
(Millipore, Billerica, US). Concentration was determined by the absorption at wavelength 
260 nm (A260). Sample integrity was confirmed by analytical native PAGE. 
 
 
5.16.2 Isotopic labeling of oligonucleotides 
DNA and RNA oligonucleotides were radioactively labeled at their 5’-ends using γ-32P-
ATP and T4 Polynucleotide Kinase (PNK) following the manufacturer’s protocol 
(Fermentas, St. Leon-Rot, Germany). 5 pmol of the oligonucleotide were incubated with 
30 µCi γ-32P-ATP, 10 units PNK and the supplied buffer A for 45 min at 37 °C. The 
reaction was stopped by incubation at 70 °C for 10 min. RNA oligonucleotides were 
purified by a Sephadex G-25 Quick Spin column (Roche, Basel, Switzerland). DNA 
oligonucleotides were purified with the Qiaquick Nucleotide Removal Kit (Qiagen, 
Hilden, Germany). Radiolabelled oligonucleotides were stored at -20 °C for up to 
1 week. 
 
 
5.16.3 Filter binding assays 
Nitrocellulose filter binding assays were performed essentially as described (Wong and 
Lohman, 1993). The protein was transferred into binding buffer (100 mM NaCl, 10 mM 
HEPES pH 8.0, 2.5 mM MgCl2, 1 mM DTT) and serial protein dilutions (0-10 µM) were 
incubated with a constant amount of radioactively labeled oligonucleotide (0.5 nM) for 
20 min at room temperature. A nitrocellulose filter (Optitran BA-S85 reinforced NC, 
Whatman/GE Healthcare, Munich, Germany) was activated by incubating in 0.4 M KOH 
for 10 min followed by washing 8 times with 200 mL water. The nitrocellulose filter and 
a nylon membrane (Roti-Nylon Plus, Roth, Karlsruhe, Germany) were equilibrated in 
binding buffer for 1 h. A Bio-Dot microfiltration apparatus (BioRad, Munich, Germany) 
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was equipped with both membranes and each well was washed with 50 µL binding 
buffer. 75 µL of each binding reaction were applied on the membranes, followed by 
washing with 75 µL binding buffer. A phosphor imager system was used to measure the 
retained radioactively labeled oligonucleotides on the nictrocellulose filter.  The storage 
phosphor screen (GE Healthcare, Munich, Germany) was exposed to the filter for 1-1.5 h 
before read out on a Storm Scanner (Molecular Dynamics, Sunnyvale, USA). 
KaleidaGraph (Synergy software, Reading, USA) was used to plot of the fraction of 
bound oligonucleotide versus the protein concentration. The equilibrium-dissociation 
constant KD was derived from the Langmuir isotherm (Smith, 1998).  
 
 
5.16.4 Electrophoretic mobility shift assays  
Electrophoretic mobility shift assays (EMSAs) were essentially performed as previously 
described (Sambrook and Russell, 2001). Protein was transferred to DEPC-treated 
binding buffer (50 mM Tris-HCl pH 7.4, 150 mM KCl, 1 mM EDTA, 1 mM MgCl2, and 
1 mM DTT) and monitored for proper folding by size-exclusion chromatography. Serial 
protein dilutions and a constant amount of radiolabeled DNA respective RNA oligomer 
(2.5 nM) were incubated in binding buffer on ice for 20 min. DNA-binding experiments 
always contained 25 µg/ml PolydI/PolydC competitor, and RNA-binding experiments 
always contained 25 µg/ml yeast tRNA as well as 200 U/mL RiboLock RNase inhibitor 
(Fermentas). Reaction mixtures (15 µl) were loaded onto 6 % TBE polyacrylamide gels 
and analyzed after electrophoresis (35 minutes, 110 V) by a phosphor imaging system 
(section 6.16.3). 
Assessment of RNA quadruplex binding was performed on 6 % TBE polyacrylamide 
gels with the addition of 20 mM KCl or LiCl, respectively. The protein was transferred in 
buffer containing 50 mM Tris-HCl pH 7.4, 1 mM EDTA, 1 mM MgCl2, 1 mM DTT and 
150 mM KCl or 150 mM LiCl, respectively. CGG 25mer RNA was transferred to the 
respective buffer and heated for 10 min at 65° C, then slowly cooled to room 
temperature. A constant amount of RNA (0.5 nM) was incubated with serial protein 
dilutions in the respective binding buffer. Binding reactions contained 25 µg/ml yeast 
tRNA as well as 200 U/mL RiboLock RNase inhibitor (Fermentas). The cationic 
porphyrin 5,10,15,20-tetra(N-methyl-4-pyridyl)porphin (TMPyP4) was added to a 
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concentraion of 5 nM and incubated in the dark. Binding reactions were incubated on ice 
for 20 min before resolved in the dark.  
 
 
5.17 Bioinformatics 
5.17.1 Protein parameters 
The ExPaSy Proteomics Server (http://www.expasy.ch) provided tools for physical and 
chemical parameter calculation of the recombinant proteins. ProtParam (Wilkins et al., 
1999) was used to determine the isoelectric point, molecular weight and extinction 
coefficient of the protein fragments. 
 
 
5.17.2 Sequence alignment and secondary structure prediction 
DNA and protein sequences were obtained from the NCBI database (Benson et al., 1994) 
(http://www.ncbi.nlm.nih.gov). Homology searches were accomplished by the BLAST 
server (Altschul et al., 1997) (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Sequence 
alignment and scoring was done with BLASTp (protein-protein BLAST). Multiple 
sequence alignment was done with ClustalW, (Larkin et al., 2007) 
(http://www.ebi.ac.uk/Tools/ clustalw2/index.html) and visualized using Jalview 
(Waterhouse et al., 2009). Repeat detection in metazoan Pur-α was done by J. Söding 
(Gene Center, Munich, Germany) using the HHRepID server (Biegert and Söding, 2008) 
(http://toolkit.tuebingen.mpg.de/hhrepid). 
Secondary structure prediction was performed with the Network Protein Sequence 
Analysis server from the Pole Bioinformatique Lyonnais using the consensus prediction 
option combining the programs DSC, MLRC, and PHD (Combet et al., 2000) 
(http://npsa-pbil.ibcp.fr/cgi- bin/npsa_automat.pl?page=/NPSA/npsa_server.html).  
The computational model of D. melanogaster Pur-α was accomplished by J. Söding 
(Gene Center, Munich, Germany), using the Structural Prediction Server HHpred 
(Söding, 2005; Söding et al., 2005) (http://toolkit.tuebingen.mpg.de/hhpred). 
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5.17.3 Structure visualization and analysis 
Images of the crystal structures were prepared with PyMol (DeLano Scientific, San 
Carlos, USA). Electrostatic surface potentials were calculated and represented with 
CCP4mg, and buried surface areas were calculated by Areaimol (Collaborative 
Computational Project, 1994). Sequence alignments was performed using T-coffee 
(Notredame et al., 2000) and a surface plot of sequence conservation was prepared with 
Chimera (Pettersen et al., 2004) Systematic structural comparison was accomplished 
using the DaliLite server (Holm et al., 2008) (http://ekhidna.biocenter. 
helsinki.fi/dali_server/). 
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Chapter 7 Appendix 
7.1 Computational model of D. melanogaster Pur-α  
 
Appendix 7-1. Computational model for D. melanogaster Pur-α . The model was build by J. Soeding 
using the program HHpred (Söding et al., 2005). The N-terminus is depicted in blue, the C-terminus is 
shown in red. Amino acids that were used for expression construct design are highlighted in black.  
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7.2 Sequence alignment and secondary structure prediction 
 
Appendix 7-2.  Amino acid sequence alignment and secondary structure prediction for different Pur-α  
orthologs. The alingment was done with T-Coffee (Notredame et al., 2000). D.m. refers to 
D. melanogaster, C.e. to Caernohabditis elegans, A.t. to Arabidopsis thaliana. Color-coding from blue to 
red reflects the range of sequence conservation from 0-100 %. Asteriks indicates complete 
conservation, colon means high conservation and point reflects moderate conservation. The crystal 
structure of D. melanogaster Pur-α  repeats I-II and the sequence alignment provided the basis for the 
secondary structure assignment for PUR repeat III and the ortholog Pur-α  proteins. 
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7.4 Abbreviations 
°C degree Celsius 
A, Å alanine, adenine, Ångström 
A280, A260 absorption at wavelengh 260 nm/ 280 nm 
Amp ampicillin 
ATP Adenosine triphosphate 
bb, B. burgdorferi Borrelia burgdorferi 
C Cysteine, cytosine 
CD circular dichroism 
Ci Curie 
D aspartic acid 
Da Dalton 
deg degree 
dm, D. melanogaster Drosophila melanogaster 
DNA desoxyribonucleic acid 
ds double stranded 
E glutamic acid 
E. coli Escherichia coli 
EDTA ethylenediaminetetraacetic acid 
EMSA electrophoretic mobility shift assay 
F phenylalanine 
for  forward 
g gram, standard accelaration  
G guanine 
Gen gentamycin 
GST glutatione S-transferase 
h hour, human 
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
I isoleucine 
K lysine 
k kilo 
Kan kanamycin 
KIF kinesin superfamily protein 
L Liter, leucine 
M mol per Liter, methionine 
m milli, meter 
MBP maltose binding protein 
MES 2-(N-morpholino)ethanesulfonic acid 
min minute 
MPD 3-Methyl-1,5pentadiol 
P proline 
PAGE polyacrylamide gel electrophoresis 
PEG poly ethlylene glycol 
PMSF phenylmethanesulphonylfluoride 
PVFD polyvinylidene fluoride 
R arginine 
rev reversed 
RNA, mRNA (messanger) ribonucleic acid 
RNP ribonucleoprotein particle 
rpm runs per minute 
s second 
S serine 
SAXS small angle X-ray scattering 
SDS sodium docecyl sulfate 
ss single stranded 
TRIS tris(hydroxymethyl)aminomethane 
Y tyrosine 
µ Micro 
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